<SEC-DOCUMENT>0000719135-23-000033.txt : 20230623
<SEC-HEADER>0000719135-23-000033.hdr.sgml : 20230623
<ACCEPTANCE-DATETIME>20230623091517
ACCESSION NUMBER:		0000719135-23-000033
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230623
DATE AS OF CHANGE:		20230623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apyx Medical Corp
		CENTRAL INDEX KEY:			0000719135
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				112644611
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31885
		FILM NUMBER:		231035046

	BUSINESS ADDRESS:	
		STREET 1:		5115 ULMERTON ROAD
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33760
		BUSINESS PHONE:		7273842323

	MAIL ADDRESS:	
		STREET 1:		5115 ULMERTON ROAD
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33760

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL Corp
		DATE OF NAME CHANGE:	20150319

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL CORP
		DATE OF NAME CHANGE:	19990216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AN CON GENETICS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>apyx-20230623.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:e38f332b-9dfc-486a-b074-c289a1ce0624,g:7252654b-46b8-4048-a632-839de6142bed,d:300043246b3a40c4967f3225093a1c39--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:apyx="http://apyxmedical.com/20230623" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>apyx-20230623</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="dei:EntityCentralIndexKey" id="f-2">0000719135</ix:nonNumeric><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-3">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="dei:DocumentType" id="f-4">DEF 14A</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="apyx-20230623.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b33c751ae2451aa979b7ec2838c3b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae6b475b9fd4b3ebfd38c5450726124_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f583035c6374528bb077736a326ab0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i365563ab8b2d4214b41460b9949f4e59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088317b3378249d1a227d77e70f4c9f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id021d1f1ba5d4ba08840bdc58f968874_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890ae3f400774879b3cda2ffd442021e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d5feed1f0be46b6bfc8ec725d826f7f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84712a841c224c4c90bd386bfd1602be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34bf3b715e8a4b3a9e44d05eebbacc21_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i387182a6d0444587a7fc93b9968a7e66_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id680e224e4af4fc6bcd722914d82eb3d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibea22881fac2490ba82e70a11d0f6191_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2d9111611954d77989482ba0f21e03a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fe9dbce7c7748a3bf1fd7f44b0db31d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f94684f847340ac9403da4875607a2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icde9e9acbfab427ebad602f8ae2a2854_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6b52cc5a3ec34719943c2826b7c63e71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="i300043246b3a40c4967f3225093a1c39_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">SCHEDULE 14A</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#253;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed by a party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Check the appropriate box:</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule 14a&#8211;6(e)(2))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#253;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Material Pursuant to Section 240.14a-12</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:114pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="apyx-20230623_g1.jpg" alt="apyxmedicallogotagline.jpg" style="height:145px;margin-bottom:5pt;vertical-align:text-bottom;width:223px"/></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="dei:EntityRegistrantName" id="f-1">APYX MEDICAL CORPORATION</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">N/A</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of filing fee (Check the appropriate box):</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#253;<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">o<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials.</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.187%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_4"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APYX MEDICAL CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5115 Ulmerton Road </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clearwater, Florida 33760 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF 2023 ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholders:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On behalf of the Board of Directors (the &#8220;Board&#8221;) of Apyx Medical Corporation (the &#8220;Company&#8221;), you are cordially invited to attend the 2023 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) to be held on August&#160;10, 2023 at 9:00 a.m. Eastern Standard Time at the offices of Ruskin Moscou, Faltischek, P.C. located at 1425 RXR Plaza, East Tower, 15th Floor, Uniondale, New York 11556, Telephone No. (516) 663-6600.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Information Concerning Solicitation and Voting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board is soliciting proxies for the Annual Meeting to be held </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on August&#160;10, 2023. This Proxy Statement contains information for you to consider when deciding how to vote on the matters brought before the An</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting materials, which include the Proxy Statement, Proxy Card and the Annual Report on Form 10-K for the year ended December 31, 2022, are being mailed to stockholders on or about June 30, 2023. The executive office of our Company is located at 5115 Ulmerton Road, Clearwater, Florida 33760, telephone number (727) 384-2323.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At the Annual Meeting, the Company&#8217;s stockholders will be asked to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10.5pt">Elect eight (8) directors to the Board to serve until the 2024 Annual Meeting of Stockholders (the &#8220;Director Proposal&#8221;);</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10.5pt">Ratify RSM US LLP as the independent registered public accounting firm for the Company for the fiscal year ending December&#160;31, 2023 (the &#8220;Auditor Proposal&#8221;);</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.75pt">Approve the Company&#8217;s 2023 Share Incentive Plan (the &#8220;Incentive Plan Proposal&#8221;); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10.5pt">Transact such other business that may properly come before the meeting.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders are referred to the Proxy Statement accompanying this notice for more detailed information with respect to the matters to be considered at the Annual Meeting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">After careful consideration, the Board unanimously recommends that you vote &#8220;FOR&#8221; the Board&#8217;s nominees for directors (Proposal 1); &#8220;FOR&#8221; the Auditor Proposal (Proposal 2); &#8220;FOR&#8221; the Incentive Plan Proposal (Proposal 3); and, in the proxy holder&#8217;s best judgment, as to any other matters that may properly come before the Annual Meeting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stockholders are invited to attend the Annual Meeting. The close of business on June 22, 2023 is the record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting. Consequently, only stockholders whose names appear on our books as owning our common stock at the close of business on June 22, 2023 will be entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">YOUR VOTE AND PARTICIPATION IN THE COMPANY&#8217;S AFFAIRS ARE IMPORTANT.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If your shares are registered in your name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, even if you plan to attend the Annual Meeting or any adjournment or postponement of the Annual Meeting in person, we request that you vote by telephone, over the Internet, or complete, sign and mail your proxy card to ensure that your shares will be represented at the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If your shares are held in the name of a broker, bank or other nominee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and you receive notice of the Annual Meeting through your broker, bank or other nominee, please vote or complete and return the materials in accordance with the instructions provided to you by such broker, bank or other nominee or contact your broker, bank or other nominee directly in order to obtain a proxy issued to you by your nominee holder to attend the Annual Meeting and vote in person. Failure to do so may result in your shares not being eligible to be voted by proxy at the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Proxy Statement contains important information concerning the Annual Meeting, including information as to how to cast your vote. We encourage you to read the accompanying Proxy Statement and other annexes to the Proxy Statement carefully and in their entirety.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="margin-bottom:13pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Your vote is important to us. Please complete, sign, date and promptly return the proxy card in the enclosed envelope, so that your shares will be represented whether or not you attend the Annual Meeting. Returning a proxy card will not deprive you of your right to attend the Annual Meeting and vote your shares in person.</span></div><div style="margin-bottom:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING TO BE HELD HELD AUGUST 10, 2023:</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">THIS NOTICE OF ANNUAL MEETING, PROXY STATEMENT, PROXY CARD AND ANNUAL REPORT ON FORM 10-K FOR THE PERIOD ENDING DECEMBER 31, 2022 ARE AVAILABLE IN THE INVESTOR RELATIONS SECTION OF OUR WEBSITE AT www.apyxmedical.com.</span></td></tr></table></div><div style="margin-bottom:6pt;padding-right:-4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:63.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.195%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">By order of the Board of Directors</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: June 23, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Andrew Makrides</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Makrides</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities regulatory agency has passed upon the adequacy or accuracy of the accompanying Proxy Statement. Any representation to the contrary is a criminal offense.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Proxy Statement is dated June 23, 2023, and is first being mailed to stockholders on or about June 30, 2023.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APYX MEDICAL CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5115 Ulmerton Road</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clearwater, Florida 33760</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">INFORMATION CONCERNING SOLICITATION AND VOTING</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Board of Directors (the &#8220;Board&#8221;) of Apyx Medical Corpo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ration (the &#8220;Company&#8221;) is soliciting proxies for the 2023 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) to be held at 9:00 a.m. Eastern Standard Time on August 10, 2023 at the offices of Ruskin, Moscou, Faltischek, P.C., located at 1425 RXR Plaza, East Tower, 15th Floor, Uniondale, New York 11556, Telephone No. (516) 663-6600.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting materials, which include the Proxy Statement, Proxy Card and our Annual Report on Form 10-K for the year ended December 31, 2022 (the &#8220;Annual Report&#8221;), are being mailed to stockholders on or about June 30, 2023. Our executive office is located at 5115 Ulmerton Road, Clearwater, Florida 33760.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will bear the expense of soliciting proxies. These expenses will include the preparation and mailing of proxy materials for the Annual Meeting. We estimate that the cost of solicitation of proxies will be approximately $50,000 to be incurred solely by us. We will reimburse banks, brokers and other custodians, nominees and fiduciaries for reasonable charges and expenses incurred in forwarding soliciting materials to their clients. We may conduct further solicitation personally or telephonically through our directors, officers, and employees, none of whom will receive additional compensation for assisting with the solicitation. We have retained the services of Laurel Hill Advisory Group, LLC (&#8220;Laurel Hill&#8221;), 2 Robbins Lane #201, Jericho, NY 11753, to assist in the solicitation of proxies at the cost of approximately $7,000, plus reimbursement of certain expenses. Stockholders may call Laurel Hill at (888) 742-1305 for assistance with voting.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following questions and answers are intended to briefly address commonly asked questions as they pertain to the Annual Meeting. These questions and answers may not address all questions that may be important to you as a stockholder. Please refer to the more detailed information contained elsewhere in this Proxy Statement and the annexes to this Proxy Statement, each of which you should read carefully.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IS A PROXY?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A proxy is another person that you legally designate to vote your stock. If you designate someone as your proxy in a written document, that document is also called a &#8220;proxy&#8221; or a &#8220;proxy card.&#8221; If you are a street name holder, you must obtain a proxy from your broker, bank or other nominee in order to vote your shares in person at the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IS A PROXY STATEMENT?</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A proxy statement is a document that regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) require that we give to you when we ask you to sign a proxy card to vote your stock at the Annual Meeting.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHO IS SOLICITING YOUR VOTE?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board is soliciting your vote for the 2023 Annual Meeting being held at 9:00 a.m. Eastern Standard Time on August&#160;10, 2023, at the offices of Ruskin, Moscou, Faltischek, P.C., located at 1425 RXR Plaza, East Tower, 15th Floor, Uniondale, New York 11556.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT WILL YOU BE VOTING ON?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1) Election of eight (8) directors to the Board (the &#8220;Director Proposal&#8221;); (2) Ratification of RSM US LLP, as the Company&#8217;s auditors for the fiscal year ending December&#160;31, 2023 (the &#8220;Auditor Proposal&#8221;); (3) Approval of the Company&#8217;s 2023 Share Inventive Plan  (the &#8220;Incentive Plan Proposal&#8221;); and (4) any other matters which may properly come before the meeting.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IS THE RECORD DATE AND WHAT DOES IT MEAN?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The record date to determine the stockholders entitled to notice of and to vote at the Annual Meeting is the close of business on June 22, 2023 (th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e &#8220;Record Date&#8221;). The Record Date was established by the Board as required by Delaware law. On the Record Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 34,613,517 shares of common stock were issued and outstanding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">HOW MANY VOTES DO STOCKHOLDERS HAVE?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of common stock at the close of business on the Record Date may vote at the Annual Meeting. You will have one vote for every share of common stock you owned of record on the Record Date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no cumulative voting.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">HOW MANY VOTES MUST BE PRESENT TO HOLD THE MEETING?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of the outstanding shares of common stock entitled to vote represented in person or by proxy at the Annual Meeting constitute a quorum. Abstentions and broker non-votes will count for purposes of determining whether a quorum exists, but not for voting purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">HOW MAY I VOTE MY SHARES?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can vote either in person at the Annual Meeting or by proxy without attending the Annual Meeting. We urge you to vote by proxy even if you plan to attend the Annual Meeting so that we will know as soon as possible that enough votes will be present for us to hold the meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">How may I vote my shares in person at the meeting?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If your shares are registered directly in your name with our transfer agent, Manhattan Transfer Registrar Co., on the Record Date, you are considered, with respect to those shares, the stockholder of record, and the proxy materials and proxy card are being sent directly to you by the Company. As the stockholder of record, you have the right to vote in person at the Annual Meeting. If your shares are held in a brokerage account or by another nominee, you are considered the beneficial owner of shares held in street name, and the proxy materials are being forwarded to you together with a voting instruction card. As the beneficial owner, you are also invited to attend the Annual Meeting. Since you are a beneficial owner and not the stockholder of record, you may not vote these shares in person at the Annual Meeting unless you obtain a &#8220;legal proxy&#8221; from the broker, trustee or nominee that holds your shares in its name, giving you the right to vote the shares at the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">How can I vote my shares without attending the meeting?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whether you hold shares directly as a registered stockholder of record or beneficially in street name, you may vote without attending the Annual Meeting. You may vote by granting a proxy or, for shares held in street name, by submitting voting instructions to your broker or nominee. In most cases, you will be able to do this by telephone, by using the Internet or by mail. Please refer to the summary instructions included with proxy materials and on your proxy card. For shares held in street name, the voting instruction card will be included in the materials forwarded by the broker or nominee. If you have telephone or Internet access, you may submit your proxy by following the instructions with your proxy materials and on your proxy card. You may submit your proxy by mail by signing your proxy card or, for shares held in street name, by following the voting instructions with your proxy materials and on your proxy card. You may submit your proxy by mail by signing your proxy card or, for shares held in street name, by following the voting instruction card included in the materials forwarded by your stockbroker or nominee and mailing it in the enclosed, postage paid envelope. If you provide specific voting instructions, your shares will be voted as you have instructed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT ARE THE BOARD&#8217;S RECOMMENDATIONS ON HOW I SHOULD VOTE MY SHARES?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board unanimously recommends that you vote your shares as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> each of the Board&#8217;s nominees for directors;</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Auditor Proposal; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Incentive Plan Proposal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IF I DO NOT SPECIFY HOW I WANT MY SHARES VOTED?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a record holder who returns a completed proxy card that does not specify how you want to vote your shares on one or more proposals, the designated proxies will vote your shares for each proposal as to which you provide no voting instructions, and such shares will be voted in the following manner:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> each of the Board&#8217;s nominees for directors;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Auditor Proposal; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Incentive Plan Proposal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a &#8220;street name&#8221; holder and do not provide voting instructions on one or more proposals, your bank, broker or other nominee may be able to vote those shares. See &#8220;What are broker non-votes?&#8221; below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT ARE &#8220;BROKER NON-VOTES&#8221;?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broker non-votes occur when a beneficial owner of shares held in &#8220;street name&#8221; does not give instructions to the broker or nominee holding the shares as to how to vote on matters deemed &#8220;non-routine.&#8221; Generally, if shares are held in street name, the beneficial owner of the shares is entitled to give voting instructions to the broker or nominee holding the shares. If the beneficial owner does not provide voting instructions, the broker or nominee can still vote the shares with respect to matters that are considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters. Under the rules and interpretations of the NASDAQ Stock Market LLC (&#8220;NASDAQ&#8221;), &#8220;non-routine&#8221; matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, election of directors (even if not consented) and executive compensation. The Director Proposal is considered a &#8220;non-routine&#8221; matter. Therefore, if you do not provide voting instructions to your broker regarding the Director Proposal, your broker will not be permitted to exercise voting authority to vote your shares on such proposals and will result in a broker non-vote.</span></div><div style="margin-bottom:7pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For Proposal 1, each of the eight (8) nominees for director receiving a majority of the votes cast by stockholders present in person or represented by proxy and entitled to vote at the Annual Meeting will be elected (A majority of votes cast means that the number of votes cast &#8220;for&#8221; a director must exceed the number of votes cast &#8220;against&#8221; that director). A proxy marked &#8220;withhold&#8221; or &#8220;abstain&#8221; with respect to the election of a director will not be voted as to the director indicated and will have the effect of a vote against the proposal, but will be counted for purposes of determining whether there is a quorum. Broker non-votes will not affect the outcome of the vote on this matter.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For Proposal 2, the affirmative vote of the majority of the votes cast by stockholders at the Annual Meeting by the holders of shares entitled to vote thereon is required to approve the ratification of the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For Proposal 3, the affirmative vote of the majority of the votes cast by stockholders present in person or represented by proxy at the Annual Meeting is required to approve the 2023 Share Incentive Plan. Abstentions and broker non-votes are counted to determine whether a quorum is present at the Annual Meeting but are not counted as a vote in favor of or against a particular matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IS THE QUORUM REQUIREMENT?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of the outstanding shares of common stock entitled to vote are present at the Annual Meeting in person or represented by proxy. On the Recor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d Date, there wer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e 34,613,517 shares of common stock issued and outstanding and entitled to vote. Thus, the holders of 17,306,759 shares of common stock must be present in person or represented by proxy at the Annual Meeting to have a quorum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Annual Meeting. Abstentions and broker non-votes will be </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares of common stock present at the Annual Meeting in person or represented by proxy may adjourn the Annual Meeting to another date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CAN YOU CHANGE YOUR VOTE?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Can a stockholder change his or her vote?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes. Any registered stockholder who voted by proxy or in person may change his or her vote at any time before recording the votes on the date of the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">How can I change my vote after I return my proxy card?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided you are the stockholder of record or have legal proxy from your nominee, you may revoke your proxy and change your vote at any time before the final vote at the Annual Meeting. You may do this by signing and submitting a new proxy card bearing a later date, or by attending the Annual Meeting and voting in person. Attending the Annual Meeting will not revoke your proxy unless you specifically request it.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IF YOU VOTE &#8220;ABSTAIN&#8221;?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A vote to &#8220;abstain&#8221; on Proposal 1 indicates that your shares will not be voted for such matter and will have the effect of a vote against the proposal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A vote to &#8220;abstain&#8221; on Proposals 2 and 3 indicates that your shares will not be voted for such matters and will have no effect on the outcome of the vote.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abstentions are considered as being present for quorum purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CAN YOUR SHARES BE VOTED IF YOU DO NOT RETURN YOUR PROXY AND DO NOT ATTEND THE ANNUAL MEETING?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A broker non-vote occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power for that particular item, and has not received instructions from the beneficial owner. Broker non-votes count for quorum purposes but not for voting purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you do not attend and vote your shares which are registered in your name or if you do not otherwise fill out the proxy card and vote by proxy, your shares will not be voted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">HOW CAN I ATTEND THE ANNUAL MEETING?</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only stockholders as of the Record Date (or their proxy holders) may attend the Annual Meeting. All stockholders seeking admission to the Annual Meeting must present photo identification. If you hold your shares in street name, to gain admission to the Annual Meeting you also must provide proof of ownership of your shares as of the record date. Proof of ownership may be a letter or account statement from your broker, bank or other holder of record. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders who wish to attend the Annual Meeting in person will need to register in advance by notifying the Company&#8217;s Secretary no later than 10:00 a.m. on August 3, 2023, at the following address, telephone number or email address: 5115 Ulmerton Road, Clearwater, Florida 33760, telephone number (727) 384-2323, email address investor.relations@apyxmedical.com, of their intention to attend the Annual Meeting. Registration will be on a first-come, first-served basis. Only stockholders as of the Record Date who have registered in advance and have a valid confirmation of registration will be admitted to the Annual Meeting. Please note that due to space constraints, we will not be able to provide access to the Annual Meeting to any stockholders who have not registered in advance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT HAPPENS IF THE MEETING IS POSTPONED OR ADJOURNED?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your proxy will still be valid and may be voted at the postponed or adjourned meeting. You will still be able to change or revoke your proxy until it is actually voted. </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT IS HOUSEHOLDING OF ANNUAL MEETING MATERIALS?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statement and annual reports. This means that only one copy of our Proxy Statement and Annual Report to Stockholders may have been sent to multiple stockholders in your household. We will promptly deliver a separate copy of either document to you if you contact the Secretary at the following address or telephone number: 5115 Ulmerton Road, Clearwater, Florida 33760, telephone number (727) 384-2323. If you want to receive separate copies of this Proxy Statement or the Annual Report in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker or other nominee record holder, or you may contact the Company at the above address or telephone number.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DO STOCKHOLDERS HAVE DISSENTERS&#8217; RIGHTS?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders do not have dissenters&#8217; rights of appraisal with respect to any of the proposals being voted on.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT SHOULD I DO IF I RECEIVE MORE THAN ONE SET OF VOTING MATERIALS?</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may receive more than one set of voting materials, including multiple copies of the Notice of Annual Meeting or this Proxy Statement and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. Similarly, if you are a stockholder of record and hold shares in a brokerage account, you will receive a notice for shares held in your name and a notice or voting instruction card for shares held in street name. Please follow the directions provided in the notice and each additional notice or voting instruction card you receive to ensure that all your shares are voted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHAT ARE THE SOLICITATION EXPENSES AND WHO PAYS THE COST OF THIS PROXY SOLICITATION?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board is asking for your proxy and we will pay all of the costs of asking for stockholder proxies. We will reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses for forwarding solicitation material to the beneficial owners of common stock and collecting voting instructions. We may use our officers and employees to ask for proxies, as described belo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">w. In addition, we have retained Laurel Hill to assist in the solicitation of proxies for a fee of approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $7,000 pl</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">us r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eimbursement of expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHERE CAN I FIND VOTING RESULTS?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to publish the voting results in a Current Report on Form 8-K, which we expect to file with the SEC within four business days following the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WHO CAN HELP ANSWER MY QUESTIONS?</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information provided above in this &#8220;Question and Answer&#8221; format is for your convenience only and is merely a summary of the information contained in this Proxy Statement. We urge you to carefully read this entire Proxy Statement, including the documents we refer to herein. If you have any questions, need additional material, or require assistance in voting your shares, please feel free to contact Laurel Hill, the firm assisting us in the solicitation of proxies. Stockholders may call Laurel Hill toll-free at (888) 742-1305.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PROPOSAL ONE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ELECTION OF DIRECTORS AND MANAGEMENT INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Governance and Nominating Committee of the Board has nominated eight (8) persons consisting of Andrew Makrides, Charles D. Goodwin, Lawrence J. Waldman, Michael Geraghty, John Andres, Craig Swandal, Minnie Baylor-Henry and Wendy Levine, each a current Director, for re-election to the Board.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each director serves from the date of election until the next annual meeting of stockholders and until a successor is duly elected and qualified. The accompanying proxy card will be voted in favor of the persons named above to serve as directors, unless the stockholder indicates to the contrary on the proxy card. See &#8220;Information Regarding Executive Officers, Directors and Director Nominees&#8221; for biographical information as to each nominee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THIS PROPOSAL 1 TO ELECT AS DIRECTORS THE EIGHT NOMINEES PROPOSED BY THE GOVERNANCE AND NOMINATING COMMITTEE OF THE BOARD.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Regarding our Board</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and Bylaws provide for our Company to be managed by or under the direction of the Board. Under our Certificate of Incorporation and Bylaws, the number of directors is fixed from time to time by the Board. The maximum number of directors permitted pursuant to our Certificate of Incorporation and Bylaws is nine. Currently, the number of Board seats constituting the entire Board is fixed at eight, and the number of directors currently serving is eight, leaving no vacancies on the Board. The Board currently has seven members who have been determined to be &#8220;independent&#8221; as defined by the applicable rules of The NASDAQ Stock Market LLC and the Securities and Exchange Commission. These &#8220;independent&#8221; directors are Andrew Makrides, Michael Geraghty, John Andres, Lawrence J. Waldman, Craig Swandal, Minnie Baylor-Henry, and Wendy Levine. Our common stock is listed on The NASDAQ Stock Market LLC under the symbol &#8220;APYX&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary responsibilities of our Board are to provide oversight, strategic guidance, counseling and direction to our management. Our Board meets on a regular basis and additionally as required. Written or electronic materials are distributed in advance of meetings as a general rule and our Board schedules meetings with, and presentations from, members of our senior management on a regular basis and as required.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are elected at the Annual Meeting and hold office until our next annual meeting of stockholders and until their successors are elected and qualified. Officers are appointed by the Board and serve at the pleasure of the Board.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board held twelve (12) meetings during the 2</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">022 fiscal year. Throughout the year and from time-to-time the Board will hold informal meetings on an as needed basis. All of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the directors attended 100% of the meetings of the Board and of the committees on which they served. While we encourage all members of the Board to attend Annual Meetings of Stockholders, there is no formal policy as to their attendance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings Involving Directors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no legal proceedings involving the nominees to the Board in the past ten years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent directors appointed Lawrence J. Waldman as the Lead Independent Director. The Lead Independent Director is appointed by the Board and is responsible for coordinating the activities of the independent directors and coordinating with the Chief Executive Officer of the Company to set agendas for Board meetings and chair executive sessions of the independent directors. The Lead Independent Director is also responsible for meeting, from time to time, with the Company&#8217;s Compensation Committee to discuss the Chief Executive Officer&#8217;s performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Corporate Governance Policies also contain several features which the Company believes will ensure that the Board maintains effective and independent oversight of management, including the following:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Executive sessions without management and non-independent directors present are a standing Board agenda item. Executive sessions of the independent directors are held at any time requested by an independent director and, in any event, are held in connection with all regularly scheduled Board meetings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The Board regularly meets in executive session with the CEO without other members of management present.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">All Board committee members are independent directors. The committee chairs have authority to hold executive sessions without management and non-independent directors present.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has no formal policy with respect to separation of the positions of Chairman and CEO or with respect to whether the Chairman should be a member of management or an independent director, and believes that these are matters that should be discussed and determined by the Board from time to time. The Chief Executive Officer of the Company, Charles D. Goodwin, is tasked with the responsibility of implementing our corporate strategy. We believe Mr. Goodwin is best suited for leading discussions, at the Board level, regarding performance relative to our corporate strategy and these discussions account for a significant portion of the time devoted at our Board meetings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Evaluations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a policy to evaluate its performance and effectiveness as well as that of the four standing committees on an annual basis. The purpose of the evaluation is to track progress in certain areas targeted for improvement from year to year and to identify ways to enhance the Board&#8217;s effectiveness. As part of the evaluation, each Director may complete a written questionnaire developed by the Governance and Nominating Committee to provide feedback on the effectiveness of the Board, the Committees, as well as each individual Director&#8217;s own contributions. The collective ratings and comments of the Directors are compiled and then presented to the Governance and Nominating Committee and to the full Board for discussion and action as necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board believes that risk management is an important component of the Company&#8217;s corporate strategy. While we assess specific risks at our committee levels, the Board, as a whole, oversees our risk management process, and discusses and reviews with management major policies with respect to risk assessment and risk management. The Board is regularly informed through its interactions with management and committee reports about risks we face in the course of our business.&#160;Our Audit Committee also takes an active role in risk assessment and risk management.</span></div><div><span><br/></span></div><div id="i300043246b3a40c4967f3225093a1c39_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">INFORMATION REGARDING EXECUTIVE OFFICERS, DIRECTORS AND DIRECTOR NOMINEES</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the names, ages and positions within the Company of each of our directors, director nominees, executive officers and key employees.</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Position</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Director Since</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer, Treasurer and Secretary</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Makrides</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1982</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lawrence J. Waldman</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Geraghty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Andres</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice-Chair of the Board</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig Swandal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnie Baylor-Henry</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wendy Levine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2021</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Diversity Matrix</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The matrix below reflects our Board&#8217;s gender and racial characteristics and LGBTQ+ status, based on the self-identification of our directors. Each of the categories listed below has the meaning as it is used in Nasdaq Rule 5605(f). </span></div><div><span><br/></span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.950%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="54" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board Diversity Matrix (as of December 31, 2022 and 2021)</span></td></tr><tr><td colspan="54" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Number of Directors                               8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Makrides</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwin</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Waldman</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Andres</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Geraghty</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Swandal</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Baylor-Henry</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Levine</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="54" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gender Identity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Male</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Female</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Binary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Did Not Disclose Gender</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="54" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Demographic Background</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">African American or Black</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alaskan Native or Native American</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hispanic or Latinx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Native Hawaiian or Pacific Islander</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LGBTQ+</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Did Not Disclose Demographic Background</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Knowledge, Skills and Experience Matrix</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The matrix below summarizes certain of the key experiences, qualifications, skills, and attributes that our directors bring to the Board to enable effective oversight. This matrix is intended only to provide a summary of our directors&#8217; qualifications and is not a complete listing of each director&#8217;s strengths and contributions to the Board. Additional information on each director is set forth in their respective biography. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.950%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="54" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Knowledge, Skills and Experience Matrix</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Makrides</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwin</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Waldman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Andres</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Geraghty</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Swandal</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Baylor-Henry</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Levine</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Public Company Board Experience</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk Management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate Governance\Ethics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legal\Regulatory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HR\Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Strategic Planning\Oversight</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales and Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical Device Industry</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Andrew Makrides, Esq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., age 81, Chairman of the Board of Directors since December 1982, received a Bachelor of Arts degree in Psychology from Hofstra University and a Juris Doctor Degree from Brooklyn Law School. He is a member of the Bar of the State of New York and practiced law from 1968 until joining Apyx Medical Corporation as a co-founder and Executive Vice President and director, in 1982. Mr. Makrides became President of the Company in 1985 and the CEO in December 1998 and served as such until March 18, 2011 at which point he relinquished his position as President, but remained CEO until December 2013. Mr. Makrides employment contract expired December 31, 2016. Mr. Makrides has over 40 years of executive experience in the medical device industry. The Company believes Mr. Makrides is qualified to serve as Chairman because of his over 40 years of experience in the medical device industry as well as with his previous tenure with the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charles D. Goodwin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 57, Chief Executive Officer and a Director of Apyx Medical since December 2017, is an accomplished senior executive with over 30 years of experience in the healthcare industry. Before joining Apyx Medical in December 2017, Mr. Goodwin was the Chief Executive Officer of MIS Implants Technologies, Inc., a privately held company specializing in dental implants. Prior to this position, Mr. Goodwin spent more than 11 years with Olympus/Gyrus ACMI in a variety of commercial and leadership roles of increasing responsibility. Mr. Goodwin began as a regional sales director for Gyrus in 2002 and was later promoted to Vice President of Sales, overseeing the Company&#8217;s strong commercial ramp and assisting Gyrus&#8217; executive leadership team in the successful acquisition of American Cytoscope Makers, or &#8220;ACMI&#8221;, for $500 million in 2005. As President of Gyrus ACMI&#8217;s surgical division, Mr. Goodwin developed the company&#8217;s global distribution network and achieved average annual sales growth of 35% for three consecutive years, resulting in a promotion to President of Worldwide Sales in 2007. As President of Worldwide Sales for Gyrus ACMI, Mr. Goodwin was responsible for a global business with approximately 700 employees and was a key contributor to the successful sale of Gyrus ACMI to Olympus for $2.2 billion in 2008. Mr. Goodwin served as Group Vice President of Olympus Corporation&#8217;s global surgical energy group, where he was responsible for commercial strategy, R&amp;D and operations for a business with more than 500 employees worldwide. Mr. Goodwin held this position for five years before joining MIS Implants Technologies, Inc. in 2014. In March, 2022 Mr. Goodwin joined the Board of ZSX Medical, LLC, a clinical stage medical device company improving minimally-invasive surgery. Mr. Goodwin holds a B.A. in Finance and Economics from Eastern Washington University. The Company believes Mr. Goodwin is qualified to serve as a Director given his over 30 years of experience in the medical device industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tara Semb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 53, Chief Financial Officer, Treasurer and Secretary since January 2019. Prior to joining Apyx Medical, Ms. Semb was the Chief Financial Officer for AVAIL Vapor LLC, a manufacturer and retailer of e-liquid for use in electronic vapor devices, from 2015 until 2018. Ms. Semb previously worked for Amsted Industries, a diversified global manufacturer of industrial components, in multiple positions of increasing responsibility from 2006 until 2015, culminating in her promotion to Director of Finance for the company&#8217;s rail bearings division in 2013. Before joining Amsted Industries as Director of Internal Audit in 2006, she held financial and operational roles at Blyth Industries, a manufacturer and seller of candles and home fragrance products, and Anixter International, a global distributor of network &amp; security solutions. She began her career in 1991 as an auditor at Price Waterhouse. Ms. Semb holds a Bachelor of Science degree in Accounting from the University of Illinois, as well as an MBA from Washington University in St. Louis. She is a Certified Public Accountant (CPA).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Todd Hornsby</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 47, Executive Vice President since January 2019, has responsibility for global Commercial operations. He is an accomplished Senior Executive with more than 20 years of success in the medical device and biotech industries. Throughout his career, Todd has held various leadership positions and has extensive experience in sales, sales management, and with building strong teams and launching new technologies. Since joining Apyx&#8482; Medical in August 2014, Todd has focused primarily on the commercialization of Apyx&#8217;s Renuvion / J-Plasma advanced energy system. Prior to joining Apyx, Todd held roles of increasing seniority and responsibility at CryoLife, Inc. During his tenure, Todd directed the US Sales team, with a diversified product portfolio of biological heart valves and vascular grafts, surgical adhesives and hemostatic agents, dialysis access and CHF chronic heart failure products. Todd also directed successful integrations of three acquisitions into the US sales channel. Early in his medical device career, Todd held positions with Ethicon - Endo Surgery and Medex Medical. Todd holds a BA in Psychology from Hope College. He is also the recipient of many awards for sales achievement and growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Moshe Citronowicz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 70, Senior Vice President since 2012, came to the United States in 1978 and has worked in a variety of manufacturing and high technology industries. In October 1993, Mr. Citronowicz joined the Company as Vice President of Operations and served as our Chief Operating Officer until November 2011. Currently, he is serving as the Senior Vice President. Mr. Citronowicz&#8217;s employment contract extends to December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lawrence J. Waldman, CPA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, age 76, Director since March 2011, Lead Independent Director, and Audit Committee Chair. Mr. Waldman has over 50 years of experience in public accounting. Mr. Waldman currently serves as a senior advisor to First Long Island Investors, LLC, an investment and wealth management firm since May 2016. Prior to that Mr. Waldman served as an advisor to the accounting firm of EisnerAmper LLP, where he was previously the Partner-in-Charge of Commercial Audit Practice Development for Long Island since September 2011. Prior to joining EisnerAmper LLP, Mr. Waldman was the Partner-in-Charge of Commercial Audit Practice Development for Holtz Rubenstein Reminick, LLP from July 2006 to August </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2011. Mr. Waldman was the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he began his career in 1972. Mr. Waldman was elected to the Board of Directors of Comtech Telecommunications Corp. in August of 2015 and since December 2015, serves as Chair of its Audit Committee, and since December 17, 2021 serves as its Lead Independent Director. In October 2016, Mr. Waldman was appointed and subsequently in December 2016 elected to the Board of Directors of CVD Equipment Corporation, and serves as the Chair of the Audit Committee and as Lead Independent Director. In January 2021, Mr. Waldman was appointed to serve as non-Executive Chairman of the Board of CVD Equipment Corporation. Mr. Waldman also served through October 2018 as a member of the Board of Directors of Northstar/ RXR Metro Income Fund, a non-traded Real Estate Investment Trust, where he also had served as a member of its Audit Committee starting in 2014.  Mr. Waldman also served as a member of the State University of New York&#8217;s Board of Trustees and as Chair of its Audit Committee. He previously served as the Chairman of the Board of Trustees of the Long Island Power Authority and as Chair and a member of the Finance and Audit Committee of its Board of Trustees. Mr. Waldman meets the definition of a financial expert as defined by the SEC and The NASDAQ Stock Market LLC. The Company believes Mr. Waldman is qualified to serve as Director, Audit Committee Chair and Lead Independent Director because of his over 50 years of experience in public accounting and his positions on various boards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Michael Geraghty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 75, Director since March 2010 and Compensation Committee Chair. Mr. Geraghty was previously employed as the President of Global Sales at Optos, Inc., a developer and manufacturer of retinal imaging devices for screening, detection and diagnosis of eye related conditions. From 2005 through 2008, he was the President of International Sales at Gyrus Acmi where he first started in 2000 as Senior Vice President of Sales for Gyrus Medical. Prior to this, Mr. Geraghty was the Vice President of Sales and Marketing for Everest Medical, Inc. and before that was the Director of Marketing for Advanced Products at Arthrocare Corporation. Mr. Geraghty specializes in building independent direct sales teams in the medical device industry and has extensive domestic and international sales and marketing experience. He received his bachelor&#8217;s degree from St. Mary&#8217;s University and graduate degree in Executive Sales Management from the University of Minnesota. The Company believes Mr. Geraghty is qualified to serve as Director and Compensation Committee Chair because of his extensive domestic and international sales, marketing, and management experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Craig Swandal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 62, Director since March 2018. Mr. Swandal has over 30 years of experience at public and privately-held medical technology and electronics manufacturing companies. He began his career in 1981 at Unisys Corporation, a manufacturer of main frame computer systems, where he held a variety of manufacturing positions of increasing responsibility. In 1995 he joined Silent Knight, a manufacturer of industrial fire and security systems, as a Manufacturing Manager and was promoted to Vice President of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2001, Mr. Swandal joined Gyrus, a manufacturer of surgical devices, where he was responsible for the company&#8217;s manufacturing operations as Director of Operations and later Vice President of Operations. Following Gyrus&#8217;s acquisition of ACMI in 2005, Mr. Swandal was promoted to Senior Vice President and was responsible for the global operations of the combined company. He developed and executed Gyrus ACMI&#8217;s strategy to consolidate its manufacturing, distribution, customer service and service and repair operations and was a member of the leadership team that successfully sold the company to Olympus Corporation for $2.2 billion in 2008. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the acquisition of Gyrus ACMI, Mr. Swandal served on the executive leadership teams of several companies, including ATS Medical, ACELL and Tendyne, where he was focused on operational development and currently holds a position. He is currently the Principal of Lead 2 Change Consulting, where he assists companies in identifying and implementing new manufacturing initiatives. Mr. Swandal serves as a member of the Board of Managers for Tiumed LLC a nontraded medical device start up. Mr. Swandal holds a Bachelor&#8217;s degree in Organizational Management and Communications from Concordia University, as well as a mini Master of Business Administration in Medical Technology from the University of St Thomas. The Company believes Mr. Swandal is qualified to serve as Director because of his extensive experience in manufacturing operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">John Andres</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 65, Vice Chairman of the Board of Directors and Governance and Nominating Committee Chair since July 2014, has over 30 years of experience in the medical device industry. Since April, 2004, Mr. Andres has been a private consultant, doing business through John C. Andres, LLC, specializing in patent/business strategy development and execution. He also is a partner of Hawk Healthcare, LLC, which provides strategic transaction management to private individuals and companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, Mr. Andres joined the Board of Directors of Adaptilens, LLC, which is developing an accommodating intraocular lens. In 2017, Mr. Andres joined the Board of Directors of Longeviti Neuro Solutions, LLC which develops and sells cranial implant products for cranial reconstruction. In 2004, Mr. Andres helped found K2M, Inc. (KTWO) and from 2004 until 2010 served as a member of the Board of Directors of K2M, Inc. Prior to 2004, Mr. Andres held various legal and strategic business development positions at the Surgical Division of Tyco Healthcare Group, LLP, now Medtronic (NYSE: MDT) and its </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">predecessor, United States Surgical Corporation. Before joining U.S. Surgical, Mr. Andres worked at the New York law firm of Morgan &amp; Finnegan. He received his Associate of Applied Science degree from Rochester Institute of Technology, his Bachelor of Arts degree from Lehigh University and his Juris Doctor from Pace University School of Law. The Company believes Mr. Andres is qualified to serve as a director because of his extensive experience in patent and business strategy development and execution in the medical device industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Minnie Baylor-Henry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 75, Director and Regulatory Compliance Committee Chair since August 2019. Ms. Baylor-Henry has over 25 years of regulatory affairs experience. She is the President of B-Henry &amp; Associates, LLC, a consulting firm that she founded to provide regulatory strategic support to life sciences companies. Prior to starting her consulting company, she held various executive level positions over a 15-year period at Johnson &amp; Johnson (J&amp;J). Before retiring from J&amp;J in 2015, she was the Worldwide Vice President of Regulatory Affairs-Medical Devices. During her time at J&amp;J, she also had served as the Vice President-Medical &amp; Regulatory Affairs in the Over-the Counter Group, as well as Senior Director, Regulatory Affairs- Pharmaceuticals. Ms. Baylor-Henry also worked for Deloitte &amp; Touche (2008-2010) as the National Director Regulatory Affairs- Life Sciences. Prior to joining the private sector, she worked for the US Food &amp; Drug Administration (1991-1999) in many roles, including serving as the Director of the Division of Drug, Marketing, Advertising &amp; Communications and the FDA&#8217;s National Health Fraud Coordinator.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, Ms. Baylor-Henry joined the Board of Directors of scPharmaceuticals, a publicly-held company focused on developing technologies that enable subcutaneous administration of therapies and in 20 she stepped down from the Board of Directors of PolarityTE, a publicly- held regenerative medicine company. She joined the Board of Directors of Paratek Pharmaceuticals, a publicly-held company focused on solutions for patients with infectious diseases.  In March, 2022, she joined the Board of Directors of Lantheus Holdings, LLC, an innovative diagnostics and targeted therapeutics company. Ms. Baylor-Henry received her pharmacy degree from Howard University&#8217;s College of Pharmacy and a law degree from Catholic University&#8217;s Columbus School of Law. The Company believes Ms. Baylor-Henry is qualified to serve as Director and Regulatory and Compliance Committee Chair because of her extensive experience in global and regulatory management and compliance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Wendy Levine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 50, Director, has over 25 years of healthcare marketing and advertising experience across the pharmaceutical, biotech, medical device and vaccine sectors. She is currently Group President and head of the advertising business at 21GRAMS, part of Real Chemistry, a global health innovation company that she founded with her partners in 2018. From 2003 to 2007, Ms. Levine worked at Johnson &amp; Johnson, where she served as Group Product Director in the Specialty Pharmaceuticals Business Unit and then as Director, Stakeholder Marketing in the Medical Device Business Unit. From 2007 to 2009, Ms. Levine held the position of Senior Director of Marketing for the influenza portfolio at Novartis Vaccines. From 2009 to 2014, a love for advertising brought her to the agency world, where she rose through the ranks within account management at The Bloc. From 2014 to 2015, Ms. Levine held the role of EVP, Managing Director at McCann Health. From 2015 to 2017, she worked as Director of Client Services at GSW. Ms. Levine received her bachelor&#8217;s degree in interdisciplinary studies (economics and Western European culture) from the University of Pittsburgh and a master&#8217;s degree in education from Beaver College (Arcadia University).  The Company believes Ms. Levine is qualified to serve as Director because of her extensive experience in marketing and advertising.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">COMMITTEES OF OUR BOARD</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a standing Audit Committee, Compensation Committee, Governance and Nominating Committee and Regulatory Compliance Committee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee assists the Board in its general oversight of our financial reporting, internal controls, cyber security risks, and audit functions, and is directly responsible for the appointment, compensation and oversight of the work of our independent registered public accounting firm. The Audit Committee reviews and discusses with management and our independent accountants the annual audited and quarterly financial statements (including the disclosures under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and matters required to be discussed by the applicable requirements of the PCAOB), reviews the integrity of the financial reporting processes, both internal and external, reviews the qualifications, performance and independence of our independent accountants, and prepares the Audit Committee Report included in its Annual Report in accordance with rules and regulations of the Securities and Exchange Commission. The Audit Committee has the power to investigate any matter brought to its attention within the scope of its duties. It also has the authority to retain counsel and advisors to fulfill its responsibilities and duties. The Audit Committee also acts as a qualified legal compliance committee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The meetings of the Committee are designed to facilitate and encourage communication among the Committee, the Company and the Company&#8217;s independent auditor. The Committee discussed with the Company&#8217;s Independent Auditor the overall scope and plans for their respective audits. The Committee meets with the independent auditor, with and without management present, to discuss the results of their examinations; their evaluations of the Company&#8217;s internal controls; and the overall quality of the Company&#8217;s financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, our Audit Committee consisted of four independent members of the Board of Directors, Lawrence J. Waldman, John Andres, Michael Geraghty and Craig Swandal. As a smaller reporting company, we are required to have at least two independent members comprising our Audit Committee in accordance with Rule 10A-3 of the Securities Exchange Act of 1934 and the rules of The NASDAQ Stock Market LLC. During 2022, Mr. Waldman served as the Audit Committee Chairperson and financial expert. The Audit Committee meets as often as it determines necessary but not less frequently than once every fiscal quarter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Audit Committee Charter will be provided to any person without charge upon written request to the Company&#8217;s address to the attention of the Secretary. A copy of the Audit Committee Charter is available in the Investor Relations section of our website at www.apyxmedical.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance and Nominating Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Governance and Nominating Committee is responsible for matters relating to the corporate governance of our company and the nomination of members of the board and committees thereof. The Governance and Nominating Committee also provides oversight to the Company over its Environmental, Social and Governance (&#8220;ESG&#8221;) initiatives. During 2022, our Governance and Nominating Committee consisted of four independent members of the Board of Directors, John Andres who serves as Chairperson, Lawrence J. Waldman, Michael Geraghty and Minnie Baylor-Henry. The Governance and Nominating Committee meets as often as it determines necessary, but not less than once a year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering whether directors and nominees have the experience, qualifications, attributes or skills, taken as a whole, to enable the Board to satisfy its oversight responsibilities effectively in light of the Company&#8217;s business and structure, the Governance and Nominating Committee focused primarily on each person&#8217;s background and experience as reflected in the information discussed in each of the directors&#8217; individual biographies set forth above. We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business. As more specifically described in such person&#8217;s individual biographies set forth above, our directors possess relevant and industry-specific experience and knowledge in the medical, engineering and business fields, as the case may be, which we believe enhances the Board&#8217;s ability to oversee, evaluate and direct our overall corporate strategy. The Governance and Nominating Committee annually reviews and makes recommendations to the Board regarding the composition and size of the Board so that the Board consists of members with the proper expertise, skills, attributes, and personal and professional backgrounds needed by the Board, consistent with applicable regulatory requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Governance and Nominating Committee believes that all directors, including nominees, should possess the highest personal and professional ethics, integrity, and values, and be committed to representing the long-term interests of our stockholders. The Governance and Nominating Committee will consider criteria including the nominee&#8217;s current or recent experience as a senior executive officer, whether the nominee is independent, as that term is defined in existing independence requirements of The NASDAQ Stock Market LLC and the Securities and Exchange Commission, the business, scientific or engineering experience currently desired on the Board, geography, the nominee&#8217;s industry experience, and the nominee&#8217;s general ability to enhance the overall composition of the Board.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Governance and Nominating Committee does not have a formal policy on diversity; however, in recommending directors, the Board and the Committee consider the specific background and experience of the Board members and other personal attributes in an effort to provide a diverse mix of capabilities, contributions and viewpoints which the Board believes enables it to function effectively as the Board of a company with our size and nature of business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The two most recent directors added to the Board are both women, one of whom is African American.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Stockholder wishes to nominate a candidate to be considered for election as a director at the 2024 Annual Meeting of Stockholders, he or she must submit nominations in accordance with the procedures set forth in &#8220;Stockholder Proposals For Next Annual Meeting.&#8221; If a Stockholder wishes simply to propose a candidate for consideration as a nominee by the Governance and Nominating Committee, he or she should submit any pertinent information regarding the candidate to the members of the Governance and Nominating Committee of Apyx Medical Corporation, c/o Secretary, 5115 Ulmerton Road, Clearwater, Florida 33760.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Governance and Nominating Committee Charter will be provided to any person without charge upon written request to the Company&#8217;s address to the attention of the Secretary. A copy of the Governance and Nominating Committee Charter is available in the Investor Relations section of our website at www.apyxmedical.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee is responsible for overseeing our compensation and employee benefit plans (including those involving the issuance of our equity securities) and practices, including formulating, evaluating and approving the compensation of our executive officers and reviewing and recommending to the full Board of Directors the compensation of our Chief Executive Officer. During 2022, our Compensation Committee consisted of four independent members of the Board of Directors, Michael Geraghty who served as Chairperson, John Andres, Lawrence J. Waldman and Wendy Levine. The Compensation Committee meets as often as it determines necessary, but not less than once a year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Compensation Committee Charter will be provided to any person without charge upon written request to the Company&#8217;s address to the attention of the Secretary. A copy of the Compensation Committee Charter is available in the Investor Relations section of our website at www.apyxmedical.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Compliance Committee </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Regulatory Compliance Committee is responsible for matters relating to the Company&#8217;s overall non-financial regulatory and compliance strategies and systems. Specifically, the Committee provides oversight of management&#8217;s efforts to comply with the requirements for a medical device company operating in a highly regulated environment with respect to healthcare compliance, product quality and safety, and other areas as directed by the Board. During 2022, our Regulatory Compliance Committee consisted of four independent members of the Board of Directors, Minnie Baylor-Henry who serves as Chairperson, John Andres, Craig Swandal and Wendy Levine. The Regulatory Compliance Committee meets as often as it determines necessary, but not less than once a year.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In carrying out its responsibilities, the Committee reviews and discusses with management the implementation and enforcement of policies, procedures, risk management and compliance programs related to the Company&#8217;s adherence with applicable laws and regulations in the areas of healthcare compliance, product quality and safety and regulatory affairs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Regulatory Compliance Committee Charter will be provided to any person without charge upon written request to the Company&#8217;s address to the attention of the Secretary. A copy of the Regulatory Compliance Committee Charter is available in the Investor Relations section of our website at www.apyxmedical.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below indicates the current membership of each committee and how many times the Board and each committee met and/or acted by written consent in 2022:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:17.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.757%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.741%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Audit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governance<br/>and<br/>Nominating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regulatory Compliance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Makrides</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Andres</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Geraghty</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lawrence J. Waldman</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig Swandal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnie Baylor-Henry</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wendy Levine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Meetings*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%">*   Includes formal meetings and acts of written consent</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%">** Mr. Waldman has also been designated the Audit Committee&#8217;s financial expert.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Stockholder Communications</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board provides a process by which Stockholders may communicate with the Board, including our independent directors. Stockholders who wish to communicate with the Board may do so by sending written communications addressed to any director or the entire Board of Directors of Apyx Medical Corporation, c/o Secretary, 5115 Ulmerton Road, Clearwater, Florida 33760. All mail received at the above address that is addressed to the Board or any individual director will be relayed by the Company to the Board or such individual director. On a periodic basis, all such communications will be compiled by the Secretary and submitted to the Board or the individual director to whom the communications are addressed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Code of Ethics</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of our Code of Ethics (the &#8220;Code&#8221;), which expressly includes the fiduciary responsibilities of the CEO and CFO, is available on our website at </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https://apyxmedical.com/code-of-ethics-and-conduct/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and is reviewed on an annual basis. We also have made available a whistleblower hotline that provides a mechanism for reporting breaches of the Code in an anonymous manner.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Review and acknowledgement of the Code is required of all new employees as part of the on-boarding process, and of all existing employees on an annual basis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Social and Governance</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Governance and Nominating Committee provides oversight to the Company over its ESG initiatives. The Chairman of that Committee has been actively involved in our work to date with the Company&#8217;s ESG efforts and continues to lead in providing suggestions as to what else can be done to further enhance our initiatives in this area, including a continued focus on Board diversity from the perspective of gender, ethnic-racial background, and relevant professional and educational experience.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our ESG initiatives are sponsored by our CEO and CFO, and include a steering committee comprised of all members of the executive management team as well as some mid-level managers in certain areas such as R&amp;D, Regulatory and Quality.  In July 2022, we published our first ESG report aligned with the Sustainability Accounting Standards Board (&#8220;SASB&#8221;) Medical Equipment industry standards.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of our ESG report is available on our website at  </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">http://apyxmedical.com/wp-content/uploads/2022/07/apyx_medical_enviornmental_social_and_governance_tear_sheet_072522.pdf</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Part of our culture is to give back and support the communities and people around us.  In 2022, we engaged in both employee volunteer and financial support in the areas of education and the environment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have also worked to create a culture that fosters employee engagement, where diverse talent is productive and passionate about the work they do.  We continuously focus our efforts on cultivating and enhancing our working culture that embraces equality, diversity and inclusion.  Currently, over half of our global workforce is represented by women, including half of our executive management team.  In addition, in the U.S., approximately 36% of our employees are from minority ethnic/racial groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Compensation Discussion &amp; Analysis (&#8220;CD&amp;A&#8221;) explains our executive compensation program for our named executive officers (&#8220;NEOs&#8221;) listed below. This CD&amp;A also describes the Compensation Committee&#8217;s process for making pay decisions, as well as its rationale for specific decisions related to the fiscal year ended December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Apyx Medical qualifies as a &#8220;smaller reporting company&#8221; as defined by the SEC, which allows us to take advantage of scaled-back disclosure requirements, we are including more extensive narrative about our executive compensation program in an effort to be more transparent. We are also committed to keeping an open dialogue with our stockholders to help ensure that we have a regular pulse on investor perspectives and, as we continue to grow, we intend to further enhance our outreach efforts during 2023 and into the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.666%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, CEO and Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While 2022 ultimately proved to be a challenging year, our team made important progress under difficult circumstances. We believe we are incrementally better positioned in 2023, with an expanding portfolio of 510(k) clearances, supported by clinical evidence, for our targeted clinical indications, recently implemented activities to reduce operating expenses while preserving our capabilities as an organization, and additional financing secured to strengthen our balance sheet and enhance our financial flexibility. Below are key financial and strategic highlights:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Total revenue of $44.5 million, representing a decline of  8.3% year-over-year</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Advanced Energy revenue of  $36.8 million, representing a decline of approximately 14.4% year-over-year</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Loss from operations of $23.6 million, vs. $14.4 million in 2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 14, 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) posted a Medical Device Safety Communication (&#8220;Safety Communication&#8221;). The FDA warned against the use of Renuvion/J-Plasma for procedures intended to improve the appearance of the skin through dermal resurfacing (a procedure on the skin to treat wrinkles) or skin contraction (a procedure under the skin that can be performed either alone or in combination with liposuction to achieve skin effects, such as &#8220;tightening&#8221;). At that time, the Renuvion/J-Plasma device system was FDA cleared for general use of cutting, coagulation, and ablation of soft tissue during open and laparoscopic surgical procedures. The use of the device had not been determined to be safe or effective for any aesthetic skin procedures (procedures intended to improve the appearance of the skin). Following the Safety Communication, we experienced slowed demand for the adoption of its Helium Plasma Technology.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 26, 2022, we announced that we received 510(k) clearance from the FDA for the use of the Renuvion&#174; Dermal Handpiece for certain dermal resurfacing procedures, specifically, for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick Skin Types I, II or III. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 2, 2022, the FDA updated the Safety Communication to inform consumers and healthcare providers about the new 510(k) clearance for the Renuvion&#174; device system for certain dermal resurfacing procedures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 18, 2022, we announced that we received 510(k) clearance from the FDA for the use of the Renuvion&#174; APR Handpiece for use in subcutaneous dermatological and aesthetic procedures to improve the appearance of lax (loose) skin in the neck and submental (under the chin) region. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 21, 2022, the FDA updated the Safety Communication to inform consumers and healthcare providers about the clearance for the Renuvion&#174; APR handpieces for use under the skin in certain procedures intended to improve the appearance of loose skin.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 27, 2023, we announced that we received 510(k) clearance from the FDA for the use of the Renuvion&#174; APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. Soft tissue includes subcutaneous tissue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 28, 2023, we announced that we received 510(k) clearance from the FDA for the use of the Renuvion&#174; APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 10, 2023, the FDA updated the Safety Communication to inform consumers and healthcare providers about the clearance for the Renuvion&#174; APR handpiece for use under the skin in certain procedures intended to improve the appearance of the skin, including for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that the May 10, 2023 FDA update to the Safety Communication addresses the issues set forth in the original Safety Communication from March 14, 2022. While no assurances can be provided, we believe that receiving these additional clearances and the corresponding updates to the Safety Communication since March 14, 2022 should mitigate the financial effects of the Safety Communication in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Events Subsequent to Year End</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Execution of Credit Agreement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 17, 2023, we entered into a Credit, Security and Guaranty Agreement (the &#8220;Credit Agreement&#8221;) with MidCap Funding IV Trust (as agent), and MidCap Financial Trust (as term loan servicer), and the lenders party thereto from time to time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement provides for an up to $35 million facility, consisting of senior secured term loans and a secured revolving facility. The Credit Agreement provides for senior secured term loans of up to $25 million, comprised of (i) an initial tranche of $10 million, (ii) a second tranche of $5 million, and (iii) a third tranche of $10 million. The secured revolving facility provides for loans in an aggregate principal amount of up to $10 million, subject to a borrowing base equal to certain percentages of the Company&#8217;s eligible accounts receivable and inventory, as determined in accordance with the terms of the Credit Agreement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a more in depth description of the terms of the Credit Agreement, see Note 6 of Notes to Condensed Consolidated Financial Statements in Item 1 of our report on Form 10-Q filed on May 11, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale Leaseback of Clearwater Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2023, our Board of Directors approved a plan to sell and leaseback our real property located in Clearwater, FL. On March 14, 2023, we entered into a Purchase and Sale Agreement (the &#8220;Purchase Agreement&#8221;) with VK Acquisitions VI, LLC (the &#8220;Purchaser&#8221;), for the sale of our facility located at 5115 Ulmerton Road, Clearwater, Florida, as more fully described in the Purchase Agreement (collectively, the &#8220;Property&#8221;) for a purchase price of $7,650,000.  On May 8, 2023, we closed on the Purchase Agreement and concurrently executed a 10-year agreement to leaseback the underlying Property from the Purchaser. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a more in depth description of the terms of the Purchase Agreement, see Note 4 of Notes to Condensed Consolidated Financial Statements in Item 1 of our report on Form 10-Q filed on May 11, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHAT GUIDES OUR COMPENSATION PROGRAM</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Compensation Philosophy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our compensation program for employees, including our compensation program for executive officers, is to attract, retain and motivate qualified individuals and reward them in a manner that is fair to all stockholders. We strive to provide incentives for every employee that reward them for their contribution to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Performance-Driven and Stockholder-Aligned</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A portion of a NEO&#8217;s total compensation should be variable (&#8220;at-risk&#8221;) and linked to the achievement of specific short- and long-term performance objectives and designed to drive stockholder value creation.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Competitively-Positioned</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Target compensation should be competitive with that being offered to individuals in comparable roles at other companies with which we compete for talent to ensure that we employ the best people to lead our success.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Responsibly-Governed</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Decisions about compensation should be guided by best-practice governance standards and rigorous processes that encourage prudent decision-making.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Pay</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these objectives in mind, our Board has built executive and non-executive compensation programs that consist of three principal elements - base salary, performance bonuses and grants of stock options.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Pay Element</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">How It&#8217;s Paid</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purpose</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Base Salary</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash (Fixed)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provide a competitive base salary rate relative to similar positions in the market and enable the Company to attract and retain critical executive talent.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Performance Bonuses (Annual Incentives) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash (Variable)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Reward executive officers for delivering on annual financial and/or strategic objectives that contribute to the creation of stockholder value.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Long-Term Incentives </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Equity (Variable)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Provide incentives for executive officers to execute on longer-term financial goals that drive the creation of stockholder value, support the Company&#8217;s retention strategy, and provide alignment with the interests of our stockholders.</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">The Decision-Making Process</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Role of the Compensation Committee.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee oversees the executive compensation program for our NEOs. The Compensation Committee is comprised of independent, non-employee members of the Board. The Compensation Committee works very closely with its independent consultant and management to examine the effectiveness of the Company&#8217;s executive compensation program throughout the year. Details of the Compensation Committee&#8217;s authority and responsibilities are specified in its charter, which may be accessed at apyxmedical.com. The Compensation Committee makes all final compensation and equity award decisions regarding our NEOs, except for the CEO, whose compensation is determined by the independent members of the full Board, based upon recommendations of the Compensation Committee.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The Role of Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Members of our management team attend regular meetings where executive compensation, Company and individual performance, and competitive compensation levels and practices are discussed and evaluated. Only the Compensation Committee members are allowed to vote on decisions regarding NEO compensation. The CEO reviews his recommendations pertaining to other executives (non-NEO) pay with the Compensation Committee providing transparency and oversight. Decisions on non-NEO pay are made by the CEO. The CEO does not participate in the deliberations of the Compensation Committee regarding his own compensation. Independent members of the Board make all final determinations regarding CEO compensation.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Role of the Independent Consultant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee engages an independent compensation consultant to provide expertise on competitive pay practices, program design, and an objective assessment of any inherent risks of any programs. Pursuant to authority granted to it under its charter, the Compensation Committee has hired Pearl Meyer &amp; Partners, LLC (&#8220;Pearl Meyer&#8221;) as its independent consultant. Pearl Meyer reports directly to the Compensation Committee and does not provide any additional services to management. The Compensation Committee has conducted an independence assessment of Pearl Meyer in accordance with SEC rules.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The Role of Peer Group Companies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Compensation Committee strives to set a competitive level of total compensation for</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each NEO as compared with executive officers in similar positions at comparable companies, which we define as our</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation peer group. The Compensation Committee looks to its independent compensation consultant to provide and</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">analyze competitive market data for each NEO, comparing each of their individual components of compensation and total</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation to market. In addition to the peer group, Pearl Meyer may reference industry-specific, size-adjusted market</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">survey data where appropriate. We continue to consult with Pearl Meyer on our compensation strategy on an ongoing basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of our last competitive assessment, Pearl Meyer recommended and the Compensation Committee approved an update to our peer group. Pearl Meyer developed a set of objective filtering and selection criteria to identify US-based, publicly traded companies in the health care equipment, supplies or technology space that were comparable to Apyx at the time in terms of both revenue and market capitalization. The Company's current compensation peer group was composed of the following companies and was unchanged in 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avedro, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GenMark Diagnostics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoPediatrics Corp.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioLife Solutions, Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iCAD, Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sensus Healthcare, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corindus Vascular Robotics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRadimed Corporation</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TransEnterix, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cutera, Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Misonix, Inc.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TransMedics Group, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ekso Bionics Holdings, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuronetics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Medical Products Inc.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of the survey confirmed that, consistent with our desired philosophy, our compensation arrangements were competitive with the marketplace, with some variation by individual.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Executive Compensation Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base Salary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay base salaries to our Executive Officers in order to provide a consistent, minimum level of pay that sustained individual performance warrants. We also believe that a competitive annual base salary is important to attract and retain an appropriate caliber of talent for each position over time.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual base salaries of our Executive Officers are determined by our Compensation Committee and approved by the Board of Directors. All salary decisions are based on each Executive Officer&#8217;s level of responsibility, experience and recent and past performance, as determined by the Compensation Committee. The Compensation Committee benchmarks base salaries using a major independent consulting firm and using their recommendations and other information the Committee evaluates and establishes the base compensation for our executives. </span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.754%"><tr><td style="width:1.0%"></td><td style="width:42.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Bonus</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance-based cash incentive bonus is designed to provide an opportunity for our senior executives, including our NEOs, to earn an annual incentive, paid in cash, based on the achievement of certain financial targets and/or strategic priorities. An executive&#8217;s incentive target is a percentage of their base salary. The Compensation Committee assessed our performance against certain financial metrics during 2022 with payouts measured on a scale of zero to 125% of target. The table below discloses the annual incentive targets for each NEO for 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.847%"><tr><td style="width:1.0%"></td><td style="width:31.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 Base Salary <br/>($)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bonus Target <br/>(% of Base Salary)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bonus at Target <br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we used Total Revenue, Operating Income/(loss) and Total Operating Cash Burn as the financial performance metrics</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for determining annual performance bonuses because we believe it is important to focus on driving our top line revenue growth, while focusing on continued improvements to our gross product margins and efficiently investing in our operations to drive</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">towards longer-term, bottom-line profitability. This ultimately results in our ability to maintain acceptable levels of cash burn,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">setting a path to generating positive cash flow through our overall business performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Annual Incentive Plan Payouts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on the actual financial performance results, the funding for performance bonuses was set at 0% of each NEO&#8217;s applicable target. The Committee retains discretion to further adjust the award upward or downward based on its assessment of individual performance. The following table lists the actual awards earned by the NEOs in 2022 (and paid in 2023):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"></td><td style="width:27.921%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bonus Target <br/>(% of Base Salary)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bonus Target<br/>($)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Award Payout<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that equity ownership in our Company is important to provide our Executive Officers and key employees with long-term incentives to better align interests of executives with the interests of stockholders and build value for our stockholders. In addition, equity compensation is designed to attract and retain the executive management team and other key employees throughout the organization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Board approved equity awards to the NEOs. These equity awards were granted using incentive stock options to the extent permitted by the IRS. Stock options are intended to align the interests of award recipients with those of stockholders, since options deliver value only if Apyx&#8217;s stock price appreciates after they are granted. This characteristic ensures that the Executive Officers and key employees have a meaningful portion of their compensation tied to future stock price increases and rewards management for long-term strategic planning through the resulting enhancement of the stock price. The 2022 awards for each NEO were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.707%"><tr><td style="width:1.0%"></td><td style="width:59.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options <br/>(# of options)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,000</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock options vest one-third per year on the anniversary date of the grant over a 3-year period, expire on the 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> anniversary of the grant date, and have an exercise price of $10.96 per share. Stock options are subject to the award recipient&#8217;s continued employment through each vesting date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards to Executive Officers and key employees are entirely discretionary. The CEO recommends to the Compensation Committee awards for individuals other than himself. The Compensation Committee considers this recommendation along with the prior contribution of these individuals and their expected future contributions to our growth. The Committee formulates and presents its recommended allocation of stock option awards to the Board of Directors for approval. The Compensation Committee then would make an independent determination on CEO stock option awards, again formulating and presenting its recommendation for the allocation of stock option awards to the Board of Directors for approval. The Board of Directors approves, rejects, or, if necessary, modifies the Committee&#8217;s recommendations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Perquisites and Other Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Executive Officers are eligible for the same health and welfare programs and benefits as the rest of our employees in their respective locations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Executive Officers are entitled to participate in and receive employer contributions to Apyx&#8217;s 401(k) Savings Plan. For more information on employer contributions to the 401(k) Savings Plan see the Summary Compensation Table and its footnotes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax and Accounting Considerations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly consider the various tax and accounting implications of our compensation plans. Section 162(m) of the Code generally prohibits any publicly held corporation from taking a federal income tax deduction for compensation paid in excess of $1 million in any taxable year to the CEO and the other &#8220;covered employees&#8221; as defined in the rule. Under the tax laws in effect before 2018, compensation that qualified as &#8220;performance-based compensation&#8221; under Section 162(m) of the Code was deductible without regard to this limitation. Effective for tax years beginning after December 31, 2017, the Tax Cuts and Jobs Act of 2017 generally eliminated the performance-based exemption, subject to a special rule that grandfathers certain awards and agreements that were in effect on November 2, 2017. While considering tax deductibility as only one of several considerations in determining compensation, the Committee believes that the tax deduction limitation should not compromise its ability to structure compensation programs that provide benefits to the Company that outweigh the potential benefit of a tax deduction and, therefore, may approve compensation that is not deductible for tax purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting considerations also play an important role in the design of our executive compensation program. Accounting rules, such as FASB ASC Topic 718-10-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payment,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> require us to expense the cost of our stock option grants which reduces the amount of our reported profits. Because of option expensing and the impact of dilution on our stockholders, we pay close attention to the number and value of the shares underlying stock options we grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Executive Officers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the compensation paid to each of our Executive Officers for the years ended December 31, 2022 and 2021 for services to our Company in all capacities:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.100%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="57" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Principal Position</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bonus<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards<br/>($) (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Equity Incentive Plan Compensation Earnings<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Pension Value and Nonqualified Deferred Compensation Earnings<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">All Other Compensation<br/>($) (2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">482,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,664,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-5">2,170,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO and Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">421,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">701,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">1,594,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">311,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">826,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Senior Vice President</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">640,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">368,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">685,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,079,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Vice President</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">347,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">657,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,017,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CFO, Treasurer and Secretary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">277,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">These columns represent the grant date fair value of the awards as calculated in accordance with FASB ASC 718 (Stock Compensation). </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The amounts for 2022 include compensation under the following plans and programs:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.339%"><tr><td style="width:1.0%"></td><td style="width:34.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.745%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.745%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.745%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.745%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.027%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C.D.<br/>Goodwin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M.<br/>Citronowicz</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">T.<br/>Hornsby</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">T.<br/>Semb</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term disability premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer 401(k) contribution</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,553&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in the table above are pro-rated where applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay vs Performance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-7" continuedAt="i6d14deb4c5ef4f13aed25441c24e0667" escape="true">This section is included to comply with the provisions of Item 402(v) of Regulation S-K. For a more comprehensive analysis of our compensation philosophy please see the General Compensation Philosophy section of this filing. In the table and footnotes below, &#8220;PEO&#8221; refers to our principal executive officer, <ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:PeoName" id="f-8">Charles D. Goodwin</ix:nonNumeric>.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:PvpTableTextBlock" id="f-9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:7.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="39" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pay versus performance table</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary compensation table total for PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation actually paid to PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average summary compensation table total for non-PEO NEOs (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average compensation actually paid to non-PEO NEOs (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of initial fixed $100 investment based on Total stockholder return </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)<br/>(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-10">2,170,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-11">653,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-12">974,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-13">55,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-14">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-15">23,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">1,594,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">3,153,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-18">776,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-19">1,383,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-20">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-21">15,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"><ix:continuation id="i6d14deb4c5ef4f13aed25441c24e0667">Reflects average compensation amounts for our non-PEO named executive officers for the respective years shown. Moshe Citronowicz, Todd Hornsby and Tara Semb are the non-PEO named executive officers for the 2022 and 2021 years presented.</ix:continuation> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-22" continuedAt="iaa2d46a74e404fd8bbcedf2d63e2430b" escape="true"><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:AdjToPeoCompFnTextBlock" id="f-23" continuedAt="ia558d8cf22fb49539b68ab969730aeb2" escape="true">The following table summarizes the adjustments from summary table total compensation to compensation actually paid:</ix:nonNumeric></ix:nonNumeric></span></div><div style="padding-left:36pt;text-align:justify"><ix:continuation id="iaa2d46a74e404fd8bbcedf2d63e2430b" continuedAt="ia1e97a34ac2c4bb5b74d959eda22c71f"><ix:continuation id="ia558d8cf22fb49539b68ab969730aeb2" continuedAt="ic9ae498186df4ca4be2312c7555b4084"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:47.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-PEO NEOs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summary compensation table total compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">2,170,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">1,594,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-26">974,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-27">776,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date fair value of awards granted during the year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26b33c751ae2451aa979b7ec2838c3b5_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-28">1,664,793</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ae6b475b9fd4b3ebfd38c5450726124_D20210101-20211231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-29">701,420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f583035c6374528bb077736a326ab0e_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">612,023</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i365563ab8b2d4214b41460b9949f4e59_D20210101-20211231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">257,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of awards granted during the year that are outstanding and unvested as of year-end</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088317b3378249d1a227d77e70f4c9f6_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">255,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id021d1f1ba5d4ba08840bdc58f968874_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">1,001,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890ae3f400774879b3cda2ffd442021e_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-34">93,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5feed1f0be46b6bfc8ec725d826f7f_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-35">368,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value from prior year-end to current year-end of awards granted in prior years that were outstanding and unvested as of year-end</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84712a841c224c4c90bd386bfd1602be_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-36">1,156,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34bf3b715e8a4b3a9e44d05eebbacc21_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-37">1,034,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i387182a6d0444587a7fc93b9968a7e66_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-38">425,076</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id680e224e4af4fc6bcd722914d82eb3d_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-39">356,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value from prior year-end to vesting date of awards granted in prior years that vested during year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibea22881fac2490ba82e70a11d0f6191_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-40">257,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2d9111611954d77989482ba0f21e03a_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-41">224,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fe9dbce7c7748a3bf1fd7f44b0db31d_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-42">86,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f94684f847340ac9403da4875607a2d_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-43">140,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation actually paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-44">653,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">3,153,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">55,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">1,383,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia1e97a34ac2c4bb5b74d959eda22c71f"><ix:continuation id="ic9ae498186df4ca4be2312c7555b4084">Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of the grant date. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, risk free rates) as of the measurement date. The change in stock price was the primary driver for the adjustments in the table above.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-48" escape="true"><ix:nonNumeric contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-49" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses and sales:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands except per share data)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholder return (change in stock price)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icde9e9acbfab427ebad602f8ae2a2854_I20221231" decimals="2" name="apyx:ShareholderReturnPerShare" scale="0" id="f-50">2.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b52cc5a3ec34719943c2826b7c63e71_I20211231" decimals="2" name="apyx:ShareholderReturnPerShare" scale="0" id="f-51">12.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="3" sign="-" name="apyx:ShareholderReturnPercentChange" scale="-2" id="f-52">81.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-53">23,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-54">15,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="3" sign="-" name="apyx:NetIncomeLossPercentChange" scale="-2" id="f-55">52.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual compensation paid to NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="-3" sign="-" name="apyx:NonPEONEOActuallyPaidCompensationAmount" scale="3" id="f-56">819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231" decimals="-3" name="apyx:NonPEONEOActuallyPaidCompensationAmount" format="ixt:num-dot-decimal" scale="3" id="f-57">7,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-<ix:nonFraction unitRef="number" contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231" decimals="3" sign="-" name="apyx:NonPEONEOActuallyPaidCompensationPercentChange" scale="-2" id="f-58">111.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employment Agreements and Potential Payments Upon Termination or Change in Control</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we were obligated under four employment agreements.</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.52pt">Employment contracts provide for the Executives to remain employed by the Company until such time as their employment is terminated pursuant to the terms of their Employment Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Charles D. Goodwin Employment Agreement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 17, 2020, the Company entered into an Amended and Restated Employment Agreement, effective as of September 17, 2020, with Charles D. Goodwin II, the Company&#8217;s President and Chief Executive Officer (the &#8220;Goodwin Agreement&#8221;). The Goodwin Agreement amends and restates Mr. Goodwin&#8217;s original employment agreement, dated as of December 15, 2017, in its entirety. The term of Mr. Goodwin&#8217;s employment under the Goodwin Agreement commenced as of the effective date thereof and shall continue until terminated in accordance with the terms of the Goodwin Agreement. Under the Goodwin Agreement, Mr. Goodwin will receive an initial annual base salary of $450,000, which shall be reviewed from time to time and may be increased, but not decreased, by the Compensation Committee of the Board of Directors (the &#8220;Committee&#8221;) in its sole and exclusive discretion. Mr. Goodwin shall be entitled to participate in (i) any bonus or incentive plan available to the Company&#8217;s executives generally, on such terms as the Committee may determine in its discretion, and (ii) the equity-based incentive plans of the Company, pursuant to which he may receive awards thereunder, as determined by the Company&#8217;s Board of Directors in its sole discretion from time to time and subject to the terms and conditions of such plans and any applicable award agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Mr. Goodwin&#8217;s employment is terminated as a result of death or disability, Mr. Goodwin or his estate shall be entitled to receive (i) any unpaid base salary earned and accrued prior to the date of termination, (ii) reimbursement for expenses incurred prior to the date of termination, (iii) a pro rata bonus for the year of termination, and, (iv) if Mr. Goodwin is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Mr. Goodwin becomes eligible for medical and dental benefits through another employer. In addition, Mr. Goodwin&#8217;s outstanding option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Mr. Goodwin&#8217;s options (i) that were exercisable as of the effective date of the Goodwin Agreement and (ii) that would have become exercisable on the next anniversary of the effective date following the date of termination shall become and remain exercisable for a period of 12 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Mr. Goodwin&#8217;s employment is terminated by the Company for cause or by Mr. Goodwin without good reason, Mr. Goodwin shall be entitled to receive any unpaid base salary earned and accrued prior to the date of termination, and reimbursement for expenses incurred prior to the date of termination. In addition, in the event Mr. Goodwin&#8217;s employment is terminated by Mr. Goodwin without good reason, Mr. Goodwin&#8217;s stock option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Mr. Goodwin&#8217;s options which were exercisable as of the date of termination shall remain exercisable for a period of 3 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Mr. Goodwin&#8217;s employment is terminated by Mr. Goodwin for good reason, by the Company without cause, or in connection with a change of control (as defined in the Goodwin Agreement), Mr. Goodwin shall be entitled to receive (i) any unpaid base salary and other benefits earned and accrued prior to the date of termination, (ii) reimbursement for expenses incurred prior to the date of termination, (iii) a pro rata bonus for the year of termination, (iv) continued payment of his base salary for the twelve (12) month period following the date of termination, and (v) if Mr. Goodwin is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Mr. Goodwin becomes eligible for medical and dental benefits through another employer. In addition, Mr. Goodwin&#8217;s outstanding option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Mr. Goodwin&#8217;s options that (i) were exercisable as of the date of termination and (ii) would have become exercisable on the next anniversary of the effective date following the date of termination, shall become and remain exercisable for a period of 12 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Goodwin Agreement contains customary non-competition, non-solicitation, and confidentiality provisions in favor of the Company. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tara Semb Employment Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 16, 2020, the Company entered into an Amended and Restated Employment Agreement, effective as of September 16, 2020, with Tara Harris Semb, the Company&#8217;s Chief Financial Officer, Secretary and Treasurer (the &#8220;Semb Agreement&#8221;). The Semb Agreement amends and restates Ms. Semb&#8217;s original employment agreement, dated as of January 2, 2019, in its entirety. The term of Ms. Semb&#8217;s employment under the Semb Agreement commenced as of the effective date thereof and shall continue until terminated in accordance with the terms of the Semb Agreement. Under the Semb Agreement, Ms. Semb will receive an initial annual base salary of $328,000, which shall be reviewed from time to time and may be increased, but not decreased, by the Committee in its sole and exclusive discretion. Ms. Semb shall be entitled to participate in any bonus or incentive plan available to the Company&#8217;s executives generally, on such terms as the Committee may determine in its discretion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Ms. Semb&#8217;s employment is terminated as a result of death or disability, Ms. Semb or her estate shall be entitled to receive (i) any unpaid base salary earned and accrued prior to the date of termination, (ii) reimbursement for expenses incurred prior to the date of termination, (iii) a pro rata bonus for the year of termination, and, (iv) if Ms. Semb is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Ms. Semb becomes eligible for medical and dental benefits through another employer. In addition, Ms. Semb&#8217;s outstanding option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Ms. Semb&#8217;s options (i) that were exercisable as of the effective date of the Semb Agreement and (ii) that would have become exercisable on the next anniversary of the effective date following the date of termination shall become and remain exercisable for a period of 12 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Ms. Semb&#8217;s employment is terminated for by the Company for cause or by Ms. Semb without good reason, Ms. Semb shall be entitled to receive any unpaid base salary earned and accrued prior to the date of termination, and reimbursement for expenses incurred prior to the date of termination. In addition, in the event Ms. Semb&#8217;s employment is terminated by Ms. Semb without good reason, Ms. Semb&#8217;s stock option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Ms. Semb&#8217;s options which were exercisable as of the date of termination shall remain exercisable for a period of 3 months following the date of termination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Ms. Semb&#8217;s employment is terminated by Ms. Semb for good reason, by the Company without cause, or in connection with a change of control (as defined in the Semb Agreement), Ms. Semb shall be entitled to receive (i) any unpaid base salary and other benefits earned and accrued prior to the date of termination, (ii) reimbursement for expenses incurred prior to the date of termination, (iii) a pro rata bonus for the year of termination, (iv) continued payment of her base salary for the twelve (12) month period following the date of termination, and (v) if Ms. Semb is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Ms. Semb becomes eligible for medical and dental benefits through another employer. In addition, Ms. Semb&#8217;s outstanding option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Ms. Semb&#8217;s options that (i) were exercisable as of the date of termination and (ii) would have become exercisable on the next anniversary of the effective date following the date of termination, shall become and remain exercisable for a period of 12 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Semb Agreement contains customary non-competition, non-solicitation, and confidentiality provisions in favor of the Company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Todd Hornsby Employment Agreement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 17, 2020, the Company entered into an Amended and Restated Employment Agreement, effective as of September 17, 2020, with Todd Hornsby, the Company&#8217;s Executive Vice President (the &#8220;Hornsby Agreement&#8221;). The Hornsby Agreement amends and restates Mr. Hornsby&#8217;s original employment agreement, dated as of January 1, 2018, in its entirety. The term of Mr. Hornsby&#8217;s employment under the Hornsby Agreement commenced as of the effective date thereof and shall continue until terminated in accordance with the terms of the Hornsby Agreement. Under the Hornsby Agreement, Mr. Hornsby will receive an initial annual base salary of $347,000, which shall be reviewed from time to time and may be increased, but not decreased, by the Committee in its sole and exclusive discretion. Mr. Hornsby shall be entitled to participate in (i) any bonus or incentive plan available to the Company&#8217;s executives generally, on such terms as the Committee may determine in its discretion, and (ii) the equity-based incentive plans of the Company, pursuant to which he may receive awards thereunder, as determined by the Company&#8217;s Board of Directors in its sole discretion from time to time and subject to the terms and conditions of such plans and any applicable award agreement.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Mr. Hornsby&#8217;s employment is terminated as a result of death or disability, Mr. Hornsby or his estate shall be entitled to receive (i) any unpaid base salary earned and accrued prior to the date of termination, (ii) reimbursement for expenses incurred prior to the date of termination, (iii) a pro rata bonus for the year of termination, and, (iv) if Mr. Hornsby is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Mr. Hornsby becomes eligible for medical and dental benefits through another employer. In addition, Mr. Hornsby&#8217;s outstanding option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Mr. Hornsby&#8217;s options (i) that were exercisable as of the effective date of the Hornsby Agreement and (ii) that would have become exercisable on the next anniversary of the effective date following the date of termination shall become and remain exercisable for a period of 12 months following the date of termination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Mr. Hornsby&#8217;s employment is terminated by the Company for cause or by Mr. Hornsby without good reason, Mr. Hornsby shall be entitled to receive any unpaid base salary earned and accrued prior to the date of termination, and reimbursement for expenses incurred prior to the date of termination. In addition, in the event Mr. Hornsby&#8217;s employment is terminated by Mr. Hornsby without good reason, Mr. Hornsby&#8217;s stock option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Mr. Hornsby&#8217;s options which were exercisable as of the date of termination shall remain exercisable for a period of 3 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event Mr. Hornsby&#8217;s employment is terminated by Mr. Hornsby for good reason, by the Company without cause, or in connection with a change of control (as defined in the Hornsby Agreement), Mr. Hornsby shall be entitled to receive (i) any unpaid base salary and other benefits earned and accrued prior to the date of termination, (ii) reimbursement for expenses incurred prior to the date of termination, (iii) a pro rata bonus for the year of termination, (iv) continued payment of his base salary for the twelve (12) month period following the date of termination, and (v) if Mr. Hornsby is eligible for and elects continuation benefits under COBRA, the Company will pay the employer portion of the COBRA coverage premium for the shorter of (x) the 12-month period following the date of termination, or (y) the time at which Mr. Hornsby becomes eligible for medical and dental benefits through another employer. In addition, Mr. Hornsby&#8217;s outstanding option grants shall continue to be treated in accordance with the terms of the applicable plan and award agreement, provided that the portion of Mr. Hornsby&#8217;s options that (i) were exercisable as of the date of termination and (ii) would have become exercisable on the next anniversary of the effective date following the date of termination, shall become and remain exercisable for a period of 12 months following the date of termination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Hornsby Agreement contains customary non-competition, non-solicitation, and confidentiality provisions in favor of the Company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Moshe Citronowicz Employment Agreement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Citronowicz employment agreement contains an automatic extension for a period of one year after the initial term unless we provide Mr. Citronowicz with appropriate 60 days written notice pursuant to his contract. Mr. Citronowicz&#8217;s employment agreement provides, among other things, that the Mr. Citronowicz may be terminated as follows: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Upon the death of the Mr. Citronowicz, in which case Mr. Citronowicz&#8217;s estate shall be paid the basic annual compensation due to Mr. Citronowicz pro-rated through the date of death.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">By the resignation of Mr. Citronowicz at any time upon at least thirty (30) days prior written notice to Apyx in which case Apyx shall be obligated to pay Mr. Citronowicz the basic annual compensation due him pro-rated to the effective date of termination.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">By Apyx, &#8220;for cause&#8221; if during the term of the employment agreement Mr. Citronowicz violates the non-competition provisions of his employment agreement, or is found guilty in a court of law of any crime of moral turpitude in which case the contract would be terminated and provisions for future compensation forfeited.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">By Apyx, without cause, with the majority approval of the Board of Directors, for Mr. Citronowicz at any time upon at least thirty (30) days prior written notice to Mr. Citronowicz. In this case Apyx shall be obligated to pay Mr. Citronowicz compensation in effect at such time, including all bonuses, accrued or prorated and expenses up to the date of termination. Thereafter, Apyx shall pay Mr. Citronowicz three times the salary in effect at the time of termination payable in one lump sum.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">If Apyx fails to meet its obligations to Mr. Citronowicz on a timely basis, or if there is a change in the control of Apyx, the executive may elect to terminate Mr. Citronowicz&#8217;s employment agreement. Upon any such termination or breach of any of its obligations under the employment agreement, Apyx shall pay Mr. Citronowicz a lump sum severance equal to three times the annual salary and bonus in effect the month preceding such termination or breach as well as any other sums which may be due under the terms of the employment agreement up to the date of termination. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other employment contracts that have non-cancelable terms in excess of one year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information with respect to each unexercised stock option held by our Executive Officers as of December 31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"># of Securities<br/>Underlying<br/>Unexercised<br/>Options<br/>(# Exercisable)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"># of Securities Underlying Unexercised Options <br/>(# Unexercisable)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Option<br/>Exercise Price<br/>($/Sh)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Expiration<br/>Range After Grant Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/15/2027</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/19/2032</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/16/2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/19/2032</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/27/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/19/2032</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/9/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/19/2032</span></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2003, the Board of Directors adopted, and our stockholders approved Apyx&#8217;s 2003 Executive and Employee Stock Option Plan covering a total of 1,200,000 shares of common stock issuable upon exercise of options to be granted under the Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 30, 2007, our stockholders approved, and the Board of Directors adopted an amendment to the 2003 Executive and Employee Stock Option Plan to increase the maximum aggregate number of shares of common stock reserved for issuance under the 2003 Plan from 1.2 million shares (already reserved against outstanding options) to 1.7 million shares, or an increase of 500,000 shares of common stock for future issuance pursuant to the terms of the plan. Except for the increase in the number of shares covered by the plan, the plan remains otherwise unchanged from its present status. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2012, the Company&#8217;s stockholders approved the 2012 Share Incentive Plan covering a total of 750,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2022 approximately 170,000 are available to be issued in this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, the Company&#8217;s stockholders approved the 2015 Executive and Employee Stock Option Plan covering a total of 2,000,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2022 approximately 40,000 are available to be issued in this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the Company&#8217;s stockholders approved the 2017 Executive and Employee Stock Option Plan covering a total of 3,000,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2022 approximately 30,000 are available to be issued in this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company&#8217;s stockholders approved the 2019 Share Incentive Plan covering a total of 2,000,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2022, approximately 200,000 are available to be issued in this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company&#8217;s stockholders approved the 2021 Share Incentive Plan covering a total of 1,375,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2022, all 1,375,000 are available to be issued in this plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in the pricing of any options previously or currently awarded.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Compensation of Non-Employee Directors </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a table showing the director compensation for the year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fees Earned Or Paid in Cash ($) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards ($) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Awards * ($) (d) (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Equity Incentive Plan Compensation ($) (e)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other Compensation ($) (g)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total ($) (h)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Makrides</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lawrence J. Waldman</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Geraghty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Andres</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig Swandal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnie Baylor-Henry (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wendy Levine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(1) Compensation included in Option Awards includes an additional 20,000 option award for additional oversight activities in her capacity as the Chair of the Regulatory Compliance Committee.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%">These columns represent the grant date fair value of the awards as calculated in accordance with FASB ASC 718 (Stock Compensation).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, our Board of Directors consisted of Charles D. Goodwin, Andrew Makrides, John Andres, Lawrence J. Waldman, Michael Geraghty, Craig Swandal, Minnie Baylor-Henry, and Wendy Levine. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2022, the Board approved the following compensation arrangement for the Corporation&#8217;s non-employee directors:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Base Annual Director Fee</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the base annual cash compensation to be paid to each of the non-employee members of the Board shall be $40,000 per year.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Executive Chair and Vice Chair</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the additional cash compensation to be paid to the Non-executive Chair of the Board shall be $30,000.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the additional cash compensation to be paid to the Vice Chair of the Board shall be $27,500.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lead Independent Director</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the additional cash compensation to be paid to the Lead Independent Director of the Board shall be $15,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to the Chair of the Audit Committee of the Board shall be $46,000 per year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to each of the members of the Audit Committee of the Board (other than Chair of the Audit Committee) shall be $7,500.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to the Chair of the Compensation Committee of the Board shall be $10,000.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to each of the members of the Compensation Committee of the Board (other than the Chair of the Compensation Committee) shall be $5,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance and Nominating Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to the Chair of the Governance and Nominating Committee of the Board shall be $5,000.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to each of the members of the Governance and Nominating Committee of the Board (other than the Chair of the Governance and Nominating Committee) shall be $2,500.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Compliance Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to the Chair of the Regulatory Compliance Committee of the Board shall be $20,000.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in addition to the foregoing, the annual cash compensation to be paid to each of the members of the Regulatory Compliance Committee of the Board (other than the Chair of the Regulatory Compliance Committee) shall be $5,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Stock Option Grant</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each non-employee member of the Board shall be granted, on the date of the Corporation&#8217;s annual meeting of stockholders, an option to purchase 17,000 shares of the Corporation&#8217;s common stock at an exercise price equal to the closing price of the Corporation&#8217;s common stock on its principal exchange, which vests ratably over a one (1) year period, and upon such other terms as the Board may resolve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in the pricing of any options previously or currently awarded.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Compensation Committee Interlocks and Insider Participation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee of the Board of Directors is responsible for determining the compensation of executive officers of the Company, as well as compensation awarded pursuant to the Company&#8217;s equity incentive plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, our Compensation Committee consisted of four independent members of the Board of Directors, Michael Geraghty (Chairperson), John Andres, Lawrence J. Waldman and Wendy Levine.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No member of the Compensation Committee is or has been an officer or employee of the Company or any of its subsidiaries. In addition, no member of the Compensation Committee had any relationships with the Company or any other entity that require disclosure under the proxy rules and regulations promulgated by the SEC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION COMMITTEE REPORT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Annual Report on Form 10-K with management. Based on our Compensation Committee&#8217;s review of and the discussions with management with respect to the Compensation Discussion and Analysis, our Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in our Proxy Statement and in this Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 for filing with the SEC. During 2022, our Compensation Committee consisted of four independent members of the Board of Directors, Michael Geraghty, who served as Chairperson, John Andres,  Lawrence J. Waldman and Wendy Levine.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael Geraghty, Compensation Committee Chair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Andres, Compensation Committee Member</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawrence J. Waldman, Compensation Committee Member</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Wendy Levine, Compensation Committee Member</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The foregoing Compensation Committee Report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, and shall not otherwise be deemed filed under these acts, except to the extent we specifically incorporate by reference into such filings.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i300043246b3a40c4967f3225093a1c39_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Security Ownership of Certain Beneficial Owners</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information as of June 20, 2023, with respect to the beneficial ownership of the Company&#8217;s common stock by its executive officers, directors, all persons known by the Company to be the beneficial owners of more than 5% of its outstanding shares and by all officers and directors as a group. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.745%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and Address</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Owned (i)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nature of Ownership</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of Ownership (i)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Archon Capital Management, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,452,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1100 19th Avenue E</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seattle, WA 98122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RTW Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250 West 55th St. 16th Floor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York, NY 10019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William Weeks Vanderfelt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,158,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coralis 44, Azzuri Village 44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roches Noires, 31201 Mauritius</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PURA VIDA INVESTMENTS, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,287,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512 West 22nd Street, 7th Floor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York, NY 10011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divisadero Street Capital Management, LP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,056,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3350 Virginia Street, 2nd Floor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami, FL 33133</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cowen Financial Products, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,775,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">599 Lexington Avenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York, NY 10022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charles D. Goodwin II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,681,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Moshe Citronowicz</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.745%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew Makrides</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">716,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(iv)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd Hornsby</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">422,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(v)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tara Semb</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(vi)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lawrence Waldman</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(vii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael E. Geraghty</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(viii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Andres</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(ix)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Minnie Baylor-Henry</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(x)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Craig Swandal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(xi)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wendy Levine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(xii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beneficial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5115 Ulmerton Rd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearwater, FL 33760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Officers and Directors as a group (11 people)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,529,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i) Based on 34,613,517 outstanding shares of Common Stock as of June 20, 2023, of which officers and directors owned a total of 1,246,129 shares at June 20, 2023. We have calculated the percentage ownership in the table above on the basis of the number of outstanding securities plus, for each person or group, any securities that person or group has current or future right to acquire pursuant to options, warrants, conversion privileges or other rights based on the 13G and 13D SEC filings at June 20, 2023 (and exercisable within 60 days thereafter).</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(ii) Includes 40,000 shares and 1,641,000 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(iii) Includes 456,504 shares and 299,000 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(iv) Includes 624,389 shares and 92,000 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(v) Includes 0 shares and 422,668 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(vi) Includes 0 shares and 225,000 vested options (and exercisable within 60 days thereafter). </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(vii) Includes 37,563 shares and 177,500 vested options (and exercisable within 60 days thereafter). The vested options are held in a spousal lifetime access trust. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(viii) Includes 27,500  shares and 138,500 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(ix) Includes 0 shares and 138,500 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(x) Includes 0 shares and 88,000 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(xi) Includes 60,173 shares and 26,827 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(xii) Includes 0 shares and 34,000 vested options (and exercisable within 60 days thereafter).</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%">Delinquent Section 16(a) Reports </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 16(a) of the Securities Exchange Act of 1934 requires our officers and directors and persons who own more than ten percent of a registered class of our equity securities, to file reports of ownership and changes in ownership with the Securities and Exchange Commission. Officers, directors and greater than ten-percent stockholders (the &#8220;Reporting Persons&#8221;) are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Company&#8217;s knowledge, based solely on its review of the copies of such reports received or written representations from certain Reporting Persons that no other reports were required, the Company believes that during its fiscal year ended December 31, 2022 all filing requirements applicable to the Reporting Persons were timely met, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">with the exception of one delinquent filing for Mr. Swandal who inadvertently failed to timely file a Form 4 showing a single transaction. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div id="i300043246b3a40c4967f3225093a1c39_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is that employees, non-employees and third parties must obtain authorization from the appropriate department executive manager, for any business relationship or proposed business transaction in which they or an immediate family member has a direct or indirect interest, or from which they or an immediate family member may derive a personal benefit (a &#8220;related party transaction&#8221;). The maximum dollar amount of related party transactions that may be approved as described above in this paragraph in any calendar year is $120,000. Any related party transactions that would bring the total value of such transactions to greater than $120,000 must be referred to the Audit Committee to determine the procedure for approval and then have the recommendations presented to the Board for approval.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several relatives of Nikolay Shilev, Apyx Bulgaria&#8217;s Managing Director, are considered related parties. Teodora Shileva, Mr. Shilev&#8217;s spouse, is an employee of the Company working in the accounting department. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Svetoslav Shilev, Mr. Shilev&#8217;s son, is a quality manager in the quality assurance department.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Independent Board Members</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board currently has seven independent members, Andrew Makrides, John Andres, Michael Geraghty, Lawrence J. Waldman, Craig Swandal, Minnie Baylor-Henry and Wendy Levine who the Board determined meet the existing independence requirements of The NASDAQ Stock Market LLC and the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_22"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PROPOSAL TWO</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%;text-decoration:underline">RATIFICATION OF AUDITORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSM US LLP (&#8220;RSM&#8221;) has acted as the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s independent registered public accounting firm since 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Representatives of RSM are expected to be available at the meeting to respond to appropriate questions and will be given the opportunity to make a statement if they desire to do so. Neither the Company&#8217;s bylaws nor the governing documents or law require stockholder ratification of the selection of RSM as the Company&#8217;s independent registered public accounting firm. However, this proposal is being submitted to the stockholders as a matter of good corporate practice. If the stockholders do not ratify RSM, the appointment of another firm of independent certified public accountants may be considered by the Audit Committee. Even if RSM is ratified, the Audit Committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year if they determine that doing so is in the best interests of the Company and its stockholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE BOARD RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE RATIFICATION OF RSM US LLP AS THE COMPANY&#8217;S INDEPENDENT AUDITORS FOR FISCAL YEAR ENDING DECEMBER&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the aggregate fees billed to us and expected to be billed to us by RSM US LLP, our principal accountant for 2022 and 2021:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit related fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fees billed</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.52pt">Audit fees consist of billed and unbilled fees for professional services rendered for the audit of Apyx&#8217;s annual financial statements and reviews of its interim consolidated financial statements included in quarterly reports and other services related to statutory and regulatory filings or engagements.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.52pt">Audit related fees consist of billed and unbilled fees for assurance and related services that are reasonably related to the performance of the audit or reviews of Apyx&#8217;s consolidated financial statements and are not reported under &#8220;Audit Fees&#8221;.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.52pt">Tax fees consist of billed and unbilled fees for professional services rendered for tax compliance and tax advice (domestic and international). These services include assistance regarding federal and international tax compliance and planning associated with transfer pricing and research and development activities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.52pt">All other fees consist of fees for products and services other than the services reported above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">AUDIT COMMITTEE REPORT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee has furnished the following report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in the &#8220;Audit Committee Report&#8221; is not to be deemed to be &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the Securities and Exchange Commission (&#8220;SEC&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the Securities Act of 1933 or the Securities Exchange Act of 1934</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, nor is such information to be incorporated by reference into any future filings under these acts, as amended, except to the extent that we specifically incorporate it by reference into such filings. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee assists the Board of Directors in fulfilling its responsibilities by overseeing the accounting and financial reporting processes of Apyx, the audits of Apyx&#8217;s consolidated financial statements, the qualifications and performance of the independent registered public accounting firm engaged as Apyx&#8217;s independent auditor, and the performance of Apyx&#8217;s internal auditors. Management is responsible for the financial statements and the reporting process, including the system of internal controls. RSM US LLP (&#8220;RSM&#8221;), Apyx&#8217;s independent registered public accounting firm, is responsible for expressing an opinion on the conformity of the audited financial statements with accounting principles generally accepted in the United States of America.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Audit Committee, in fulfilling its responsibilities, among other things:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewed and discussed the audited financial statements contained in the Annual Report on Form 10-K for the year ended December 31, 2022 with Apyx&#8217;s management and with RSM;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discussed with RSM the matters required to be discussed by Statement on Auditing Standards No. 1301, Communication with Audit Committees, as amended and adopted by the Public Company Accounting Oversight Board; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">received written disclosures and the letter from RSM required by Public Company Accounting Oversight Board Rule 3526, Communication with Audit Committees Concerning Independence, and discussed with RSM its independence from Apyx and its management.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In reliance on the reviews and discussion noted above, the Audit Committee recommended to the Board of Directors, and the Board of Directors has approved, that the audited financial statements be included in Apyx&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, for filing with the SEC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lawrence J. Waldman, Audit Committee Chair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Andres, Audit Committee Member</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael Gera</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ghty, Audit Committee Member</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Craig Swandal, Audit Committee Member</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 14, 2023 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_2579"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PROPOSAL THREE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%;text-decoration:underline">APPROVAL OF THE 2023 SHARE INCENTIVE PLAN</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Annual Meeting, stockholders will be asked to approve the Company&#8217;s 2023 Share Incentive Plan (the &#8220;2023 Plan&#8221;), which was adopted by the Board subject to approval by the Company&#8217;s stockholders. The Board considers the 2023 Plan to be important to: (i) aid in maintaining and developing key employees capable of assuring the future success of the Company and to offer such personal incentives to put forth maximum efforts for the success of the Company's business; (ii) to enhance the Company's ability to attract and retain the services of experienced and knowledgeable outside directors; and (iii) to afford such key employees and outside directors an opportunity to acquire a proprietary interest in the Company, thereby aligning their interests with the interests of the Company&#8217;s stockholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE BOARD RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE APPROVAL OF THE 2023 SHARE INCENTIVE PLAN.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Summary of the New Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary of the main features of the 2023 Plan is qualified in its entirety by reference to the complete text of the 2023 Plan, which is set forth as Exhibit A to this Proxy Statement. For purposes of the discussion contained in this Proposal No. 3, all capitalized terms shall have the meaning proscribed to such terms in the 2023 Plan, except as otherwise provided.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Plan authorizes the grant and issuance of two different types of Awards: Options (&#8220;Stock Options&#8221;), which can qualify as &#8220;incentive stock options&#8221; under the Code, or as &#8220;non-qualified stock options;&#8221; and Restricted Stock, which is stock that is contingent on an employee satisfying conditions, including without limitation continued employment, passage of time or satisfaction of performance criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Plan has a number of special terms and limitations, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The exercise price for Stock Options granted under the 2023 Plan must at least equal the Shares&#8217; fair market value at the time the Stock Option is granted;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The 2023 Plan expressly states that Stock Options granted under it cannot be &#8220;repriced,&#8221; as defined in the 2023 Plan, without stockholder approval;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">1,600,000 shares, are proposed to be available for granting any Award under the 2023 Plan; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Stoc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">kholder approval is required for certain types of amendments to the 2023 Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Eligibility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Key Employee, including any Key Employee who is an officer or director of the Company or any Affiliate, any Outside Director or a third party consultant to the Company or any Affiliate shall be eligible to be designated a Participant; provided however, that an Incentive Stock Option shall not be granted to: (1) an Outside Director; or (2) an employee of an Affiliate unless such Affiliate is also a &#8220;subsidiary corporation&#8221; of the Company within the meaning of Section 424(f) of the Code.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Administration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Plan may be administered by a committee of the Board comprised of non-employee directors (the &#8220;Committee&#8221;), although the Board may exercise any authority of the Committee under the 2023 Plan in lieu of the Committee&#8217;s exercise thereof.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the Plan and applicable law, the Committee shall have full power and authority to: (i) designate Participants; (ii) determine the type or types of Awards to be granted to each Participant under the Plan; (iii) determine the number of Shares to be covered by (or with respect to which payments are to be calculated in connection with) Awards; (iv) determine the terms and conditions of any Award or Award Agreement; (v) amend the terms and conditions of any Award or Award Agreement and accelerate the exercisability of Options or the lapse of restrictions relating to Restricted Stock; (vi) determine whether to, to what extent and under what circumstances Awards may be exercised in cash, Shares, other securities, other Awards or other property, or canceled, forfeited or suspended; (vii) determine whether, to what extent and under what circumstances cash or Shares payable with respect to an Award under the Plan shall be deferred either automatically or at the election of the holder thereof or the Committee; (viii) interpret and administer the Plan and any instrument or agreement </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relating to, or Award made under, the Plan; (ix) establish, amend, suspend or waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of the Plan; and (x) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares Available for Awards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate number of Shares that can be issued under the 2023 Plan may not exceed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1,600,000 (including pursuant to Incentive Stock Options). If any Shares covered by an Award or to which an Award relates are not purchas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed or are forfeited or if an Award otherwise terminates without the delivery of any shares or cash payments to be received thereunder, then the number of Shares counted against the aggregate number of Shares available under the Plan with respect to such Award, to the extent of any such forfeiture or termination, shall again be available for granting Awards under the Plan. In addition, any shares that are used by a Participant as full or partial payment to the Company of the purchase price of Shares acquired upon exercise of an Option or satisfy applicable tax withholding requirements (including social insurance requirements) upon the exercise or vesting of an Award shall again be available for granting Awards.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Committee shall determine that any dividend or other distribution (whether in the form of cash, Shares, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company or other similar corporate transaction or event affects the Shares such that an adjustment is determined by the Committee to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and type of Shares (or securities or other property) which thereafter may be made the subject of Awards, (ii) the number and type of Shares (or securities or other property) subject to outstanding Awards and (iii) the exercise price with respect to any Award; provided, however, that the number of Shares covered by any Award or to which such Award relates shall always be a whole number.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Awards</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Plan authorizes the grant and issuance of the following types of Awards: Stock Options and Restricted Stock.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to the express provisions of the 2023 Plan and as discussed in this paragraph, the Committee has discretion to determine the vesting schedule of Stock Options, the events causing a Stock Option to expire, the number of shares subject to any Stock Option, the restrictions on transferability of a Stock Option, and such further terms and conditions, in each case not inconsistent with the 2023 Plan, as may be determined from time to time by the Committee. The 2023 Plan expressly provides that the Company cannot &#8220;reprice&#8221; Stock Options without stockholder approval. The exercise price for Stock Options may not be less than 100% of the fair market value of the Common Stock (as determined pursuant to the 2023 Plan) at the time the Stock Option is granted. The term of each Option shall be fixed by the Committee, but such term shall not exceed 10 years from the date on which such Option is granted. The Committee shall determine the time or times at which an Option may be exercised in whole or in part and the method or methods by which, and the form or forms (including, without limitation, cash, Shares, other securities, cashless exercise, other Awards or other property, or any combination thereof, having a Fair Market Value on the exercise date equal to the relevant exercise price) in which payment of the exercise price with respect thereto may be made or deemed to have been made.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee may make Awards of restricted stock to participants, which will be subject to restrictions on transferability and other restrictions as the Committee may impose, including, without limitations on the right to vote restricted stock or the right to receive dividends, if any, on the restricted stock. These Awards may be subject to forfeiture and reacquired by the Company upon any conditions or criteria established by the Committee, including without limitation termination of employment or upon resignation or removal as an Outside Director during the applicable restriction period.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amendments and Termination</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may amend, alter, suspend, discontinue or terminate the Plan; provided, however, that, notwithstanding any other provision of the Plan or any Award Agreement, without the approval of the stockholders of the Company, no such amendment, alteration, suspension, discontinuation or termination shall be made that:</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:50.5pt">change the maximum number of shares of Common Stock for which Awards may be granted under this Plan;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:50.5pt">extend the term of this Plan; or</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:50.5pt">change the class of persons eligible to participate in the Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee may amend, alter or discontinue an Award made under the Plan which would impair the rights of any Award holder, without such holder&#8217;s consent, under any Award theretofore granted; provided that no such consent shall be required if the Committee determines in its sole discretion and prior to the date of any change in control, recapitalization, stock dividend, stock split, reorganization, merger, consolidation or similar type transaction that such amendment or alteration either is required or advisable in order for the Company, the Plan or any Award granted to satisfy any law or regulation or to meet the requirements of any accounting standard.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No Award granted under the 2023 Plan shall be granted pursuant to the 2023 Plan more than 10 years after the date of the Company&#8217;s stockholders&#8217; adoption of the 2023 Plan.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Withholding; Tax Bonuses</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Withholding.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In order to comply with all applicable federal, state or foreign income tax or social insurance contribution laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal, state or foreign payroll, withholding, income, social insurance contributions or other taxes, which are the sole and absolute responsibility of a Participant, are withheld or collected from such Participant. In order to assist a Participant in paying all federal, state and foreign taxes to be withheld or collected upon exercise or receipt of (or the lapse of restrictions relating to) an Award, the Committee, in its discretion and subject to such additional terms and conditions as it may adopt, may permit the Participant to satisfy such tax obligation by (i) electing to have the Company withhold a portion of the Shares otherwise to be delivered upon exercise or receipt of (or the lapse of restrictions relating to) such Award with a Fair Market Value equal to the amount of such taxes or (ii) delivering to the Company Shares other than Shares issuable upon exercise or receipt of (or the lapse of restrictions relating to) such Award with a Fair Market Value equal to the amount of such taxes. The election, if any, must be made on or before the date that the amount of tax to be withheld is determined.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Bonuses. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee, in its discretion, shall have the authority, at the time of grant of any Award under this Plan or at any time thereafter to approve bonuses to designated Participants to be paid upon their exercise or receipt of (or the lapse of restrictions relating to) Awards in order to provide funds to pay all or a portion of federal, state and foreign taxes due as a result of such exercise or receipt (or the lapse of such restrictions). The Committee shall have full authority in its discretion to determine the amount of any such tax bonus.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effect to Company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company generally will be entitled to a tax deduction in connection with an Award under the 2023 Plan in an amount equal to the compensation income (ordinary income) realized by a Participant and at the time the Participant recognizes such income (for example, the exercise of a NQSO). Special rules limit the deductibility of compensation paid to certain Covered Employees of the Company (as defined by Section 162(m) of the Code, the annual compensation paid to any of these Covered Employees will be deductible only to the extent that it does not exceed $1,000,000 or if the compensation is paid solely on account of attaining one or more pre-established, objective performance goals. The 2023 Plan has been constructed such that some Awards in the Committee&#8217;s discretion may qualify as &#8220;performance-based compensation&#8221; under Section 162(m) of the Code and thus would be deductible even if the total compensation paid to the Covered Employee is in excess of $1,000,000. However, whether an Award will qualify under Section 162(m) as &#8220;performance-based compensation&#8221; will depend on the terms, conditions and type of the Award issued to the Covered Employee. For example, grants of Stock Options or Restricted Stock often vest only according to the optionee&#8217;s or grantee&#8217;s length of employment rather than pre-established performance goals. Therefore, the compensation derived from the Awards made to Covered Employees may not be deductible by the Company to the extent the Covered Employee&#8217;s total compensation exceeds $1,000,000.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming a quorum is present at the Annual Meeting, the affirmative vote of a majority of votes cast by the holders of Common Stock represented and entitled to vote at the Annual Meeting is required to approve the 2023 Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board believes that the approval of the 2023 Plan is in the Company&#8217;s and the stockholders&#8217; best interests. The Company&#8217;s non-employee directors have an interest in the proposal to adopt the 2023 Plan since each is an eligible Participant in Awards under the 2023 Plan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS FOR NEXT ANNUAL MEETING</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder proposals intended to be considered for inclusion in the proxy statement for presentation at the Company&#8217;s&#160;2024&#160;Annual Meeting of Stockholders must be received in writing at the Company&#8217;s offices at&#160;5115 Ulmerton Road, Clearwater, Florida 33760, Attn: Corporate Secretary, no later than March 1, 2024, for inclusion in the Company&#8217;s proxy statement and proxy card relating to such meeting. Such proposals must comply with applicable SEC rules and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for any proposal that is not submitted for inclusion in next year&#8217;s proxy statement (as described in the preceding paragraph) to be presented directly at next year&#8217;s annual meeting, we must receive written notice of the proposal in a timely manner, but in any event no later than&#160;March 29, 2024. If such notice is received, proxies may be voted at the discretion of management if we advise stockholders in next year&#8217;s proxy statement about the nature of the matter and how management intends to vote on such matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Securities Exchange Act of 1934 no later than June 11, 2024.</span></div><div><span><br/></span></div><div id="i300043246b3a40c4967f3225093a1c39_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOUSEHOLDING OF PROXY MATERIALS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission permits companies and intermediaries such as brokers to satisfy the delivery requirements for proxy materials with respect to two or more stockholders sharing the same address by delivering a single set of proxy materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding&#8221;, potentially provides extra conveniences for stockholders and cost savings for companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not intend to household for our stockholders of record, some brokers household our proxy materials, delivering a single set of proxy materials to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate set of proxy materials, or if you are receiving multiple sets of proxy materials and wish to receive only one, please notify your broker. Stockholders who currently receive multiple sets of the proxy materials at their address and would like to request &#8220;householding&#8221; of their communications should contact their broker.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_34"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board is not aware of any other matter other than those set forth in this Proxy Statement that will be presented for action at the Annual Meeting. If other matters properly come before the Annual Meeting, the persons appointed as proxies intend to vote the shares they represent in accordance with their best judgment in the interest of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCLUDED WITH THIS PROXY STATEMENT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WE ARE PROVIDING HEREWITH, A COPY OF THE COMPANY&#8217;S ANNUAL REPORT ON FORM 10-K, WITHOUT EXHIBITS, FOR THE YEAR ENDED&#160;DECEMBER&#160;31, 2022, INCLUDING THE FINANCIAL STATEMENTS AND SCHEDULES FILED THEREWITH. IF ANY PERSON RECEIVES THIS PROXY MATERIALS WITHOUT THE FOREGOING DOCUMENTS, THE COMPANY UNDERTAKES TO PROVIDE, WITHOUT CHARGE, UPON A WRITTEN OR ORAL REQUEST OF SUCH PERSON AND BY FIRST CLASS MAIL OR OTHER EQUALLY PROMPT MEANS WITHIN ONE BUSINESS DAY OF RECEIPT OF SUCH REQUEST, A COPY OF THE COMPANY&#8217;S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED&#160;DECEMBER&#160;31, 2022, INCLUDING THE FINANCIAL STATEMENTS AND SCHEDULES FILED THEREWITH. WRITTEN REQUESTS FOR SUCH REPORTS SHOULD BE ADDRESSED TO THE OFFICE OF THE SECRETARY, APYX MEDICAL CORPORATION,&#160;5115 ULMERTON ROAD, CLEARWATER, FLORIDA 33760. THE COMPANY&#8217;S TELEPHONE NUMBER AT SUCH OFFICE IS&#160;(727) 384-2323.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_40"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHETHER OR NOT YOU INTEND TO BE PRESENT AT THE ANNUAL MEETING, PLEASE COMPLETE, SIGN, DATE AND RETURN THE ENCLOSED PROXY AT YOUR EARLIEST CONVENIENCE.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the information and reporting requirements of the Securities Exchange Act of 1934 and in accordance with that act, we file periodic reports, documents and other information with the Securities and Exchange Commission relating to our business, financial statements and other matters. These reports and other information may be inspected and are available for copying at the offices of the Securities and Exchange Commission, 100 F. Street NE, Washington, DC 20549 or may be accessed at&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:46.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">By order of the Board of Directors</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: June 23, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Andrew Makrides</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Makrides</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board of Directors</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_43"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">APYX MEDICAL CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PROXY</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">You may vote by:</span></div><div><img src="apyx-20230623_g2.jpg" alt="2023 Proxy Card2 sizedv2.jpg" style="height:183px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROXY FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON&#160;AUGUST&#160;10, 2023. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned hereby acknowledges receipt of Notice of Annual Meeting of Stockholders and Proxy Statement of Apyx Medical Corporation in connection with the&#160;2023&#160;Annual Meeting to be held on&#160;August&#160;10, 2023, and appoints&#160;Andrew Makrides&#160;and&#160;Charles D. Goodwin, or either of them, proxy with power of substitution, for and in the name of the undersigned, and hereby authorizes each or either of them to represent and to vote, all the shares of common stock of Apyx Medical Corporation, a Delaware corporation (&#8220;Company&#8221;), that the undersigned would be entitled to vote at our Annual Meeting of Stockholders (&#8220;Annual Meeting&#8221;) on&#160;August 10, 2023&#160;and at any adjournments thereof, upon the matters set forth in the Notice of Annual Meeting, hereby revoking any proxy heretofore given. The proxy holders appointed hereby are further authorized to vote in their discretion upon such other business as may properly come before the Annual Meeting. This proxy will be voted as specified.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If no direction is made, this proxy will be voted in favor of all proposals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board recommends that you vote &#8220;FOR&#8221; the Board&#8217;s nominees for directors (Proposal 1); &#8220;FOR&#8221; the ratification of RSM US LLP (Proposal 2); &#8220;FOR&#8221; the approval of the 2023 Incentive Plan (Proposal 3); and, in the proxy holder&#8217;s best judgment, as to any other matters that may properly come before the Annual Meeting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;Please mark your votes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as in this example using</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">dark ink only.</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The election of the following nominees to the Company&#8217;s Board of Directors to serve until the 2024 Annual Meeting of Stockholders: Andrew Makrides, Charles D. Goodwin, Michael Geraghty, Lawrence J. Waldman, John Andres, Craig Swandal, Minnie Baylor-Henry and Wendy Levine.<br/></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Makrides</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles D. Goodwin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Geraghty</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">04)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lawrence J. Waldman</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Andres</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">06)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Craig Swandal</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnie Baylor-Henry</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">08)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wendy Levine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The ratification of RSM US LLP as the Company&#8217;s independent public accountants for the year ending December 31, 2023.<br/></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The approval of the 2023 Share Incentive Plan.<br/></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AGAINST</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABSTAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In their discretion, the proxy holders are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof, all as set out in the Notice and Proxy Statement relating to the Annual Meeting, receipt of which are hereby acknowledged.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please sign exactly as your name appears and return this proxy card immediately in the enclosed stamped self-addressed envelope.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTE: Please mark, date and sign exactly as name(s) appear on this proxy and return the proxy card promptly using the enclosed envelope. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. Executors, administrators, attorneys, trustees, or guardians should state full title or capacity. Joint owners should each sign. If signer is a partnership, please sign in partnership name by authorized person.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i300043246b3a40c4967f3225093a1c39_2585"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit A</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APYX MEDICAL CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 SHARE INCENTIVE PLAN</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1. Purpose.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purposes of the Apyx Medical Corporation Share Incentive Plan (the &#8220;Plan&#8221;) are to: (i) aid in maintaining and developing key employees capable of assuring the future success of Apyx Medical Corporation (the &#8220;Company&#8221;), and to offer such personnel incentives to put forth maximum efforts for the success of the Company&#8217;s business; (ii) to enhance the Company&#8217;s ability to attract and retain the services of experienced and knowledgeable outside directors; and (iii) to afford such key employees and outside directors an opportunity to acquire a proprietary interest in the Company, thereby aligning their interests with the interests of the Company&#8217;s stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2. Definitions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in the Plan, the following terms shall have the meanings set forth below:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Award&#8221; shall mean any Option or Restricted Stock granted under the Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;Award Agreement&#8221; shall mean any written agreement, contract or other instrument or document evidencing any Award granted under the Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended from time to time, and any regulations promulgated thereunder.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;Committee&#8221; shall mean a committee of the Board of Directors of the Company designated by such Board to administer the Plan and composed of not less than three (3) directors, each of whom is a &#8220;Non-Employee Director&#8221; within the meaning of Rule 16b-3.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">&#8220;Fair Market Value&#8221; shall mean, with respect to any property (including, without limitation, any Shares or other securities), the fair market value of such property determined by such methods or procedures as shall be established from time to time by the Committee. Notwithstanding the foregoing, for purposes of the Plan, the Fair Market Value of Shares on a given date shall be the closing price of the Shares on such date on The NASDAQ Stock Market LLC (&#8220;NASDAQ&#8221;) or any other national securities exchange on which the Company&#8217;s Common Stock is listed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Incentive Stock Option&#8221; shall mean an option granted under Section 6(a) of the Plan that is intended to meet the requirements of Section 422 of the Code or any successor provision thereto.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Key Employee&#8221; shall mean any employee of the Company or any Affiliate who the Committee determines to be a key employee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;Non-Qualified Stock Option&#8221; shall mean an option granted under Section 6(a) of the Plan that is not intended to be an Incentive Stock Option.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;Option&#8221; shall mean an Incentive Stock Option or a Non-Qualified Stock Option.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Outside Director&#8221; shall mean each member of the Board of Directors of the Company that is not also an employee of the Company or any Affiliate of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;Participant&#8221; shall mean either: (i) a Key Employee, (ii) an Outside Director, or (iii) a third party consultant to the Company or any Affiliate designated to be granted an Award under the Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">&#8220;Person&#8221; shall mean any individual, corporation, partnership, association or trust.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Restricted Stock&#8221; shall mean any Share granted under Section 6(b) of the Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Rule 16b-3&#8221; shall mean Rule 16b-3 promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, or any successor rule or regulation thereto.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;Shares&#8221; shall mean shares of Common Stock, $0.001 par value, of the Company or such other securities or property as may become subject to Awards pursuant to an adjustment made under Section 4(c) of the Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3. Administration.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Power and Authority of the Committee.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Plan shall be administered by the Board of Directors, or if the Board of Directors shall so designate, by the Committee. For purposes of this Plan, references to the Committee shall mean either the Board of Directors or the Committee if the Committee has been designated by the Board of Directors to administer the Plan. Subject to the terms of the Plan and applicable law, the Committee shall have full power and authority to: (i) designate Participants; (ii) determine the type or types of Awards to be granted to each Participant under the Plan; (iii) determine the number of Shares to be covered by (or with respect to which payments are to be calculated in connection with) Awards; (iv) determine the terms and conditions of any Award or Award Agreement; (v) amend the terms and conditions of any Award or Award Agreement and accelerate the exercisability of Options or the lapse of restrictions relating to Restricted Stock; (vi) determine whether, to what extent and under what circumstances Awards may be exercised in cash, Shares, other securities, other Awards or other property, or canceled, forfeited or suspended; (vii) determine whether, to what extent and under what circumstances cash or Shares payable with respect to an Award under the Plan shall be deferred either automatically or at the election of the holder thereof or the Committee; (viii) interpret and administer the Plan and any instrument or agreement relating to, or Award made under, the Plan; (ix) establish, amend, suspend or waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of the Plan; and (x) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan. Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations and other decisions under or with respect to the Plan or any Award shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon any Participant, any holder or beneficiary of any Award and any employee of the Company or any Affiliate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Meetings of the Committee.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee shall select one of its members as its chairman and shall hold its meetings at such times and places as the Committee may determine. A majority of the Committee&#8217;s members shall constitute a quorum. All determinations of the Committee shall be made by not less than a majority of its members. Any decision or determination reduced to writing and signed by all of the members of the Committee shall be fully effective as if it had been made by a majority vote at a meeting duly called and held. The Committee may appoint a secretary and may make such rules and regulations for the conduct of its business as it shall deem advisable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 4. Shares Available for Awards.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Shares Available.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Subject to adjustment as provided in Section 4(c), the number of Shares available for the granting of Awards under the Plan shall be 1,600,000. If any Shares covered by an Award or to which an Award relates are not purchased or are forfeited, or if an Award otherwise terminates without delivery of any Shares or cash payments to be received thereunder, then the number of Shares counted against the aggregate number of Shares available under the Plan with respect to such Award, to the extent of any such forfeiture or termination, shall again be available for granting Awards under the Plan. In addition, any Shares that are used by a Participant as full or partial payment to the Company of the purchase price of Shares acquired upon exercise of an Option or to satisfy applicable tax withholding requirements (including social insurance requirements) upon the exercise or vesting of an Award shall again be available for granting Awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Accounting for Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For purposes of this Section 4, if an Award entitles the holder thereof to receive or purchase Shares, the number of Shares covered by such Award or to which such Award relates shall be counted on the date of grant of such Award against the aggregate number of Shares available for granting Awards under the Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that the Committee shall determine that any dividend or other distribution (whether in the form of cash, Shares, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company or other similar corporate transaction or event affects the Shares such that an adjustment is determined by the Committee to be </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and type of Shares (or securities or other property) which thereafter may be made the subject of Awards, (ii) the number and type of Shares (or securities or other property) subject to outstanding Awards and (iii) the exercise price with respect to any Award; provided, however, that the number of Shares covered by any Award or to which such Award relates shall always be a whole number.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5. Eligibility.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Key Employee, including any Key Employee who is an officer or director of the Company or any Affiliate, any Outside Director or a third party consultant to the Company or any Affiliate shall be eligible to be designated a Participant; provided, however, that an Incentive Stock Option shall not be granted to: (1) an Outside Director; or (2) an employee of an Affiliate unless such Affiliate is also a &#8220;subsidiary corporation&#8221; of the Company within the meaning of Section 424(f) of the Code.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 6. Awards.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Options.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee is hereby authorized to grant Options to Participants with the following terms and conditions and with such additional terms and conditions not inconsistent with the provisions of the Plan as the Committee shall determine:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.73pt">Exercise Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The purchase price per Share purchasable under an Option shall be determined by the Committee; provided, however, that such purchase price shall not be less than the Fair Market Value of the Shares on the date such option is granted.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.96pt">Option Term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The term of each Option shall be fixed by the Committee, but such term shall not exceed 10 years from the date on which such Option is granted.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.19pt">Time and Method of Exercise.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee shall determine the time or times at which an Option may be exercised in whole or in part and the method or methods by which, and the form or forms (including, without limitation, cash, Shares, other securities, cashless exercise, other Awards or other property, or any combination thereof, having a Fair Market Value on the exercise date equal to the relevant exercise price) in which payment of the exercise price with respect thereto may be made or deemed to have been made.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Restricted Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee is hereby authorized to grant Awards of Restricted Stock to Participants with the following terms and conditions and with such additional terms and conditions not inconsistent with the provisions of the Plan as the Committee shall determine:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.73pt">Restrictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Shares of Restricted Stock shall be subject to such restrictions as the Committee may impose (including, without limitation, any limitation on the right to vote a Share of Restricted Stock or the right to receive any dividend or other right or property with respect thereto), which restrictions may lapse separately or in combination at such time or times, in such installments or otherwise as the Committee may deem appropriate.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.96pt">Stock Certificates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Any Restricted Stock granted under the Plan shall be evidenced by issuance of a stock certificate or certificates. Such certificate or certificates shall be registered in the name of the Participant and shall bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Restricted Stock.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.19pt">Forfeiture; Delivery of Shares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except as otherwise determined by the Committee, upon termination of employment or upon resignation or removal as an Outside Director (as determined under criteria established by the Committee) during the applicable restriction period, all Shares of Restricted Stock at such time subject to restriction shall be forfeited and reacquired by the Company; provided, however, that the Committee may, when it finds that a waiver would be in the best interest of the Company, waive in whole or in part any or all remaining restrictions with respect to Shares of Restricted Stock. Shares representing Restricted Stock that are no longer subject to restrictions shall be delivered to the holder thereof promptly after the applicable restrictions lapse or are waived.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.73pt">No Cash Consideration for Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except as otherwise determined by the Committee, Awards shall be granted for no cash consideration or for such minimal cash consideration as may be required by applicable law.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.96pt">Awards May Be Granted Separately or Together. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with or in substitution for any other Award or any award granted under any plan of the Company or any Affiliate other than the Plan. Awards granted in addition to or in tandem with other Awards or in addition to or in tandem with awards granted under any such other plan of the Company or any Affiliate may be granted either at the same time as or at a different time from the grant of such other Awards or awards.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.19pt">Forms of Payment Under Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Subject to the terms of the Plan and of any applicable Award Agreement, payments to be made by the Company or an Affiliate upon the grant, exercise or payment of an Award may be made in Shares, cash or a combination thereof as the Committee shall determine, and may be made in a single payment, in installments or on a deferred basis, in each case in accordance with rules and procedures established by the Committee. Such rules and procedures may include, without limitation, provisions for the payment or crediting of reasonable interest on installments or deferred payments.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.3pt">Limits On Transfer of Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No Award and no right under any such Award shall be assignable, alienable, salable or transferable by a Participant otherwise than by will or by the laws of descent and distribution; provided, however, that a Participant may, in the manner established by the Committee,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.28pt">designate a beneficiary or beneficiaries to exercise the rights of the Participant and receive any property distributable with respect to any Award upon the death of the Participant, or</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.84pt">transfer a Non-Qualified Stock Option to any &#8220;family member&#8221; (as such term is used in Form S-8 under the Securities Act of 1933) of such Participant, provided that (1) there is no consideration for such transfer or such transfer is effected pursuant to a domestic relations order in settlement of marital property rights, and (2) the Non-Qualified Stock Options held by such transferees continue to be subject to the same terms and conditions (including restrictions or subsequent transfers) as were applicable to such Non-Qualified Stock Options immediately prior to their transfer.</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Award or right under any Award shall be exercisable during the Participant&#8217;s lifetime only by the Participant, by a transferee pursuant to a transfer permitted by clause (B) of this Section 6(c)(iv), or, if permissible under applicable law, by the Participant&#8217;s or such transferee&#8217;s guardian or legal representative. No Award or right under any such Award may be pledged, alienated, attached or otherwise encumbered, and any purported pledge, alienation, attachment or encumbrance thereof shall be void and unenforceable against the Company or any Affiliate.</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Term of Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Subject to the terms of the Plan, the term of each Award shall be for such period as may be determined by the Committee.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">vi.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.3pt">Restrictions; Securities Exchange Listing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All certificates for Shares delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the Securities and Exchange Commission and any applicable federal, state or foreign securities laws, and the Committee may cause a legend or legends to be placed on any such certificates to make appropriate reference to such restrictions. If the Shares are traded on a securities exchange, the Company shall not be required to deliver any Shares covered by an Award unless and until such Shares have been admitted for trading on such securities exchange.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 7. Amendment and Termination; Adjustments.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except to the extent prohibited by applicable law and unless otherwise expressly provided in an Award Agreement or in the Plan:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Amendments to the Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board of Directors of the Company may amend, alter, suspend, discontinue or terminate the Plan; provided, however, that, notwithstanding any other provision of the Plan or any Award Agreement, without </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the approval of the stockholders of the Company, no such amendment, alteration, suspension, discontinuation or termination shall be made that:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">absent such approval, would cause Rule 16b-3 to become unavailable with respect to the Plan;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">requires the approval of the Company&#8217;s stockholders under any rules or regulations of The NASDAQ Stock Exchange LLC, or, if applicable Financial Industry Regulatory Authority, Inc. or any securities exchange that are applicable to the Company; or</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">requires the approval of the Company&#8217;s stockholders under the Code in order to permit Incentive Stock Options to be granted under the Plan.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Amendments to Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee may waive any conditions of or rights of the Company under any outstanding Award, prospectively or retroactively, subject to Section 7(c) of the Plan. The Committee may not amend, alter, suspend, discontinue or terminate any outstanding Award, prospectively or retroactively, without the consent of the Participant or holder or beneficiary thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Prohibition on Option Repricing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee shall not reduce the exercise price of any outstanding Option, whether through amendment, cancellation or replacement grants, or any other means, without shareholder approval.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Correction of Defects, Omissions and Inconsistencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem desirable to carry the Plan into effect.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 8. Income Tax Withholding; Tax Bonuses.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Withholding.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In order to comply with all applicable federal, state or foreign income tax or social insurance contribution laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal, state or foreign payroll, withholding, income, social insurance contributions or other taxes, which are the sole and absolute responsibility of a Participant, are withheld or collected from such Participant. In order to assist a Participant in paying all federal, state and foreign taxes to be withheld or collected upon exercise or receipt of (or the lapse of restrictions relating to) an Award, the Committee, in its discretion and subject to such additional terms and conditions as it may adopt, may permit the Participant to satisfy such tax obligation by (i) electing to have the Company withhold a portion of the Shares otherwise to be delivered upon exercise or receipt of (or the lapse of restrictions relating to) such Award with a Fair Market Value equal to the amount of such taxes or (ii) delivering to the Company Shares other than Shares issuable upon exercise or receipt of (or the lapse of restrictions relating to) such Award with a Fair Market Value equal to the amount of such taxes. The election, if any, must be made on or before the date that the amount of tax to be withheld is determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Tax Bonuses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee, in its discretion, shall have the authority, at the time of grant of any Award under this Plan or at any time thereafter to approve bonuses to designated Participants to be paid upon their exercise or receipt of (or the lapse of restrictions relating to) Awards in order to provide funds to pay all or a portion of federal, state and foreign taxes due as a result of such exercise or receipt (or the lapse of such restrictions). The Committee shall have full authority in its discretion to determine the amount of any such tax bonus.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 9. General Provisions.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">No Rights to Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No Key Employee, Participant or other Person shall have any claim to be granted any Award under the Plan, and there is no obligation for uniformity of treatment of Key Employees, Participants or holders or beneficiaries of Awards under the Plan. The terms and conditions of Awards need not be the same with respect to different Participants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Delegation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee may delegate to one or more officers of the Company or any Affiliate or a committee of such officers the authority, subject to such terms and limitations as the Committee shall determine, to grant Awards to Key Employees who are not officers or directors of the Company for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">Terms of Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The specific terms of an Award pursuant to the Plan shall be set forth in an Award Agreement duly executed (by manual, facsimile or electronic signature) on behalf of the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">No Limit on Other Compensation Arrangements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting or continuing in effect other or additional compensation arrangements, and such arrangements may be either generally applicable or applicable only in specific cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.07pt">No Right to Employment or Directorship.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The grant of an Award shall not be construed as giving a Participant the right to be retained in the employ of the Company or any Affiliate or any right to remain as a member of the Board of Directors, as the case may be. In addition, the Company or an Affiliate may at any time dismiss a Participant from employment (or remove an Outside Director), free from any liability or any claim under the Plan, unless otherwise expressly provided in the Plan or in any Award Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.17pt">Governing Law.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The validity, construction and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with the laws of the State of Delaware, without regard to its conflicts of laws principals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Severability. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Committee, materially altering the purpose or intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction or Award, and the remainder of the Plan or any such Award shall remain in full force and effect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">No Trust or Fund Created.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and a Participant or any other Person. To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured general creditor of the Company or any Affiliate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.73pt">No Fractional Shares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No fractional Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine whether cash shall be paid in lieu of any fractional Shares or whether such fractional Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.73pt">Headings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Headings are given to the Sections and subsections of the Plan solely as a convenience to facilitate reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of the Plan or any provision thereof.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 10. Effective Date of the Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan shall be effective as of the date of its approval by the stockholders of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 11. Term of the Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards shall be granted under the Plan during a period commencing the date the Plan was approved by the stockholders of the Company, through a date which is ten (10) years from the date of such shareholder approval. However, unless otherwise expressly provided in the Plan or in an applicable Award Agreement, any Award theretofore granted may extend beyond the ending date of the period stated above, and the authority of the Committee provided for hereunder with respect to the Plan and any Awards, and the authority of the Board of Directors of the Company to amend the Plan, shall extend beyond the end of such period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>apyx-20230623.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e38f332b-9dfc-486a-b074-c289a1ce0624,g:7252654b-46b8-4048-a632-839de6142bed-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:apyx="http://apyxmedical.com/20230623" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://apyxmedical.com/20230623">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="apyx-20230623_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="apyx-20230623_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="apyx-20230623_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="apyx_EquityAwardsGrantedInPriorYearsVestedMember" abstract="true" name="EquityAwardsGrantedInPriorYearsVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" abstract="true" name="EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="apyx_ShareholderReturnPerShare" abstract="false" name="ShareholderReturnPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="apyx_NetIncomeLossPercentChange" abstract="false" name="NetIncomeLossPercentChange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="apyx_NonPEONEOActuallyPaidCompensationAmount" abstract="false" name="NonPEONEOActuallyPaidCompensationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="apyx_ShareholderReturnPercentChange" abstract="false" name="ShareholderReturnPercentChange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="apyx_EquityAwardsGrantedDuringTheYearMember" abstract="true" name="EquityAwardsGrantedDuringTheYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="apyx_NonPEONEOActuallyPaidCompensationPercentChange" abstract="false" name="NonPEONEOActuallyPaidCompensationPercentChange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" abstract="true" name="EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>apyx-20230623_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e38f332b-9dfc-486a-b074-c289a1ce0624,g:7252654b-46b8-4048-a632-839de6142bed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedDuringTheYearMember_2da92880-a989-4dec-88d8-d5e4c36abc25" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedDuringTheYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedDuringTheYearMember_2da92880-a989-4dec-88d8-d5e4c36abc25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember_b0432b64-ce97-4a5b-9cc0-ad45b54ca4d9" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember_b0432b64-ce97-4a5b-9cc0-ad45b54ca4d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember_b2e1d786-cf71-4d96-aa26-04ad57a12d43" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember_b2e1d786-cf71-4d96-aa26-04ad57a12d43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedInPriorYearsVestedMember_f8113f91-a2da-4f4c-9e9a-88348084af2f" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedInPriorYearsVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedInPriorYearsVestedMember_f8113f91-a2da-4f4c-9e9a-88348084af2f" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>apyx-20230623_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e38f332b-9dfc-486a-b074-c289a1ce0624,g:7252654b-46b8-4048-a632-839de6142bed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_apyx_ShareholderReturnPercentChange_label_en-US" xlink:label="lab_apyx_ShareholderReturnPercentChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Return, Percent Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_ShareholderReturnPercentChange" xlink:href="apyx-20230623.xsd#apyx_ShareholderReturnPercentChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_ShareholderReturnPercentChange" xlink:to="lab_apyx_ShareholderReturnPercentChange" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_EquityAwardsGrantedInPriorYearsVestedMember_label_en-US" xlink:label="lab_apyx_EquityAwardsGrantedInPriorYearsVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards Granted In Prior Years, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedInPriorYearsVestedMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedInPriorYearsVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_EquityAwardsGrantedInPriorYearsVestedMember" xlink:to="lab_apyx_EquityAwardsGrantedInPriorYearsVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember_label_en-US" xlink:label="lab_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards Granted During The Year, Outstanding And Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" xlink:to="lab_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_NetIncomeLossPercentChange_label_en-US" xlink:label="lab_apyx_NetIncomeLossPercentChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Percent Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_NetIncomeLossPercentChange" xlink:href="apyx-20230623.xsd#apyx_NetIncomeLossPercentChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_NetIncomeLossPercentChange" xlink:to="lab_apyx_NetIncomeLossPercentChange" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember_label_en-US" xlink:label="lab_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards Granted In Prior Years, Outstanding And Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" xlink:to="lab_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_ShareholderReturnPerShare_label_en-US" xlink:label="lab_apyx_ShareholderReturnPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Return, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_ShareholderReturnPerShare" xlink:href="apyx-20230623.xsd#apyx_ShareholderReturnPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_ShareholderReturnPerShare" xlink:to="lab_apyx_ShareholderReturnPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_NonPEONEOActuallyPaidCompensationAmount_label_en-US" xlink:label="lab_apyx_NonPEONEOActuallyPaidCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_NonPEONEOActuallyPaidCompensationAmount" xlink:href="apyx-20230623.xsd#apyx_NonPEONEOActuallyPaidCompensationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_NonPEONEOActuallyPaidCompensationAmount" xlink:to="lab_apyx_NonPEONEOActuallyPaidCompensationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_NonPEONEOActuallyPaidCompensationPercentChange_label_en-US" xlink:label="lab_apyx_NonPEONEOActuallyPaidCompensationPercentChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Actually Paid Compensation, Percent Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_NonPEONEOActuallyPaidCompensationPercentChange" xlink:href="apyx-20230623.xsd#apyx_NonPEONEOActuallyPaidCompensationPercentChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_NonPEONEOActuallyPaidCompensationPercentChange" xlink:to="lab_apyx_NonPEONEOActuallyPaidCompensationPercentChange" xlink:type="arc" order="1"/>
    <link:label id="lab_apyx_EquityAwardsGrantedDuringTheYearMember_label_en-US" xlink:label="lab_apyx_EquityAwardsGrantedDuringTheYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards Granted During The Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedDuringTheYearMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedDuringTheYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apyx_EquityAwardsGrantedDuringTheYearMember" xlink:to="lab_apyx_EquityAwardsGrantedDuringTheYearMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>apyx-20230623_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e38f332b-9dfc-486a-b074-c289a1ce0624,g:7252654b-46b8-4048-a632-839de6142bed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_ShareholderReturnPerShare" xlink:href="apyx-20230623.xsd#apyx_ShareholderReturnPerShare"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_apyx_ShareholderReturnPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_ShareholderReturnPercentChange" xlink:href="apyx-20230623.xsd#apyx_ShareholderReturnPercentChange"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_apyx_ShareholderReturnPercentChange" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_NetIncomeLossPercentChange" xlink:href="apyx-20230623.xsd#apyx_NetIncomeLossPercentChange"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_apyx_NetIncomeLossPercentChange" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_NonPEONEOActuallyPaidCompensationAmount" xlink:href="apyx-20230623.xsd#apyx_NonPEONEOActuallyPaidCompensationAmount"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_apyx_NonPEONEOActuallyPaidCompensationAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_NonPEONEOActuallyPaidCompensationPercentChange" xlink:href="apyx-20230623.xsd#apyx_NonPEONEOActuallyPaidCompensationPercentChange"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_apyx_NonPEONEOActuallyPaidCompensationPercentChange" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedDuringTheYearMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedDuringTheYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedDuringTheYearMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_apyx_EquityAwardsGrantedInPriorYearsVestedMember" xlink:href="apyx-20230623.xsd#apyx_EquityAwardsGrantedInPriorYearsVestedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_apyx_EquityAwardsGrantedInPriorYearsVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>apyx-20230623_g1.jpg
<TEXT>
begin 644 apyx-20230623_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *0 _(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "L;Q5XNTGP5I$NI:S>)9VB< MRSMV5
M5'+'V%/\4^)K#P=X?O=8U*3RK.U3>Y')8YP% [DD@#W-?"'Q(^(^J_$OQ!)J
M.H2,D"DBVLU8F.W3T'N<#+=_R ^7SO.X93348J]26R_5^7YGU>0Y%/.*CE)\
MM..[[^2\_P CU#QW^UEK>JS20>&+=-'L^@N9T66X;WP<JOTPWUKR#5_'7B+7
MG9M1UW4;S/\ #-<N5'?@9P/PK#HK\>Q69XS&R<J]1ORV7W;'[1A,KP6!BHT*
M27GN_O>I=@US4;6020ZA=0R#H\<S C\0:[KPK^T%XX\*R)MUB35+<'FWU+,X
M/_ B=X_!J\XHKFHXO$8>7-1J.+\F=5?!X;$QY*U-27FD?;/PL_:%T+XB216%
MPO\ 8^MMPMK,^4F/_3-^,G_9.#Z9ZUZO7YHQR-%(KHQ1U.593@@CN*^O/V<O
MC2_C2R_X1[6I]^MVL>Z&>0_-=1#U]77C/J.>Q-?J.0\2/&36%Q?QO9]_)^?Y
M_G^4<0<,K!0>+P?P+==O->7XKTV]RHHHK]!/SD**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLWQ%KEMX9T
M&_U:\?;;6<+3/[@#.![GH/<U,I*$7*3LD5&,IR48J[9\S_M;>/#?:U9>%;67
M]Q9J+F[53UE8?(I_W4.?^VGM7SS6AXAURY\3:Y?ZK>-NNKR9II/0%CG ]AT'
MTK/K^=\SQLLPQ<\0]F]/3I^!_265X&.78.GAENEKYOK^(4445YAZ@4444 %:
M7AO7[OPKKUAJ]BYCNK.994.>N#R#[$9!]B:S:*J,I0DI1=FB91C.+A)73/T>
M\.ZY;>)M!L-6LWW6UY"LR>P(S@^XZ'W%:5?/'[(_CK[=HM_X6N),S6)-U:@]
M3$Q^=1_NN0?^VE?0]?T/EF,6882GB%NUKZ]?Q/YNS3 RR[&5,,]D]/1[?@%%
M%%>H>4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?/'[7'CK[#HMAX6MY,37Q%U= =1$I^13_ +S@G_MG7T'/,EM#
M)-*ZQQ1J7=V. H R2:_/OXF>,I/'WCC5=:8MY,TNV!6_AA7Y4&.W !/N37Q?
M%6/^JX+V$7[U33Y=?\OF?<<)9?\ 6\=[>:]VGK\^G^?R.7HHHK\6/W ***.M
M !174^/_ (>ZE\.[W3[;45PUY917:\$;2P^9#_M*P(/X>M<M6M6E.A-TZBLU
MT,J5:G7@JE)WB^H4445D:G4?#/QE)X!\<:5K2EO)AEVSJO\ %"WRN,=^"2/<
M"OT$@F2YACFB=9(I%#HZG(8$9!%?FG7V=^S#XZ_X2KX?IIL\N^^T9A;,">3"
M<F(_D"O_  "OT?@_'\E6>"F]):KU6_WK\C\TXTR_VE*&.@M8Z/T>WW/\SV*B
MBBOU8_(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ&X
MNH;*!YKB6."%!EI)&"JH]23TKS/Q/^TEX&\-EXTU)]8N%_Y9Z;'Y@_[[.$/X
M$UR8C%X?"1YJ\U'U9V8;!XG&2Y</3<GY(]2HKY:\0?MBZA(S+HGA^WMUZ"2^
ME:4GWVKMQ^9KS_6/VC?'^K[A_;?V*,_\L[.!(\?\"QN_6OF*_%F74M(-S]%_
MG8^KP_"&9UM9J,/5_P"5S[EJ*:XBMU#2RI$I. 78#^=?GCJ'CSQ+JV?MOB#5
M+H'M->2,._8GW/YUB22/,Y=V9W/5F.2:\:IQI#_EW0OZRM^C/:I\#S?\3$)>
MD;_JC]&V\3:0K%6U6Q# X(-RF1^M'_"4:-_T%K'_ ,"4_P :_.*BN;_72I_S
MX7_@7_ .C_4>G_T$/_P'_@GZ0PZYIMUGR=0M9L<'RYE;'Y&K]?F?5JSU6]TT
MYM+RXM3ZPRLG\C6L.-/YZ'_DW_ ,Y<#_ ,F(^^/_ -L?I-17Y_Z7\8/&VC$?
M9O$^I8'19YS,H_!\BNWT/]J_QKIK*+X6&KI_$9X/+?\  QE0/R->I1XPP,]*
MD)1^YK\[_@>36X+Q]/6E.,OO3_*WXGV317@'AO\ :_T*^98]:TB[TMSP9+=A
M<1CW/W6'X UZYX6^(?AOQJ@;1=8M;Y\9,*OME ]T;##\J^FPN:8+&Z4*J;[;
M/[GJ?+8O*<=@=<12:7?=?>KHZ.BBBO5/)"BBB@ HHJ.:(3PR1DLH=2I9&*L,
MCL1R#[T@)**^#_&GBCQQX-\5ZIHMQXLU[S+.=HPQU&;YUZJWWNZE3^-8O_"S
M_&7_ $-NN?\ @RF_^*K\_J<84:<W"=&2:=GJNA^C4^"ZU6"J0KQ::NM'U/T*
MHK\]?^%G^,O^AMUS_P &4W_Q5*GQ1\91L&'BS7"0<_-J,Q'Y%JC_ %SP_P#S
MY?WHT_U(Q/\ S^C]S/T)HKXX\ ?M1>)?#MY%%KTG]O:82 ^]56XC'JK@#<?9
MNO3(KZVT'7K'Q-H]KJFF7"W5C<IOCE7N/0CL0<@@]",5]1EF<87-(OV+M);I
M[_\ #'R>:9+BLIDO;J\7LUM_P&:-%%%>X>"%%%% !1110 4444 %%%% !111
M0 4444 %%%% !17(?$KXE:7\,= .HZAF::0E+:TC(#SOCH/0#C+=L]S@'Y+\
M5?M%>-_$UU(T6J-H]J3\EOI_[O:/=_O$_C^ KYS,\^PF5R]G4O*?9?KV/ILJ
MX?QF;1]I3M&'=_IW/N.BOSU_X6?XR_Z&W7/_  93?_%4?\+/\9?]#;KG_@RF
M_P#BJ^=_USP__/E_>CZ3_4C$?\_H_<S]"J*_/7_A9_C+_H;=<_\ !E-_\57O
M7[*\_B3Q1J&K:UJ^NZIJ&GVJ"UBANKR22-I6PS'#,1E5 _[[KT,!Q-3S#$1P
MU.D[OS6AYV8<*U,NPTL34K)J/2SU/I"BBO%/VD/#_B6+1E\2>&M;U6R-FF+V
MSL[R6-&B_P">H56QE>_'3G^&OI\;B982A*O&#ERZV6]O^ ?*X'#1QF(C0E-0
MYM+O:_3[SVNBOSU_X6?XR_Z&W7/_  93?_%4?\+/\9?]#;KG_@RF_P#BJ^(_
MUSP__/E_>C[O_4C$?\_H_<S]"J*_/7_A9_C+_H;=<_\ !E-_\51_PM#QE_T-
MNN?^#&;_ .*H_P!<\/\ \^7]Z#_4C$?\_H_<S]"J*^)_!O[2OC'PQ=Q_;KS^
MWK'(WV][C?C_ &9 -P/UR/:OK?P+XXTOXA>'8-8TJ0M!(2KQR8$D+CJC#L1Q
M]001P:^ERS/,+FEXTKJ2Z/?Y=SY?-<AQ>4VE62<7U6WH^QT-%%%?0'SH4444
M %%%% !1110 4444 %%%% !117C?QL_: M_AO*VCZ5#'?Z^R!G\P_NK8$9&X
M#DL1R%XX()/0'BQF,HX&DZ]>5HK^K([L'@J^85E0P\;R?]7?D>R45\"ZQ\;/
M'.M3M+/XFU" DY"V<QMU'L!'BL__ (6?XR_Z&W7/_!E-_P#%5\5+C/#7]VE)
MKY'W4>",4U[U:*?S/T*HK\]?^%G^,O\ H;=<_P#!E-_\51_PL_QE_P!#;KG_
M (,IO_BJC_7/#_\ /E_>BO\ 4C$?\_H_<S]"J*_/W3_'WCK5KZWLK3Q-K]Q=
M7$BQ11)J,Q9V)P /F]:^V_AWX9O_  IX5M+'5-4N]8U(CS;FZN[AYCYA RJE
MCD*,8 ]L]2:]_*<[6;3DJ=)I1W;?X'SV<9$\GA%U*JE*6R2U]3IZ**^:/&WP
MI\>>#?"NI:V_Q.U>Z6RB,IA6XG4OR!C/FG'6O3QV+JX.'/"DYK5NS2M;U_3L
M>7E^#I8V?LZE90=TE=-W;]/U[GTO17R_\._AOX[^('@[3]?C^)>KV27GF8@:
MXG<KLD9.OFCKMST[UT?[3FMZUX2\'^&4T_6;ZSN?-,4UQ:W#Q--B,<L5.3SS
MS7G+.)K!RQM2@XP236JU3]/U/2>2PEC88&E74IMM/1KE:[WW^1[[17$?!WQX
MOQ$\!V&ILP-]&/L]XH[3*!D_\"&&_P"!5YS^U'\4KOPQ9V'A_1K^:QU*Y/VF
MXGM93')'$"0JAE.1N;/X+[UVXC-*&'P7UYN\6DUYWV1PX;*L1B,=]02M--I^
M5MW_ %N>^T5\T>'?%FN3>']+DDUK4))'M8F9FNG))*#))SUHKBCG=.45+D>I
MWRR&I&3CSK0^EZ***^D/EPHHHH **** "BBB@ HHHH **** /'?VGO'7_"*_
M#]]-@EV7VLL;90#R(1@RG\B%_P"!U\8UZ5^T%XX_X3?XCWS0R^9I^G_Z%;;3
MP0I.]O?+;N?0+7FM?@W$&/\ K^/G*+]V/NKY=?FS^@N'<O\ [/R^$9+WI>\_
MGLODK?,****^;/I@KTG]GWP-_P )Q\1K%9H_,T_3_P#3;G(X(4C8OOEMO'H&
MKS:OL_\ 9A\#?\(K\/TU*>+9?:RPN&)'(A'$0_(EO^!U])P_@?K^/A&2]V/O
M/Y=/F_P/F>(LP_L_+YRB_>E[J^>[^2_$/VGO W_"5?#]]2@BWWVC,;A2!R83
MQ*/R ;_@%?&%?I7/!'=020RHLL4BE'1AD,I&""/3%?GY\3/!LG@'QQJNBN#Y
M4,NZW8\[H6^9#GN=I /N#7T?&& Y*L,;!:2T?JMOO7Y'S7!>8>TI3P,WK'5>
MCW^Y_F<O1117YP?I85Z5^S[XX_X0CXCV+32^7I^H?Z%<[CP Q&QO;#;>?0M7
MFM'2NK"XB>$KPKT]XNYRXK#0QE">'J;25C],**X/X)^./^$^^'NFW\L@DOH1
M]EN_7S4 &X_[PVM_P*N\K^B\/7AB:4:U/:23^\_FG$4)X6M.A46L6T_D%%%%
M=!SA1110 4444 %%%% !1110 4444 %%%% !117FWQ9^-VC_  OMS;G&H:Y(
MN8K"-L;<]&D/\*^W4]O4<V(Q-'"4W6KRY8HZL-A:V,JJC0CS29W>L:U8>']/
MEOM2O(;&TB&7FG<*H]LGO[=Z^?/B!^UM!;M+9^$K(73#C^T;P$)]4CX)^K$?
M0UX-XY^(VN_$34C=ZS>-*%),5LGRPPCT5>WUZGN37,U^59GQ97K-T\$N2/?[
M3_R_/S/UO*^$,/ATJF.?/+M]E?Y_EY&]XJ\>>(/&USYVMZK<7_.Y8W;$:'_9
M085?P%8-%%?"5*DZLG.HVV^KU/OZ=.%&*A3BDET6B"BBBLS0**** "BBB@ H
MHHH **** "GPS/;R+)$[1R*<JZ'!!]0:910!ZUX%_:6\6^$6C@OIQX@L%/,=
MZQ,H'^S+U_[ZW?2OI;X=?&[PS\2%6&RN39ZGC)T^[PLGOMYPX^G/J!7P?3HY
M'AD61&9)%(974X((Y!!KZO+N),;@6HS?/#L_T>_YKR/DLRX9P.8)RA'V<^ZV
M^:V?X/S/TNHKY0^$?[4%YH[P:7XN>2_L.%34L%IH>WS_ -]??[W7[W2OJ?3[
M^VU2SAN[.>.ZM9E#QS0L&1U/0@CK7ZWEN:8;-*?/0>JW3W7]=S\=S/*<5E53
MDKK1[-;/^NQ8HHHKUSQCY?\ VO/!/DWFE^*;>/Y)A]BNB.FX9:-OQ&X?\!6O
MF^OT*^)'@^/QWX)U;17"^9<0DPNW195^9#_WT!GVS7Y\30R6TTD,J-'+&Q1T
M88*D'!!K\8XKP/U;&^WBO=J:_-;_ */YG[?PCC_K6!^KR?O4]/D]OU7R&444
M5\2?<A7TA^R'XX:.\U/PK<RDQR+]LM%8]&&!(H^HVG'^RWK7S?6UX+\33^#?
M%6EZU;@F2RG60J.-Z]&7\5)'XUZV58UY?C*=?HGKZ/<\C-L"LQP53#]6M/5;
M'Z+456T^^@U2QMKVVD$MM<Q+-%(.C(P!4_B"*LU_0R:DKH_F]IQ=F%%%%,04
M444 %%%% !1110 4444 %%%% !117&?%[QH/ 7P_U;54<)=^7Y-KZF9^%(]<
M<M]%-85ZT,/2E6J;13;^1O0HSQ%6-&FM9-)?,^3_ -H;QP?&GQ(OEBEWZ?II
M-E;@?=^4_.WXOGGN M>94I)8DDY)Y.:2OYSQ6(GBZ\Z]3>3N?TOA<-#!T(8>
MGM%6_P"#\PHHHKE.H4 L0 ,D\#%??OPD\&#P'\/])TID"W2Q^==>IF?YF'OC
M.WZ**^3?V>/!?_"9?$RP,J;K+3O].GXX.PC8OXN5X] :^Y*_4N#L#:-3&R6_
MNK]?T^YGY1QKC^:5/ P>WO/\E^OWH*9)&DT;QR(KQL"K*PR"#U!%/HK]+/RX
M^'OCU\*7^&OBDRV<;?V%?DR6C=1$>K1$^W;U!'4@UYA7Z&^/_!%C\0O"UYHM
M^-J2C=%,!EH9!G:X^A_,$CO7P-XF\.7WA'7KW2-2B\F\M9#&X['T8>H(P0>X
M-?B/$>4?V?7]K27[N>WD^W^7_ /W;AG.?[2P_L:K_>PW\UW_ ,_/U,NBBBOD
M#[(*](^!OQ4D^&?BI#<NQT2](BO(QSM_NR@>JY_$$CTKS>BNG#8FIA*T:])V
ME$Y<5AJ6,HRH5E>,E8_2R">.ZACFA=98I%#I(IR&4C((/IBI*^;OV6_BX;F)
M?!NJS9EC!;3I7/WE')A_#DK[9'85](U_0.6X^GF6&CB*?7==GU1_.V9Y?5RS
M$RP]7IL^ZZ/^NH4445Z9Y04444 %%%% !1110 4456U#4+;2K&XO+N9+>UMX
MVEEFD.%10,DG\*3:BKL:3D[(Y+XM?$BV^&/A&?4I-LM_+F*RMV_Y:2D<$_[*
M]3],=2*^#M2U*YU?4+F^O)FN+NXD:665SDLQ.2:Z_P",'Q+N/B=XNFOR7CTV
M',-E;L?N1Y^\1_>8\G\!V%</7X9Q!FSS/$VIO]W'1>?=_/IY'[YP[DZRO#<U
M1?O)ZOR[+Y=?/Y!1117RQ]6%%%>E_ GX5O\ $OQ4IND8:'8E9+Q^F_\ NQ#W
M;'/H ?:NG"X:IC*T:%)7E(Y<5B:6#HRQ%9VC%7/6/V6_A+]AME\9:K#_ *1,
MI73HW'W(SP9?JW0>V3W%?1M1QQI!&D<:+'&@"JBC 4#@ #M4E?T%EV!IY=AH
MX>GTW?=]6?SKF685<SQ,L15Z[+LNB_KJ%<-\</\ DDOB?_KT/\Q7<UPWQP_Y
M)+XG_P"O0_S%7C_]TK?X9?DS/+O]]H_XH_FC,_9M_P"2*^'?^WG_ -*9:X[]
MK0!M+\)@C(.HG(_X"*[']FW_ )(KX=_[>?\ TIEKC_VM/^0;X2_[")_]!%?-
MXK_DG8_X(?\ MI]1A/\ DI9?]?*G_MQC:+?0_L\?&35-,O','A+6HC=0/_#$
M1N90/H=T>.I!0FN(U32[GQYX)^(/Q*U6(AII8;;3XVY\M?M$0)'^ZFU >^7K
MZ9^)7PIT7XIV-G;ZLUS ;60R13VC*L@R,,N65A@X!Z?PBN2^-7AVR\(_L[ZI
MH^G(R6=G':Q1[B"S?Z3$2QQW)R3QU)KBQF4UJ=*O&37L(1G*"\W';TCJUZG;
M@<WHU:M"44_K%25.,W_=4EKZR5D_0\T\+_\ (M:3_P!>D/\ Z **/"__ "+6
MD_\ 7I#_ .@"BO-I?PX^B/6K?Q)>K/JNBBBOU(_) HHHH **** "BBB@ HHH
MH *X+XV>.?\ A ?AYJ-_%)LOIQ]EM.>?-<$9'^Z-S?\  :[VOC[]JSQS_;_C
M2'0K>3=9Z0F)-IX:=P"W_?(VCV.ZOG\^QW]GX&=2+]YZ+U?^2U/H^'\O_M''
MPIR7NQ]Y^B_S=D>(=:***_ C^A0HHHH ZCX9^#9/'WCC2M%0'RII=UPPXVPK
M\SG/8[00/<BOT#@@CM8(X8D6**-0B(HP%4#  'IBOGW]D;P/]AT74/%-Q'B:
M])M;4D=(E.78>Q8 ?]LZ^AZ_:>%<#]5P7MI+WJFORZ?Y_,_#^+<P^MX[V$7[
MM/3Y]?\ +Y!7SQ^USX'^W:+I_BFWCS-9$6MT0.L3'*,?8,2/^VE?0]9OB/0K
M;Q-H-_I-XNZVO(6A?U (QD>XZCW%?09G@UF&$J8=[M:>O3\3YS*\=++L93Q*
MV3U]'O\ @?G#16AX@T.Y\-:Y?Z5>+MNK.9X)/0E3C(]CU!]#6?7\\2BX2<9*
MS1_2,9*<5*+NF%%%%24>W_LI^.?[ \:3:%<2;;/5TQ'N/"SH"5_[Z&X>YVU]
M@U^:^GWT^EW]M>6LAAN;>198I%ZJRG(/YBOT*\#>*H/&WA/2];M\!+N$.R*?
MN..'7\&!'X5^M<(8_P!I0E@YO6&J]'O]S_,_'^,\O]E7AC8+2>C]5M]Z_(WJ
M***_0S\W"BBB@ HHHH **** "BBB@ HHHH ***X+XR?$Z#X7^$I+P;9-3N28
M;&!OXGQRQ']U1R?P'>N?$5Z>%I2K57:,=6=&'P]3%5HT**O*3LCFOCM\=(OA
MU:G2=(:.X\13+SGYEM$(X=AW8\84_4\8!^.+Z^N-2O)KN[GDN;F9B\DTK%F=
MCU))ZT[4M2NM8U"XOKV=[F[N',DLTARSL3DDU6K\'S;-JV:UN>>D%LNW_![G
M]!9/D]'**')#6;^)]_\ @=@HHHKPCW@HHHH ***LZ?IMYJURMO8VL][<-TAM
MXS(Y_ #--)R=D)M15V]"M17HNC_L]^/M:4/'H$MK&?XKV1(<?\!8[OTKK]/_
M &0O%=P UWJ>DV@]%DDD8?AL _6O7I9/F%;6%"7W6_.QX];.LNH:3KQ^^_Y7
M/"Z*^C8/V-;UMGG>*((^?F\NS9L?3+C-6)/V,G6,F/Q<K/V#:=@?GYIKM7#>
M:M7]C^,?\S@?$^4)V]O_ .2R_P CYJHKZ&NOV.=70?Z-XBLICC_EM \?.?8M
M7-ZI^RGXYL%)@33]2Q_#;76TG_OX%K"ID.9TU>5!_+7\KG13X@RNKI&NOGI^
M=CQVBNG\0?#'Q9X75GU/P_?VT2]9A"7C'U=<K^M<Q7C5*-2C+EJ1<7YJQ[=.
MM3K1YJ4E)>3N%%%%9&H4444 %>F_!GXVZA\,=06VG,EYX>F?,]IG)C)ZR1^A
M]1T/Y$>945U87%5<'55:A*TD<N*PM'&TI4*\;Q?]?>?I'H^KVFO:7;:CI]PE
MU9W*"2*:,\,I_P ].U7:^-OV=?C$W@?6ET/5)_\ B0W\@"LYXM93P']E/ ;T
MX/8Y^R:_>,HS2GFN'56.DEI)=G_D^A_/^<Y54RG$NE+6+UB^Z_S74*^*OVFO
M!/\ PBOQ&FO88]ECK"_:T(& ),XE'UW8;_@8K[5KR?\ :4\%?\)9\-[JYAC#
M7NDG[9&<<F,#]XO_ 'S\WU05Q\18'Z[@)\J]Z'O+Y;_@=G#6/^HYC#F?NS]U
M_/;\;?*Y\3T445^$G[\%%%% 'V+^ROXU_P"$@\!OH\\FZ[T>3RU!/)A;)0_@
M=R_0"O:Z^&/V??&W_"%_$K3WE?98ZA_H-QD\ .1M;\'"\^F:^YZ_<N&<=]<P
M$8R?O0]U_I^&GR/P;BC ?4LPE**]VI[R]>OXZ_,****^K/D HHHH **** "B
MBB@ HHHH **** "OE']KGQM_:'B#3_#-O)F'3T^T7('0S./E!_W4Y_[:&OJ#
M6M6MM T>]U*\?R[6TA:>5O15&3CWXK\[_$NO7/BCQ!J.KW9S<7L[3.,Y"Y.0
MH]@, >PKX+B['>QPL<+%ZS>OHO\ -V_$_0N#<![?%RQ<EI36GJ_\E?\  S:*
M**_'S]F"BBMOP5X8G\9^*]+T2WR)+R=8RP_@3J[?@H)_"KITY59J$%=MV7S(
MJ5(TH.I-V25WZ(^K/V5_!9\.^ 7U:9-MWK$GFC(Y$*Y$8_'YV^C"O::KV-C#
MIMC;V=L@BM[>-8HD'154  ?D*L5_1F!PL<%AJ>'C]E?CU?S9_-./Q<L=BJF)
ME]I_AT7R04445W' %>*?M)?"3_A--!_M[3(=VMZ=&=Z(,M<0#DK[LO)'XCN*
M]KHKAQN#I8^A+#U5H_P\_D=^!QM7+\1'$47K'\5U3]3\SZ*]I_:2^$O_  A>
MO?V[ID&W1-1<ED1?EMYCR5]E;DC\1V%>+5_/N-P=7 UY8>JM5^/G\S^B\#C*
M688>.)HO27X=T_0****XCN)K*\GTZ\@N[65H+F!UEBE0X9&!R"#Z@BONSX-?
M$^#XG^$X[MBL>JVV(KZ!?X7QPX']UNH_$=J^#:Z_X6_$2[^&GBVVU6#=);-^
MZN[<'B6(GD?4=0?4>F:^FR'-GE>)]]_NY:2_S^7Y'R_$&3K-L-[B_>1UC_E\
M_P S] :*I:/K%IK^EVNHV$RW%G=1B6*1>A4C]#[=JNU^ZQDI)2B[IGX#*+BW
M&2LT%%%%42%%%% !1110 5\N?M2?%HWEPW@W2IOW$)#:E(A^^XY6+Z#@GWP.
MQKUKXY?%2/X9^%&:W=3K=\&BLXSSM_O2$>BY_$D>]?#<TTEQ,\LKM)*[%G=C
MDL2<DD^M?G7%6;^RA]0HOWG\7DNWSZ^7J?I?"63>VG_:%=>['X?-]_ET\_09
M1117Y.?KH4444 :7ASP_?>*M<L])TZ(S7MW((XU[>Y)[ #))[ &OOCX>>!;'
MX=^%;31K$;O+&^:;&#-*?O.?Z>@ ':O-?V:/A+_PB.A_\)%J<.W6-2C'E1N.
M;> X('LS<$^@P..:]PK]EX9RCZG1^M5E^\G^"_S?4_$^*LY^O5_JE%_NX/7S
M?^2V7S"BBBON#X,*KWUA;:I:RVMY;Q7=M*NV2&= Z./0J>"*L44FDU9C3<7=
M%33=+L]&LXK/3[2"QM(\[+>VC6.-<DDX50 ,DD_4U#JWA_2]?6)=4TVSU)86
MWQK=P)*$;U7<#@_2M&BH]G%QY&M.W0I5)J7.GKWZA534M+L]9LY;/4+2"^M)
M,;[>YC62-L$$95@0<$ _45;HJY14E9[$QDXM-.S1DQ>$]#AC2./1=/CC0!51
M;5 % Z #'2BM:BL_94_Y5]QK[:I_,_O"BBBM3$**** "BBB@ HHHH **** ,
M'QSXJ@\$^$]4UNXP4M(2ZHQ^^YX1?Q8@?C7YZZA?3ZI?W-Y=2&:YN)&EED;J
MS,<D_F:^C/VO/'&Z33/"EM)D+_IMWM/?D1J?PW,1[J:^:Z_&>+,?]8QBP\7[
MM/\ -[_=HOO/VWA#+_JN#>)FO>J?DMOOU?W!1117Q!]V%:'A_0[GQ+KEAI5F
MNZZO)D@C] 6.,GV'4GT%9]?0?[(_@;[?KE_XHN(\PV*FVM6;_GLP^=A]$./^
MVE>GEF#EF&+IX==7KZ=?P/+S3'1R[!U,2]TM/7I^)]-^'-"MO#.@V&DV:[;:
MSA6%/4@#&3[GJ?<UI445_1$8J$5&*LD?S;*4IR<Y.[844451)\I?M<>!OL&N
M6'BBWCQ#?*+:Z9?^>RCY&/U08_[9U\^5^@OQ/\&Q^/O ^JZ,54SS1;[=F_AF
M7E#GMR,'V)K\_9H7MYGBE0QR1L596&""#@@_C7XKQ5@?JN-]M%>[4U^?7_/Y
MG[CPEF'UO ^PD_>IZ?+I_E\AE%%%?&'VX5]*?LA^.-LFI^%+F3 ;_3;3<>_
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MVX9RCZ]6^LUE^[A^+[?+=_<?#<49S]0H?5J+_>3_  7?U>R^;->BBBOV<_$
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MK\\/$WA^Y\*^(-1TB['^D64[0L<8#8/##V(P1[&OR+B_ ^RQ$<7%:3T?JO\
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MR/R+C3'^TK0P47I'5^KV^Y?F%%%%?HI^:!1110 4444 %%%% !1110 4444
M1RQ)<1/%*BR1.I5D<9# \$$=Z^'?CI\*Y/AGXJ8VR,VB7Q:6SD[)S\T1/JN1
MCU!'O7W-7,_$3P+8_$7PK=Z-? +Y@WP38R891]UQ_(^H)'>OG,\RJ.:8;EC\
M<=8_Y?,^ER'-Y93BE*7\.6DE^OJO\S\]:*T?$7A^^\*ZY>:3J4)@O;60QR)V
M]B#W!'(/<$5G5^#RC*$G&2LT?T#&49Q4XNZ84445)04444 %%%% !7T]^RW\
M)?L\2^,]5A_>2 KIL3CE5.0TOX]%]LGN*\G^!WPLD^)GBQ8[A&&BV166]D!(
MW#/RQ@^K8/T )]*^Y8(([6&.&&-8H8U")&@PJJ!@ #L *_1.%<H]M/Z_67NQ
M^'S??Y=//T/S;BW.?8P_L^@_>E\7DNWSZ^7J2T445^LGY %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R?^UMXX_M+Q%8^&+=\V
M^G*+BY Z&9Q\H/\ NH?_ !\^E?3GB;Q!;>%?#^H:O>'%M9PM,PZ%L#A1[DX
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M\[****_FD_J **** /H[]C7_ )"7BG_KC;_^A25]15\N_L:_\A+Q3_UQM_\
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M6C7I.THO^OO.7%86GC*$\/65XR5OZ]#]+E99%5E(96&00<@BG5X+^R[\5/\
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MYJZ:L_F:4ZDJ,XU(.S3NO5'YJ7=K-8W4UM<1F*XA=HY(VZJP."#]"*BKV/\
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M<![#"O%36L]O1?YO]#\8XQS#ZQBHX2#]VGO_ (G_ )*WXA1117WI^?!1110
MUF"*68@*!DD]!7XE?M6_&)OCC\<?$/B**4R:3')]@TL9.!:Q$A&&>F\[I,=C
M(:_27]OCXR_\*F^ FI6EI/Y6N>)2=)M-K89(V7]_(._$>5R.C2(:_'ZOJ\EP
M]E*O+T7ZG@9E6NU27JPHHHKZ@\,**** "OV(_80^,O\ PMWX":7'>3^;KGAX
MC2;W<V6=44>3(<\G='M!)ZLCU^.]?3?_  3Y^,P^%GQVM=*O9_*T3Q0JZ9<;
MCA4GSFW<_P# R4]A*3VKR<SP_M\.[;QU._!5O95E?9Z'Z\4445\$?6!1110
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MC"/#3?O4_P GM]SO^!^+<89?]7Q:Q4%[M3?_ !+?[U9_>7****^Z/@ HHHH
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M/X/HG_H6?05X'7XYQ1FWUNO]4I/W(;^<O^!M]Y^U<*91]3H?6ZR]^:T\H_\
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M*^8/J0KW#]F/XJ?\(KX@_P"$<U&;;I.IR#R6<\0W!P ?8-PI]]OO7A]'2N_
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M,_9.#<O]CAI8R:UGHO1?YO\ )!1117Y^?H@5);V\EW<100HTLTC!$11DLQ.
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MK[B/[/H=F?EG_P .LOBO_P!#!X-_\#;O_P"1:/\ AUE\5_\ H8/!O_@;=_\
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M:<8'EN2=H]E;<O\ P&OO.O$?VJO W_"0>"8M;MTW7FCN6; Y:!\!_P CM;V
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MWK#[DW#!6!"0GYG<WN"M>WU7L;&#3;*WL[:,16]O&L44:]%50 !^ %6*_HK
M82.!PT,/'[*_'J_FS^:\PQDL?BJF)G]I_AT7R04445WGGA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !5>^L8-2LKBSN8Q+;W$;12QMT96
M!!'X@U8HI-)JS&FXNZ/SM\>>%)_!'B_5=$GR3:3%$<_QQGE&_%2#^-8-?3G[
M7G@?S(--\5VZ?-'_ *%=D?W228V/T.X?BM?,=?SWF^!>7XV=#INO1[?Y']'9
M/CUF6!IXCKL_5;_Y_,****\<]D<CM&ZNC%74Y#*<$&OOWX2^-E^('@/2]6+
MW13R;I1VF7AOSX8>S"O@"O?/V2_'/]E>)KSPU<R8MM33S;<'H)T&2/\ @29_
M[X K['A?'_5,<J4G[M33Y]/\OF?%\69?]<P#K17O4]?EU_S^1]:4445^V'X6
M?GK\3_\ DI7BW_L+W?\ Z.>N9KIOB?\ \E*\6_\ 87N__1SUS-?S7BO]XJ>K
M_,_I["_[O3_PK\D%%%%<QU!177?"?PU9>,/B#H^CZBKM9W;2))Y;;6'[MB"#
MZ@@'\*Z3XK? '6_AS)+>6ZMJVA9)%Y"GS0CTE4=/]X<?3I7HT\OQ%7#/%TXW
M@G9VZ:)_=KN>=4S##4<5'!U)6G)75^NK6_?38\MHHHKSCT0HHHH **** "BB
MB@ HHHH **** "BBB@ HHKLO /PE\2_$:=1I5BRVF[:]]<?) G_ OXC[*"?:
MMJ-"KB)JG1BY2?1&%:O2P\'4K248KJSCT1I75$4L[' 51DDU]*_ _P#9M99+
M?7O%]MC&)+;2I!^(:4?^R?GZ5Z1\+/@#H7PW6.\E U;6P,_;9DPL1_Z9KSM^
MO)]QG%>HU^I9+PNJ#6(QVLND>B]>_IMZGY1GG%CQ">'P&D>LMF_3MZ[^@G3@
M<"EHHK]%/S4**** "BBB@ HHHH **** "BBB@ KX2^/7@L>"?B5J5O$FRRO#
M]MMO0(Y.5'L&##Z 5]V9QR>!7P+\9/&G_">?$/5=3CD\RS5_L]ISD>2G"D>S
M'+?\"-? <8NE]4IJ7Q\VGI;7]/P/T3@I5OKE1Q^#EU];Z?/?\3BJ***_(3]D
M"BBE +$ #)/ Q0!] ?LC^"?[0\0W_B:>/,&GI]GMV(X,SCYB/HG'_;05]7UQ
M?P?\%CP'\/=*TMTV79C\^Z]?.?YF!^G"_117:5_0&28'ZA@:=)KWGJ_5_P"6
MWR/YVSW'?VACZE5/W5HO1?Y[_,****]T\ **** "BBB@ HHHH **** "BBB@
M""]O(-.LY[NZE6"V@1I)97.%10,DD^@ KX-^+WQ(G^)GC"XU EDT^',-E"W&
MR('@D?WFZGZX["O8_P!JKXJ;5'@S39?F.V749%/0<%(OY,?^ ^]?,M?D?%6;
M>WJ_4:3]V/Q>;[?+\_0_8N$<H^KTOK]9>]+X?)=_G^7J%%%%?GQ^C!116AH.
MAWGB;6;/2M/B,]Y=R"*-!ZGN?0 9)/8 FJC%SDHQ5VR92C"+E)V2/2OV=?A;
M_P )]XL%_?0[M$TQEDFW#Y9I.J1^X[GV&.XK[6KF_A_X)LOA]X4LM%LL,(5S
M+-C!FE/WG/U/Y  =JZ2OWO),L65X54W\;UEZ]OD?SYGN:RS7%NHO@CI%>7?U
M?^2Z!1117T!\X%%%% !1110 4444 %8/C;PA9>.O#%]HM^O[FY3"R ?-&XY5
MQ[@X/Z5O45G4IQJP=.:NGHS2G4G1FJD'9K5,_./Q1X;O?"/B"^T?48_+N[20
MQN.S=PP]0001[$5EU]<?M1?"W_A(M!'BC3X<ZEIJ8N54<RV_7/U0DGZ%O05\
MCU^ 9QELLKQ4J+^'>+[K_@;,_HC)LSAFN$C77Q+22[/_ ">Z"BBBO%/<"OI/
M]E7XJ>7(?!NIS?*Q:33G<]#U>+\>6'ON'<5\V5-97D^G7D%W:RM!<P.LL4J'
M#(P.00?4$5ZF6X^IEN)CB(=-UW75?UU/*S/+Z>9X66&J==GV?1_UT/TJHKA_
MA!\2(/B9X/M]0!5-0AQ#>PKQLE Y(']UNH^N.QKN*_H*A7IXFE&M2=XR5T?S
MIB*%3"U94:JM*+LPHHHK<YPHHHH **** "BBB@#Y+_:T\<_VKXFL_#5M)FVT
MQ/-N .AG<9 _X"F/^^R*\#KZMUK]DM->U:]U*\\67$EU=S-/*WV(<LQ)/\?3
MFJ?_  QK9_\ 0TS_ /@$O_Q=?CN8Y)F^/Q53$2I;O3WH[=.O8_:<MSW)\OPE
M/#1J_"M?=EOUZ=SY>HKZA_X8UL_^AIG_ / )?_BZ/^&-;/\ Z&F?_P  E_\
MBZ\[_5C-?^?7_DT?\ST_]:LH_P"?O_DLO\CY>KZI_93^&,^CV=QXLU& Q37D
M?DV*.,,(<Y:3'^T0,>P)Z$5T_@O]F'PCX5NH[N[$VNW2'*_;<>2I]?+ P?\
M@1(KU_IP.!7UV1<-5,'66*Q;5ULEKKW?Z?>?&Y_Q/3QE!X3!IV>[>FG9?K?T
ML+1117Z*?FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &/XN\-6WC#PSJ6BW?\ J+R%HBV,E#U5A[A@"/I7Y^^*O"^H>#=>
MN](U2 P7=NVUA_"P[,I[J1R#7Z-5R_CCX;>'_B)9I;ZW8K.T8(BN$.R:+/\
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MX'Z]CX1DO=C[S^7^;LCYKB+'_P!GY?.47[TO=7J_\E=GME%%%?O1_/@4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHK[H^ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?GK\3_^2E>+?^PO=_\ HYZY
MFNF^)_\ R4KQ;_V%[O\ ]'/7,U_->*_WBIZO\S^GL+_N]/\ PK\D%%%%<QU'
MH7[/W_)8O#7_ %VD_P#13U]W5\(_L_?\EB\-?]=I/_13U]W5^P<&_P"XU/\
M&_R1^,\;?[_3_P "_-A1117WI^>A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5\-_M)?\EJ\1?\ ;M_Z315]R5\-_M)?\EJ\1?\
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MBBOK#Y **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[QJ7(N "Q"C)  SV%<O_ ,/3?BO_ -"_X-_\ KO_ .2:^>?VBO\ DX+XG?\
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MO':^]HX'#2I1;@KV1\I4Q593DE+J?8__  ]-^*__ $+_ (-_\ KO_P"2:/\
MAZ;\5_\ H7_!O_@%=_\ R37QQ16WU#"_\^T9?6Z_\[/L?_AZ;\5_^A?\&_\
M@%=__)-3V?\ P50^)L<V;OPSX3GC_NPV]U&?S,[?RKXQHH_L_"_\^T'UNO\
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MB5%,L3'WRC(/^NAKLS/#JM0<K:QU_P SGP-9TJJ71Z'ZVT445\&?5A7YZ_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?A;^T5_R<%\3O\ L9]4_P#2N6O/J]!_:*_Y."^)
MW_8SZI_Z5RUY]7Z;1_AQ]$?$5/CEZA0K%&#*2K Y!'45[S\1/@BMK^RK\*OB
MAID&%NC>Z7J^Q?XQ?7)@F/U4&,D_W8QWKP:G3J1JIN/1M?<*<'!I/R?WG[4_
MLA_&@?'+X':)K5S/Y^N6:_V=JN?O&XC !<_[ZE'^KD=J]JK\G?\ @G+\;/\
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MN<8RQ4$U=K.\._\ (OZ7_P!>L7_H K1K\Y>Y]DM@HHHI#/Q._;&_Y.<^(O\
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M_>:GJSZS"_P8>@4445Q'2?B=^V-_R<Y\1?\ L*-_Z"M>.U[%^V-_R<Y\1?\
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M97/B?(_?BQM%L;&WMD8LD,:QJS=2 ,<_E5BBBORT^Z"OSU_X*T_\TJ_[BO\
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M_!AZ+\CXJM_$EZL_6S_@FQ_R;#8_]A2[_P#0A7U/7RQ_P38_Y-AL?^PI=_\
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M*7D89X!VJ0,]R.O2OT>4HTH-O1(^,BG.5ENSSNBOTZ_X=4_#[_H;O$WYV_\
M\:H_X=4_#[_H;O$WYV__ ,:KRO[6PO=_<>A_9]?M^)^8M%?IU_PZI^'W_0W>
M)OSM_P#XU1_PZI^'W_0W>)OSM_\ XU1_:V%[O[@_L^OV_$_,6BOTZ_X=4_#[
M_H;O$WYV_P#\:KX]_;"_9M@_9K^(&G:5IM[=:GHFI6(NK:ZO OF;PQ62,[0
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MJ]!_:*_Y."^)W_8SZI_Z5RUY]7Z;1_AQ]$?$5/CEZG[&_P#!/_\ Y-&\!_\
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M,E9:16W^9]/A,*L/&[^)A1117E'>%?GK_P %:?\ FE7_ '%?_;.OT*K\]?\
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MOP-:I.LHRDVC[9HHHKXT^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6*W\[^]A[&G_ "K[CQO_ (8[^"W_ $3K1O\ OVW_ ,51_P ,=_!;_HG6C?\
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M?C-XLC\-^%=9N+[5I(7G6*2PFA&Q!ECN90.]>T5^2/\ P39_Y.>L?^P7=_\
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MUYHHHKQ3TPHHHH XWXT?\D=\=_\ 8!O_ /TG>OP>K]X?C1_R1WQW_P!@&_\
M_2=Z_!ZOK<D^"?JCY_-/BB?L;_P3_P#^31O ?_;_ /\ I?<U]#5\\_\ !/\
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MPG5]E9IGVS1117DGH!17Y'_&#]N[XHWWQ0\42>$_&5QIOAI;^6/3K>&W@91
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MW8[_ '>7]=3Y(_8Y_P"3G/AU_P!A1?\ T%J_;&OQ._8Y_P"3G/AU_P!A1?\
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MY;:?BSBI<F)Q#G5>G]61[5I_["OP.L=)-A_P@MO<(R@--<7=PTS>^_S,J?\
M=P*^-?VT/V%[7X-Z$_C?P-+<S^&(Y%2_TVY?S)+'<0JR*_5HRQ"D'YE)!R03
MM^T/^&XO@;_T4"S_ / 6Y_\ C5<O\4/VN/@5XY^&_BGP])XZL;@:IIEQ:",V
MMP,L\;*N#Y?!R00>Q&:\+#U<=2J*4E)KK=,]2M3PM2#2<4^FQ^:7[.OQFO\
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M*G_DL7BW_L G_P!*(J^8_CK\3I/C)\7/%'C)HF@35+LO!"_WD@11'"K>XC1
M<=P:^G/^"5/_ "6+Q;_V 3_Z415]MB(.GE[@]U%?H?+T9*IC.9;-L_3VO*/V
MI/A;_P +A^!/BSPY%%YNH-:F[L /O?:8CYD8'IN*[#[.:]7HKXFG-TY*<=T?
M42BIQ<7LS^>^&:6SN(Y8G:&:)@Z.IPRL#D$>A!K]6?CG^TE%>_L)Q^,[6X5-
M4\5Z=%I2>6P&VZE!CNE7'0H$N,8_NCI7P=^V5\+?^%2_M#>*-,AB$.F7TO\
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M&T"-;A&UO0;>/2M2M=PWHT:[8Y"/1T56SC&=X_A-?0%<-7-,52J2IR2T\O\
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MGZ5^.=FL+7<"W+,EN742,G4+GDCWQFNG)J,.259K6]C#,JLN94UMN>P_"?\
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MJ<.(_P!]^:_0_9^BBBOBCZ8_&_\ ;^_Y.Y\>?]N'_I!;5[M_P2=_Y&#XC_\
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M^\T_5?F<V)_@S]&?D%7]"=?SV5_0G7NYY_R[^?Z'EY7]OY?J%?C1^W)\*_\
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ML1/$=TO^#^AX$J[J48T>W](_2_\ X)?_  L/AOX6ZUXVNX=EUXBNO(MF8?\
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M:XN/ %K'(3G;:7MU;)_WS%*J_I7:_#O]GOX;_"BX%UX4\'Z9I-X 5%X(S+<
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M/4_$;G6+C<,$(X A7Z>4J-]7-?2=06=G#I]G!:VT206\"+%%%&,*B@8"@=@
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MO4KGQ#K=S=ZE>:A.YEU&Z+.9I %+#<>I 9.!T!7H,5[=^P#_ ,G<^ _^W_\
M](+FOT(^,7[#_@'XL>'O"6A0M=>$M)\-+<K:6NB+&JMYWE;R^]6+-^Y7YCR2
M2236)\%_V /!WP3^)>C^--*\1:Y?W^F>=Y=O>&'RF\R%X3NVH#P)"1@]0*JI
MFF'J8>4-FTU;\A1P-6%:,MTFCZCKYT_;L^"=_P#&KX&W,6BV[7>OZ)<+JEI;
MQC+W"JK++$OJ2C$@#DLBCO7T717RM*I*C452.Z/>J052#A+9G\^,,UQIMY'-
M#)+:W=O('21"4>-U.001R""/PQ7TGHW_  44^-FDZ=#:/KEAJ)B7:+B\TZ)I
M6 X&XJ%R?<C)[DU]_P#Q?_8A^%7QFU:?5M2TBXT;6;ABT^H:),+>29CU9U*M
M&S9Y+%<GN37DDG_!*OX>%V*>+/$RIG@,UN2![GRA7U;S+!8B*]M'7S5SP%@L
M31;]F_Q/M>O@7_@K%_R+_P ./^OJ^_\ 0(:^^J\9_:0_9?T#]I>RT*VUW5=2
MTM-(DFDB;3S&"YD" [MZMTV#IZU\[@JL:&(C4GLO\CV<53E5HRA'=GY:?L<_
M\G.?#K_L*+_Z"U?MC7R=\+_^"=?@KX5_$#0_%NG^)=>N[W2;@7$4%T8/+=@"
M,-MC!QSV-?6-=698FGBJD94]DC# T9T(.,^Y^>O_  5I_P":5?\ <5_]LZ^:
MOV'?^3JOA]_U]3?^DTM?IE^TE^RKX>_::_X1W^W=7U/2O[$^T>3_ &<8_P!Y
MYWE;MV]6Z>2N,>IK@OA'_P $]?!GP?\ B-HOC'3?$FNWM]I<CR1071A\IRT;
M(=VV,'HQZ'M7;0QU&G@O82?O6?XW.6MA:L\3[5+2Z_"Q]54445\T>V?C?^W]
M_P G<^//^W#_ -(+:O=O^"3O_(P?$?\ Z];'_P!#FKW?XT?L >#OC9\2]8\:
M:KXBURPO]3\GS+>S,/E+Y<*0C;N0GD1@G)ZDUU_[-_[)7AS]FB]UVYT+6-4U
M1]7CACE74#&0@C+D;=BKUWGK7TM;'4)X)4$_>LE]UCQ*>%JQQ7M6M+L]TK\T
MO^"@G[)>K:3XLU'XG^$].DOM$U$^?K%M:IN>SGQ\\^T<F-_O,?X6W$X!&/TM
MHKQL+B9X6I[2)Z5>A'$0Y)'\]B.T;*Z,4=3D,IP0?6NCU'XF>+]7TUM.O_%>
MN7M@R[#:W&HS21%0,8V%L8Q[5^R7C3]DGX/_ ! O);O6O 6EO=2G=)/9A[-W
M;.<L8&0D^YY-4O"_[&/P5\'WB76G?#_37G1MZG4))KT ^H$[N/TKZ/\ MF@U
M=P=_D>-_9M5.RDK'Y$7?PC\3Z=\+8?B#>Z=)9>&KG48],M)[@%&NI'CED+1
MCYD41$%NF2 ,X;"?!?\ Y+%X$_[#UC_Z4)7Z&_\ !4[4;6S^"'A/25VQS3>(
M(YX8U  \N*VG5L#T!E3\Z_/WX!Z?)JWQS^'EG'G=-XAT]<@9VC[0F3CV&3^%
M>CA\0\3AY59*VYQUJ*HUE33OL?NQ1117Y^?7!1110!QOQH_Y([X[_P"P#?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<91P]#ZMAW=[>B_S'AL/4K5?;5EYG6T445\D?0A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>apyx-20230623_g2.jpg
<TEXT>
begin 644 apyx-20230623_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X2:817AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(S.C V.C(R(# X.C0T.C4V   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,P,0  DI(  @    ,P,0  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,SHP-CHR,B P.#HS,SHR-P R,#(S.C V.C(R(# X.C,S.C(W      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  %.P         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 10$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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M@WJ7YQ?_ !% !_9$_P#T&]2_.+_XBJ&KV]YIEE'=1:Q?.PNK="LGEE2KS(K
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M)N7(&><=*H3_ !!TJWB9WANN(A*,(#N!0.!UZE3G'L: .HAD\Z%)-C)N&=K
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MFC*KR.Y(_'GZT 2126D:+%"\*J!\J(0 !C/ 'MS4X((R#D&@#(T+[VJ?]?\
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M\,%A31MT4;$*PN=HP3R<9'7)//\ ]:HOLN02=$E+0*D6TS]5(RQ!Z$@]>YH
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M /P6O_\ 'Z #_A&=;_Z#.G_^"U__ (_1_P (SK?_ $&=/_\ !:__ ,?H /\
MA&=;_P"@SI__ (+7_P#C]'_",ZW_ -!G3_\ P6O_ /'Z #_A&=;_ .@SI_\
MX+7_ /C]'_",ZW_T&=/_ /!:_P#\?H /^$9UO_H,Z?\ ^"U__C]'_",ZW_T&
M=/\ _!:__P ?H /^$9UO_H,Z?_X+7_\ C]'_  C.M_\ 09T__P %K_\ Q^@
M_P"$9UO_ *#.G_\ @M?_ ./T?\(SK?\ T&=/_P#!:_\ \?H /^$9UO\ Z#.G
M_P#@M?\ ^/T?\(SK?_09T_\ \%K_ /Q^@"*V\(ZQ:P+#'K5B57.-VG/GDY_Y
M[>]2_P#",ZW_ -!G3_\ P6O_ /'Z #_A&=;_ .@SI_\ X+7_ /C]'_",ZW_T
M&=/_ /!:_P#\?H /^$9UO_H,Z?\ ^"U__C]'_",ZW_T&=/\ _!:__P ?H /^
M$9UO_H,Z?_X+7_\ C]'_  C.M_\ 09T__P %K_\ Q^@ _P"$9UO_ *#.G_\
M@M?_ ./T?\(SK?\ T&=/_P#!:_\ \?H /^$9UO\ Z#.G_P#@M?\ ^/T?\(SK
M?_09T_\ \%K_ /Q^@ _X1G6_^@SI_P#X+7_^/T?\(SK?_09T_P#\%K__ !^@
M _X1G6_^@SI__@M?_P"/TT^$]5FEMQ<:Q9-$EQ%*RQZ>RLVQU?&3,<9V^AH
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M *MS^/\ _P"$-_\ ;Z/^&^?^K<_C_P#^$-_]OKZJHH ^5?\ AOG_ *MS^/\
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M#D;L@,I5@".,[A^NJCGUK\9_^"@/_*3;P=_U]:!_Z/6OV:[T +1110 4444
M%%%(QPI- "U1US6].\-Z3=ZIJ]_:Z7IEK&9;B\O9EAAA0=6=V(51[DUY_P#$
MO0?B?JGCWP#=>"O$NDZ-X5LKQG\36-_:^9/?VY*82%BC8. _0I@D'+8VUE?M
M?.(_V9_B*2R)C29,M(?E7D<GV% '8^$OC!X#^(&I2:?X6\;^'/$FH11&XDM-
M'U6WNY4B!"ERD;DA0S*,D8RP'>NDN]4LM,FLXKN[@M9;R3R;>.655:>0(SE$
M!Y9MB.V!DX1CT!KY2^*7QBN=:^%?B*UT_P"-O@CQ#J;2:<L*^ 0;/4;=7U*U
MCDE#C4+@[=DC*?E ^<9..#R/CBS;1/C19:5=:_K=QI7AOQY!'I4FJ^([L^1)
M=>'I9$B>9I@S![E8U578_P"M>-2$E96!GW.*=7YL0_$SQS-\,]0NK?Q[+%KK
M^'6E\16UKXHU&_U&WO#<P+YC0/:1QZ3(CM+'Y*R!74X DV;Z^M/V@X;KX:?
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M? RRMXH(/"7CR&")!''%'IEBJHH&  !>8  QBI/^'U/P0_Z%;Q__ ."ZQ_\
MDR@#-^%?['/Q._:>^+T/Q8_:FAM;6WTL^7H_@&U<-:H%VG<ZJ[A8MPW;"S/(
M0-YV@*UC]H_]GWQ5^R#X_O?VA?@%;K'I.#+XQ\"QC%K=6X):2:)!T49+$*,Q
MG+K\NY:M?\/J?@A_T*WC_P#\%UC_ /)E(W_!:?X'NI!\+>/B.X.G6/\ \F4
M>M>)OVBO"'[3/["?Q8\7>$;PR1/X-UF.\T^; N;"?[!*6AE4=".H/1@002*\
M2_X(F_\ ) _'7_8SG_TD@KX1^-G[1W@'2O'_ (H\0?L]1>)/!VD>--)O-)\2
M^&=:L[>*P=+B-XV:!8IY,#]XS*I \MQ\IVL4'W=_P1/_ .2#>.O0^)CV_P"G
M6"@#]%**** "BBB@ HHHH **** "OE/]J3_D[']E#_L,ZU_Z0K7U97RG^U)_
MR=C^RA_V&=:_](5H ^J:*** /E?]N#_D>/V:/^RFV'_HJ6OJG^(U\K?MP?\
M(\?LT?\ 93;#_P!%2U]4_P 1H =1110 4444 %%%% !1110 C?=ZX]Z_%_\
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MIX>\'JK:]KVF:(&AEN%?4[R. -'$%,CC>PRJ;D+'HNX9QD4 ;U%,7[Q^M/H
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M/3M0^&/PC^)WP>T2"XNO$WBGQ3I?A9+6UV&>3-E"UZZ[V5.0K@EF"CS.2!R
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M#=>"O$NDZ-X5LKQG\36-_:^9/?VY*82%BC8. _0I@D'+8VUA?MG''[*_Q/\
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MV-XC\'^7H6J_#CSO&CZC!8QV.FW]YJ%JR26!O/,>2UT^6<.%5E*);. PSOV
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MYI?#?[&]ZVH>#3XS\=_\)3I_@C0+SP]X:AM='6QFMX[F 6SS7,GFR">40*B
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M45U<Y()\R55W/DC/S$\@56L?A3X)TN'6(K/P=H%K%K63J4<.EP1K>Y/_ "V
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M_D2@#Z9HKYF_X7]\6?\ H4?!?_@]O/\ Y$H_X7]\6?\ H4?!?_@]O/\ Y$H
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MIC [ 5Y)IGAOXCV_B6TMX;/7(M$_MC2[Q9;G5XI!;6,=H([BWD_TAF8^9\S
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M /X5]G_\;H_X3C]I#_HUR_\ _"OL_P#XW0![/S1S7C'_  G'[2'_ $:Y?_\
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M /&Z /9^:.:\8_X3C]I#_HUR_P#_  K[/_XW1_PG'[2'_1KE_P#^%?9__&Z
M/9^:.:\8_P"$X_:0_P"C7+__ ,*^S_\ C='_  G'[2'_ $:Y?_\ A7V?_P ;
MH ]GYHYKQC_A./VD/^C7+_\ \*^S_P#C='_"<?M(?]&N7_\ X5]G_P#&Z /9
M^:.:\8_X3C]I#_HUR_\ _"OL_P#XW1_PG'[2'_1KE_\ ^%?9_P#QN@#V?FCF
MO&/^$X_:0_Z-<O\ _P *^S_^-T?\)Q^TA_T:Y?\ _A7V?_QN@#V?FCFO&/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140241529648624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">APYX MEDICAL CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000719135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140241531474320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:7.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="39" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pay versus performance table</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(h)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary compensation table total for PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation actually paid to PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average summary compensation table total for non-PEO NEOs (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average compensation actually paid to non-PEO NEOs (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of initial fixed $100 investment based on Total stockholder return </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)<br/>(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,170,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(653,639)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">974,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55,170)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23,184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,594,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,153,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">776,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,383,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="text">This section is included to comply with the provisions of Item 402(v) of Regulation S-K. For a more comprehensive analysis of our compensation philosophy please see the General Compensation Philosophy section of this filing. In the table and footnotes below, &#8220;PEO&#8221; refers to our principal executive officer, Charles D. Goodwin.Reflects average compensation amounts for our non-PEO named executive officers for the respective years shown. Moshe Citronowicz, Todd Hornsby and Tara Semb are the non-PEO named executive officers for the 2022 and 2021 years presented.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 2,170,236<span></span>
</td>
<td class="nump">$ 1,594,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="num">$ (653,639)<span></span>
</td>
<td class="nump">3,153,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="text">The following table summarizes the adjustments from summary table total compensation to compensation actually paid:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:47.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-PEO NEOs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summary compensation table total compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date fair value of awards granted during the year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,664,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(701,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612,023)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of awards granted during the year that are outstanding and unvested as of year-end</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value from prior year-end to current year-end of awards granted in prior years that were outstanding and unvested as of year-end</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425,076)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value from prior year-end to vesting date of awards granted in prior years that vested during year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation actually paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653,639)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,170)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of the grant date. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, risk free rates) as of the measurement date. The change in stock price was the primary driver for the adjustments in the table above.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 974,614<span></span>
</td>
<td class="nump">776,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="num">$ (55,170)<span></span>
</td>
<td class="nump">1,383,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="text">The following table summarizes the adjustments from summary table total compensation to compensation actually paid:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:47.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-PEO NEOs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summary compensation table total compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date fair value of awards granted during the year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,664,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(701,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612,023)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of awards granted during the year that are outstanding and unvested as of year-end</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value from prior year-end to current year-end of awards granted in prior years that were outstanding and unvested as of year-end</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425,076)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value from prior year-end to vesting date of awards granted in prior years that vested during year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation actually paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653,639)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,170)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of the grant date. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, risk free rates) as of the measurement date. The change in stock price was the primary driver for the adjustments in the table above.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses and sales:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands except per share data)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholder return (change in stock price)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-81.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-52.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual compensation paid to NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-111.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses and sales:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands except per share data)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholder return (change in stock price)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-81.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-52.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual compensation paid to NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-111.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (23,184,000)<span></span>
</td>
<td class="num">$ (15,172,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Charles D. Goodwin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_apyx_ShareholderReturnPerShare', window );">Shareholder Return, Per Share</a></td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="nump">$ 12.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_apyx_ShareholderReturnPercentChange', window );">Shareholder Return, Percent Change</a></td>
<td class="num">(81.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_apyx_NetIncomeLossPercentChange', window );">Net Income (Loss), Percent Change</a></td>
<td class="num">(52.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_apyx_NonPEONEOActuallyPaidCompensationAmount', window );">Non-PEO NEO Actually Paid Compensation Amount</a></td>
<td class="num">$ (819,000)<span></span>
</td>
<td class="nump">$ 7,303,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_apyx_NonPEONEOActuallyPaidCompensationPercentChange', window );">Non-PEO NEO Actually Paid Compensation, Percent Change</a></td>
<td class="num">(111.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards Granted During The Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">$ (1,664,793)<span></span>
</td>
<td class="num">(701,420)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards Granted During The Year, Outstanding And Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">255,114<span></span>
</td>
<td class="nump">1,001,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards Granted In Prior Years, Outstanding And Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(1,156,271)<span></span>
</td>
<td class="nump">1,034,657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards Granted In Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(257,925)<span></span>
</td>
<td class="nump">224,025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards Granted During The Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(612,023)<span></span>
</td>
<td class="num">(257,861)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards Granted During The Year, Outstanding And Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">93,787<span></span>
</td>
<td class="nump">368,129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards Granted In Prior Years, Outstanding And Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(425,076)<span></span>
</td>
<td class="nump">356,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards Granted In Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">$ (86,472)<span></span>
</td>
<td class="nump">$ 140,606<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apyx_NetIncomeLossPercentChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apyx_NetIncomeLossPercentChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apyx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apyx_NonPEONEOActuallyPaidCompensationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apyx_NonPEONEOActuallyPaidCompensationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apyx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apyx_NonPEONEOActuallyPaidCompensationPercentChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apyx_NonPEONEOActuallyPaidCompensationPercentChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apyx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apyx_ShareholderReturnPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apyx_ShareholderReturnPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apyx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apyx_ShareholderReturnPercentChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">apyx_ShareholderReturnPercentChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>apyx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=apyx_EquityAwardsGrantedDuringTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=apyx_EquityAwardsGrantedDuringTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=apyx_EquityAwardsGrantedInPriorYearsVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=apyx_EquityAwardsGrantedInPriorYearsVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>apyx-20230623_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:apyx="http://apyxmedical.com/20230623"
  xmlns:dei="http://xbrl.sec.gov/dei/2022q4"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="apyx-20230623.xsd" xlink:type="simple"/>
    <context id="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i26b33c751ae2451aa979b7ec2838c3b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0ae6b475b9fd4b3ebfd38c5450726124_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f583035c6374528bb077736a326ab0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i365563ab8b2d4214b41460b9949f4e59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i088317b3378249d1a227d77e70f4c9f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id021d1f1ba5d4ba08840bdc58f968874_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i890ae3f400774879b3cda2ffd442021e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8d5feed1f0be46b6bfc8ec725d826f7f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84712a841c224c4c90bd386bfd1602be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i34bf3b715e8a4b3a9e44d05eebbacc21_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i387182a6d0444587a7fc93b9968a7e66_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id680e224e4af4fc6bcd722914d82eb3d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibea22881fac2490ba82e70a11d0f6191_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id2d9111611954d77989482ba0f21e03a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9fe9dbce7c7748a3bf1fd7f44b0db31d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f94684f847340ac9403da4875607a2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">apyx:EquityAwardsGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icde9e9acbfab427ebad602f8ae2a2854_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b52cc5a3ec34719943c2826b7c63e71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-2">0000719135</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-3">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-4">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-1">APYX MEDICAL CORPORATION</dei:EntityRegistrantName>
    <ecd:PeoTotalCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-5"
      unitRef="usd">2170236</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-6"
      unitRef="usd">1594394</ecd:PeoTotalCompAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-7">This section is included to comply with the provisions of Item 402(v) of Regulation S-K. For a more comprehensive analysis of our compensation philosophy please see the General Compensation Philosophy section of this filing. In the table and footnotes below, &#x201c;PEO&#x201d; refers to our principal executive officer, Charles D. Goodwin.Reflects average compensation amounts for our non-PEO named executive officers for the respective years shown. Moshe Citronowicz, Todd Hornsby and Tara Semb are the non-PEO named executive officers for the 2022 and 2021 years presented.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-8">Charles D. Goodwin</ecd:PeoName>
    <ecd:PvpTableTextBlock
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pay versus performance table&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary compensation table total for PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation actually paid to PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average summary compensation table total for non-PEO NEOs (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average compensation actually paid to non-PEO NEOs (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value of initial fixed $100 investment based on Total stockholder return &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net income (loss)&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,170,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(653,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;974,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(55,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,594,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;776,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,383,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-10"
      unitRef="usd">2170236</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-11"
      unitRef="usd">-653639</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-12"
      unitRef="usd">974614</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-13"
      unitRef="usd">-55170</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-14"
      unitRef="usd">33</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="-3"
      id="f-15"
      unitRef="usd">-23184000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-16"
      unitRef="usd">1594394</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-17"
      unitRef="usd">3153022</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-18"
      unitRef="usd">776134</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-19"
      unitRef="usd">1383313</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-20"
      unitRef="usd">178</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="-3"
      id="f-21"
      unitRef="usd">-15172000</us-gaap:NetIncomeLoss>
    <ecd:AdjToNonPeoNeoCompFnTextBlock
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-22">The following table summarizes the adjustments from summary table total compensation to compensation actually paid:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Summary compensation table total compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant date fair value of awards granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,664,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(701,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(612,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of awards granted during the year that are outstanding and unvested as of year-end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value from prior year-end to current year-end of awards granted in prior years that were outstanding and unvested as of year-end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,156,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(425,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value from prior year-end to vesting date of awards granted in prior years that vested during year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation actually paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(653,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,383,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of the grant date. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, risk free rates) as of the measurement date. The change in stock price was the primary driver for the adjustments in the table above.</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-23">The following table summarizes the adjustments from summary table total compensation to compensation actually paid:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.014%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Summary compensation table total compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant date fair value of awards granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,664,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(701,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(612,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of awards granted during the year that are outstanding and unvested as of year-end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value from prior year-end to current year-end of awards granted in prior years that were outstanding and unvested as of year-end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,156,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(425,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value from prior year-end to vesting date of awards granted in prior years that vested during year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation actually paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(653,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,383,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of the grant date. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, risk free rates) as of the measurement date. The change in stock price was the primary driver for the adjustments in the table above.</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-24"
      unitRef="usd">2170236</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-25"
      unitRef="usd">1594394</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-26"
      unitRef="usd">974614</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-27"
      unitRef="usd">776134</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i26b33c751ae2451aa979b7ec2838c3b5_D20220101-20221231"
      decimals="0"
      id="f-28"
      unitRef="usd">-1664793</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i0ae6b475b9fd4b3ebfd38c5450726124_D20210101-20211231"
      decimals="0"
      id="f-29"
      unitRef="usd">-701420</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i4f583035c6374528bb077736a326ab0e_D20220101-20221231"
      decimals="0"
      id="f-30"
      unitRef="usd">-612023</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i365563ab8b2d4214b41460b9949f4e59_D20210101-20211231"
      decimals="0"
      id="f-31"
      unitRef="usd">-257861</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i088317b3378249d1a227d77e70f4c9f6_D20220101-20221231"
      decimals="0"
      id="f-32"
      unitRef="usd">255114</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="id021d1f1ba5d4ba08840bdc58f968874_D20210101-20211231"
      decimals="0"
      id="f-33"
      unitRef="usd">1001366</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i890ae3f400774879b3cda2ffd442021e_D20220101-20221231"
      decimals="0"
      id="f-34"
      unitRef="usd">93787</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i8d5feed1f0be46b6bfc8ec725d826f7f_D20210101-20211231"
      decimals="0"
      id="f-35"
      unitRef="usd">368129</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i84712a841c224c4c90bd386bfd1602be_D20220101-20221231"
      decimals="0"
      id="f-36"
      unitRef="usd">-1156271</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i34bf3b715e8a4b3a9e44d05eebbacc21_D20210101-20211231"
      decimals="0"
      id="f-37"
      unitRef="usd">1034657</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i387182a6d0444587a7fc93b9968a7e66_D20220101-20221231"
      decimals="0"
      id="f-38"
      unitRef="usd">-425076</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="id680e224e4af4fc6bcd722914d82eb3d_D20210101-20211231"
      decimals="0"
      id="f-39"
      unitRef="usd">356305</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ibea22881fac2490ba82e70a11d0f6191_D20220101-20221231"
      decimals="0"
      id="f-40"
      unitRef="usd">-257925</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="id2d9111611954d77989482ba0f21e03a_D20210101-20211231"
      decimals="0"
      id="f-41"
      unitRef="usd">224025</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i9fe9dbce7c7748a3bf1fd7f44b0db31d_D20220101-20221231"
      decimals="0"
      id="f-42"
      unitRef="usd">-86472</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i0f94684f847340ac9403da4875607a2d_D20210101-20211231"
      decimals="0"
      id="f-43"
      unitRef="usd">140606</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-44"
      unitRef="usd">-653639</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-45"
      unitRef="usd">3153022</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="0"
      id="f-46"
      unitRef="usd">-55170</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="0"
      id="f-47"
      unitRef="usd">1383313</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-48">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses and sales:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholder return (change in stock price)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-81.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual compensation paid to NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-111.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      id="f-49">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses and sales:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.759%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.523%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholder return (change in stock price)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-81.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-52.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual compensation paid to NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-111.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <apyx:ShareholderReturnPerShare
      contextRef="icde9e9acbfab427ebad602f8ae2a2854_I20221231"
      decimals="2"
      id="f-50"
      unitRef="usdPerShare">2.34</apyx:ShareholderReturnPerShare>
    <apyx:ShareholderReturnPerShare
      contextRef="i6b52cc5a3ec34719943c2826b7c63e71_I20211231"
      decimals="2"
      id="f-51"
      unitRef="usdPerShare">12.82</apyx:ShareholderReturnPerShare>
    <apyx:ShareholderReturnPercentChange
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="3"
      id="f-52"
      unitRef="number">-0.817</apyx:ShareholderReturnPercentChange>
    <us-gaap:NetIncomeLoss
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="-3"
      id="f-53"
      unitRef="usd">-23184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="-3"
      id="f-54"
      unitRef="usd">-15172000</us-gaap:NetIncomeLoss>
    <apyx:NetIncomeLossPercentChange
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="3"
      id="f-55"
      unitRef="number">-0.528</apyx:NetIncomeLossPercentChange>
    <apyx:NonPEONEOActuallyPaidCompensationAmount
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="-3"
      id="f-56"
      unitRef="usd">-819000</apyx:NonPEONEOActuallyPaidCompensationAmount>
    <apyx:NonPEONEOActuallyPaidCompensationAmount
      contextRef="i41e275f1fcc24fedb7bbdfc19a6e4723_D20210101-20211231"
      decimals="-3"
      id="f-57"
      unitRef="usd">7303000</apyx:NonPEONEOActuallyPaidCompensationAmount>
    <apyx:NonPEONEOActuallyPaidCompensationPercentChange
      contextRef="i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231"
      decimals="3"
      id="f-58"
      unitRef="number">-1.112</apyx:NonPEONEOActuallyPaidCompensationPercentChange>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>20</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>6</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="apyx-20230623.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="apyx-20230623.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" original="apyx-20230623.htm">apyx-20230623.htm</File>
    <File>apyx-20230623.xsd</File>
    <File>apyx-20230623_def.xml</File>
    <File>apyx-20230623_lab.xml</File>
    <File>apyx-20230623_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>apyx-20230623_g1.jpg</File>
    <File>apyx-20230623_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2022q4</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/ecd/2022q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "apyx-20230623.htm": {
   "axisCustom": 0,
   "axisStandard": 2,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://xbrl.sec.gov/dei/2022q4": 4,
    "http://xbrl.sec.gov/ecd/2022q4": 43
   },
   "contextCount": 20,
   "dts": {
    "definitionLink": {
     "local": [
      "apyx-20230623_def.xml"
     ]
    },
    "inline": {
     "local": [
      "apyx-20230623.htm"
     ]
    },
    "labelLink": {
     "local": [
      "apyx-20230623_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "apyx-20230623_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "apyx-20230623.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_def.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_lab.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_pre.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"
     ]
    }
   },
   "elementCount": 222,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022q4": 3,
    "total": 3
   },
   "keyCustom": 5,
   "keyStandard": 18,
   "memberCustom": 4,
   "memberStandard": 2,
   "nsprefix": "apyx",
   "nsuri": "http://apyxmedical.com/20230623",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "apyx-20230623.htm",
      "contextRef": "i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "995100 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "apyx-20230623.htm",
      "contextRef": "i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "apyx-20230623.htm",
      "contextRef": "i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "2",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "apyx-20230623.htm",
      "contextRef": "i1491a60ad7ed4334ba8042ef3e4158f2_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 6,
   "tag": {
    "apyx_EquityAwardsGrantedDuringTheYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Granted During The Year [Member]"
       }
      }
     },
     "localname": "EquityAwardsGrantedDuringTheYearMember",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "apyx_EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Granted During The Year, Outstanding And Unvested [Member]"
       }
      }
     },
     "localname": "EquityAwardsGrantedDuringTheYearOutstandingAndUnvestedMember",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "apyx_EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Granted In Prior Years, Outstanding And Unvested [Member]"
       }
      }
     },
     "localname": "EquityAwardsGrantedInPriorYearsOutstandingAndUnvestedMember",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "apyx_EquityAwardsGrantedInPriorYearsVestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Granted In Prior Years, Vested [Member]"
       }
      }
     },
     "localname": "EquityAwardsGrantedInPriorYearsVestedMember",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "apyx_NetIncomeLossPercentChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Percent Change"
       }
      }
     },
     "localname": "NetIncomeLossPercentChange",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "percentItemType"
    },
    "apyx_NonPEONEOActuallyPaidCompensationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "NonPEONEOActuallyPaidCompensationAmount",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "apyx_NonPEONEOActuallyPaidCompensationPercentChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Actually Paid Compensation, Percent Change"
       }
      }
     },
     "localname": "NonPEONEOActuallyPaidCompensationPercentChange",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "percentItemType"
    },
    "apyx_ShareholderReturnPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Return, Per Share"
       }
      }
     },
     "localname": "ShareholderReturnPerShare",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "perShareItemType"
    },
    "apyx_ShareholderReturnPercentChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Return, Percent Change"
       }
      }
     },
     "localname": "ShareholderReturnPercentChange",
     "nsuri": "http://apyxmedical.com/20230623",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "percentItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "localname": "AuditorTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the contained file.",
        "label": "Contained File Information, File Description"
       }
      }
     },
     "localname": "ContainedFileInformationFileDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_ContainedFileInformationFileName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the contained file.",
        "label": "Contained File Information, File Name"
       }
      }
     },
     "localname": "ContainedFileInformationFileName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The SEC Document Number of the contained file.",
        "label": "Contained File Information, File Number"
       }
      }
     },
     "localname": "ContainedFileInformationFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_ContainedFileInformationFileType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.).",
        "label": "Contained File Information, File Type"
       }
      }
     },
     "localname": "ContainedFileInformationFileType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentCopyrightInformation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The copyright information for the document.",
        "label": "Document Copyright Information"
       }
      }
     },
     "localname": "DocumentCopyrightInformation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentCreationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different.",
        "label": "Document Creation Date"
       }
      }
     },
     "localname": "DocumentCreationDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the document.",
        "label": "Document Description"
       }
      }
     },
     "localname": "DocumentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases.",
        "label": "Document Effective Date"
       }
      }
     },
     "localname": "DocumentEffectiveDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement",
        "label": "Document Financial Statement Error Correction [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b).",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Text Block]"
       }
      }
     },
     "localname": "DocumentInformationTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_DocumentName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'.",
        "label": "Document Name"
       }
      }
     },
     "localname": "DocumentName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentSubtitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'.",
        "label": "Document Subtitle"
       }
      }
     },
     "localname": "DocumentSubtitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentSynopsis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'",
        "label": "Document Synopsis"
       }
      }
     },
     "localname": "DocumentSynopsis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'.",
        "label": "Document Title"
       }
      }
     },
     "localname": "DocumentTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentVersion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The version identifier of the document.",
        "label": "Document Version"
       }
      }
     },
     "localname": "DocumentVersion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAccountingStandard": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element.",
        "label": "Entity Accounting Standard"
       }
      }
     },
     "localname": "EntityAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses.",
        "label": "Entity Address, Address Description"
       }
      }
     },
     "localname": "EntityAddressAddressDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityContactPersonnelLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Contact Personnel [Line Items]"
       }
      }
     },
     "localname": "EntityContactPersonnelLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityHomeCountryISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element.",
        "label": "Entity Home Country ISO Code"
       }
      }
     },
     "localname": "EntityHomeCountryISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityLegalForm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc.",
        "label": "Entity Legal Form"
       }
      }
     },
     "localname": "EntityLegalForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'.",
        "label": "Entity Listing, Depository Receipt Ratio"
       }
      }
     },
     "localname": "EntityListingDepositoryReceiptRatio",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "pureItemType"
    },
    "dei_EntityListingDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security.",
        "label": "Entity Listing, Description"
       }
      }
     },
     "localname": "EntityListingDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingForeign": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt.",
        "label": "Entity Listing, Foreign"
       }
      }
     },
     "localname": "EntityListingForeign",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityListingPrimary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity.",
        "label": "Entity Listing, Primary"
       }
      }
     },
     "localname": "EntityListingPrimary",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'",
        "label": "Entity Listing, Security Trading Currency"
       }
      }
     },
     "localname": "EntityListingSecurityTradingCurrency",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Phone Fax Numbers [Line Items]"
       }
      }
     },
     "localname": "EntityPhoneFaxNumbersLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityReportingCurrencyISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'.",
        "label": "Entity Reporting Currency ISO Code"
       }
      }
     },
     "localname": "EntityReportingCurrencyISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "currencyItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to serve as parent of six Entity related Table concepts.",
        "label": "Entity [Text Block]"
       }
      }
     },
     "localname": "EntityTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r48",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_FormerFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former end date of previous fiscal years",
        "label": "Former Fiscal Year End Date"
       }
      }
     },
     "localname": "FormerFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LegalEntityIdentifier": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI.",
        "label": "Legal Entity Identifier"
       }
      }
     },
     "localname": "LegalEntityIdentifier",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "legalEntityIdentifierItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NameChangeEventDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type.",
        "label": "Name Change Event Date [Axis]"
       }
      }
     },
     "localname": "NameChangeEventDateAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table.",
        "label": "Name Change Event [Line Items]"
       }
      }
     },
     "localname": "NameChangeEventLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period.",
        "label": "Name Change Event [Table]"
       }
      }
     },
     "localname": "NameChangeEventTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherAddressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other address for entity",
        "label": "Other Address [Member]"
       }
      }
     },
     "localname": "OtherAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_ParentEntityLegalName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity",
        "label": "Parent Entity Legal Name"
       }
      }
     },
     "localname": "ParentEntityLegalName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PhoneFaxNumberDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Phone or Fax Number",
        "label": "Phone Fax Number Description"
       }
      }
     },
     "localname": "PhoneFaxNumberDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940.",
        "label": "Registration Statement Amendment Number"
       }
      }
     },
     "localname": "RegistrationStatementAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r56",
      "r68",
      "r84",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r55",
      "r67",
      "r83",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r51",
      "r63",
      "r79",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r52",
      "r64",
      "r80",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r59",
      "r71",
      "r87",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r54",
      "r66",
      "r82",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r101": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r102": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r103": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r104": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r105": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r106": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r107": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r108": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r109": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r111": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r112": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r113": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r114": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r115": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r116": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r117": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r118": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r119": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r121": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r122": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r123": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r124": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r125": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r126": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r127": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r128": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r37": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r38": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r43": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r46": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Form 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r49": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r55": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r58": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r59": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r61": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form 8-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form F-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form N-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Form N-4",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Form N-6",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r88": {
   "Name": "Form S-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r89": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r92": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r95": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r97": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r98": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r99": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000719135-23-000033-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000719135-23-000033-xbrl.zip
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M'@]HJ'I *Z?!^SX/KO[V1@1;7_MO (<%=S_\,A8)9_CJEOASZEW_[<U!&"1
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MF:/4006*<CP1#N9JN,P+F)?$S!GQ"';P[HG@\8*"':M 4R[#%4X84?/!_6D
MC!9'O?EPNMU= Y-B+4!7+/3>GBH4/!=1' 9OXW?LD^>C#,RIT!7F#9?[59<:
M;NLH"C?%P=G0FWP!:]VK53NUU:8MI,YZ^Q5HH.=\3L%:(,>A),*A$.SM4B?M
MNY_AI95!H)]KLRCOQR#:_O 4ULMK\.2?AH0L$;:$C81;W5#,>!)K]C7@PR=
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MLF^0P6%CW ,Y.^(VJO-&Q=Y<8O^C($,_E3Y822!K%#5+P/[:RBNCJB T Y
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M651!XJ1)Y--Y )FHCRFA&@B'3V/);?4'S*O$ 5PO=D /Q=LTH[GIH8J7KJC
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M]P$O!?0=??&-ET*J$%8I+L6*)CHO2(EE]3FJ+$#H84D9!:C\%5:"&]5[Q X
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M==>%E'DI/B"YG'0XI8% U!=C64$0B2NJCJ2" 1DT-PXA='*EC48!=R)D-M0
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M(5Q"N(3P:X7P"K/_9"-"F6I/8>Z]((/@DQ?PP/$>YZEX2IBMRQP;S )*:&T
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M74N!"CL^/D!.[8#,DX(J00+(*2F:<0.'CL)K7!N8:8 ]OC_?\H)KX)#7@HY
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MR2CU19A5R)R0[.[L %@>;FK5"Q_.(LQ8B$2NV!5#D,_:_<(MMS6I<0FNA,;
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MX;-TPL6(.U+>W0D5-L)1R;X,WA7ZF%'_E,=IC! <0<4X&--#G%"V!36*I;;
MJJK1G2:RO4JBO?T*OTWM)$Q%S1/15IT&L?"U$HJM&Z@SR7#J#SW?I_DR&?)Z
MF_HCA9P+O\JI<@BCEJG"+!,F4I<-=;?:''UC.6_'2E)JJ1B:BP4TK"(,5@.#
M#"2]#KF#8)8X@/V[X(2H4W*FFIWQ<9CVIM:Z7Z9/3I#IFV/X3H9X9#="XP94
M2TKY1;X+OIG%+BKMJIZ&."ZD7%]?X2/1H\^5$Q>>>Q$A$WIO4;W%%^/\UV71
MK?ERP7IUNS#5K T;Q5F<'AA 3)(H"?5.5*,JPSWE2L0-E[HQX/9[_;=K[D^S
MY+T(P)P\?6]@K7=/")^RROP,!:QS@]%?!22E4Q[9=YY;8'#6HSZB *]AGL'+
MQ"US&HMN_ HK["QD):I66+Y@5SJH[7(NZ@<.]A9V6A:1)=-,O'@F:=66K=)(
M2S#M/0;^/ L+5XXS1-*?5+3] G%S >*&U6O=K6:!C#'RI>N02E7?:[8,!DI!
MA<DMMU6=9XZDN)-/D?0DYST(Z%CI(_DB^&)A(.D9G<2@\@>R$P:5]$9C=,>Q
M@/*,T$6$UYL$(8(SQF1RT]Z"^DJ&"!TL)4!5+$;WHM+--IATNH [$\-&"HX#
M]P\HXV//7IT[09B)$D"=E&:1CNQ3-)W@WR*<(B!DQI)AY=O,,RKN(OG$QO5I
M-(\4*V4[:*">E9:*"<77W/-)]52JBVY0!>J75JQB5>ZM]+V9&( ]3)0VF\VJ
M?#*_4;& *M#61IQ_L:=B!5_.)FQ^L3U10ZE-JSBSO,6*M]0.\N5HA<".RE@4
M["J=6"&9D].;@E K!U1*FI5"U.%"AQ_E.HAE1B(<2BZXDAL.U623-Y_:R5EJ
ME,$UU,-[P;47A<&8[G"IL'YH^F9;7WNK3,Y>_[,R#=]EJXT6Y/$J2WVTC+;$
M,9N-PGQO)<FKEHCR0NE=D*JW.N17EDF5K%!*)1&G6.<F%P9^PZ ?G;LK"&-F
M(X$H;I)0I1U(="*HAN5:J') '>>H+)CW0)A4 XKX'K'X.X@N^"L&$]6M/H ;
MOB#=727"I B%T1:8)Q[.B1I2>EFP3\5P*$T,V1O+M[U/>1F7!GUE&O^4JHJE
M+;4**A4V;A8<*V((I],/F6LXE3LD#7XCIQJJEEU**GH!N4&(_Z3VF*>F5GLQ
M)Z%O&4KK:3!L?A7QR0CA$0MJ.X@VTP"V!*0E='!+!JF1H--CU4F86$^"M]?
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M;Y)%";.H!1L-^,?D\396PB#V8SZ^.OJBKQQO8='2T+(I73??N!C=[A1/GH6
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M<9' *"F^[+NLF\T9Z6QMIGJ-PH0'4;@R.J":P?2R&JHH6 47"R\/>##W 15
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M2D:;#?,QP'[(X/NGEM%LU U@)]"V*OE0SAGA74DI^7/FH+"HW!R%0=V))'8
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M4^E\GI;KO(K"+F-4U"5;S.$;P-.J/DG& RAD56H<NU '!%'T7>+;3:FN9VT
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M$F:D]'!0542DRF"0_(DT+L$3OG<\O_RH,I>'G1%8Z#&.Q39 ENGX[1C6/O]
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MQ]!CZ#'T&.N.<0(GJW<\YNQ6#+KZ*%6W*]'1SDI'J99N5Z)Y3B<2-<]IGCL
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M=3#\G%:MTVAN 6/,L=J;QQB##^MZLGJRM;JY'"[>2^M%-G'Q=NX8QX=.MV7
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MR1/P3_H%2'2A2GXDJ8A0BLGPZALX/Y)V/[VY[6^$8)T#)9BD3ZF9,-'E&^5
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M:,>E4."?"U]B7#[P(_I/CPQJDG5!3_D\]D52 Z55^/L&FH*E9M'G'HTH#^R
M3_K^,)&7!F:]E^PM2A;P /CQ*7P/!"[&RNH$?8,,?LQ"3\3*^D0_8.@L$%*M
MQM+'5R8H&F3!/=U8Z#[1X[=7ET?!%W-.9+]^OKGZ<GMQ=_WU"X-?/E_?W5U=
ML6]7-U^_W1W#LN<4^L]72\C[Z(B(1^$1?R 394FB"O_'OO51?D2F )Z\"'GP
M!#H-55O*X:6>]'C@+RIZ^B; )TW1]?P4Q0-FUL__KV1K6!&7]P9J#&OE/7QF
MOO(L+(N<J?2DY 2]8D[)Y-#R=[2/H$++MNJY!2W4XZ"/X6=4VT4R9H9A)KE<
MFH 0DI2OD>';;TAL;U.035H+/K\$=?-;&#UX$SQ";KN<ZT?ADBZ2E_ML4][X
MH"_T_ "]A4+AH Y@'[,8_[A[NX;Q2,2 T_'R"7!GR<I-&+G]6[F]UD#,]Q@K
M/_49=[-F<]?25P/VNIPQKIRSDL\D"95?RLRK=(>]I+(VV,!:=&W6<[59G8.L
MS:J,DWI7/B28QZ_*^,N49ABEZ$-X GP%=!-<E0R4;GTL>D+*M!^"QX(QA++X
MHRCA5KA@[^F>^04X2V"AS8YMLVCJTRN5-2P]YLB,X&@J%*$\8O9R-"EX(_Q;
MO!!OV[DI:$OQPQ7#PCN#+2#'33!TVOP> @4$3^45S5@092'EBC:89%@LWK[W
M[U>^#7S@V);3[-K<J;M.I]GJV9;5J'=L;KIVYR^S^:H2>G%V&@[<O-^_7=_]
MAWW]\\O5M]M?KF_8UT_L\NK;W<7U%_;AZLO5I^O+ZXO?U.?LXLM']OGBR\7/
M5Y^OOAQ%M#2'+I+;G]C7QQ#<3@C&Z5:ZB#'(81]$*( O??"NY>?'0(CY#N;H
MYC>A<H!?GB:HG2!4<!5%_!!^'Z@4(;GZOV:A0)P+C!YL8V8<UAV1,2J3>58^
M<>P< ^0?TR[3:4QC=+,<%!*H(ADS).Q["&_(\QMY,D6>KLZ<"4YC /I7'I(V
M_IEG>J(L35+0=$@,=:B#>@\&QK<5V5091.>!(!"$,\1+&>X*24#M4^Y&Q*!Q
M$:DEX,-$O,U_> =Q\S#@3V_]D/:=OO1.H8 HWP.-[01:"[U0?JSL<*=3:S1-
M-,4*9U"]6%GI&EGI"0@9^9G=K#D=<^[']=JZGS5L9ZUO+IJL:=4:C>;Q3W;A
MAM5:3N/X2;"?R3;G?UP>]J5H]'6$9IH%:+6),3HO0L67OM!N\+ F(8&F' &*
M+KYD>?+^EM3]7'C1JFS H8^Q!;S:O("F2FS%![**]<+#C-%Z;#6Q\K6V0HVA
M? 3$_D+<MB0*?(\A%0Y+6N_\-)B/ +P1.F@JO\>8QV-G_OSF(#OBVDV.<1"4
M_\)3/-D%:U3$I579@X.@WXV(<5+\?IR&4[R\KHLU5\"?D?$Y%@K&V3:=9H.
M7L1N'U.-?.BG$!-_+LY3#?;;;Y?[]H'6I?(^^7%.FU#*:FR5GDNT55B:GON&
ML%V.J+;A-"RC;J_9=&$5[GHQAO !>>O'(W6C]*V6O(T2ME/K5$_F]D"'?[[,
MF5@[HMV;OV#"?YC92?OLXD&$F6!757%+]1@G,L86>G163<IN!4_30!CLSPO6
M:9N6M6]'7(]Q8F,H(9NH;#+I_EUE-($>0X^Q8TNQNXYXRUF*;W=_LNL0;W-B
MTJ8RAU8'$1U6(R=S>,&?;=B=MF&UU@P!3SBS<E#B49WDR>&)2*>VGZ;<QY@"
MJ9K)M1IU]B<87-9HI'UVF]:8V<2.3T%40GVODANDQSC>,4[ Q<51_A/%WPWV
MY3\,_F1VJN+EZC%.9 R=#=%C'/P8)Y W_],/ I\/P#T3WQ/V!\<+:#T1I%4Q
M& <1]^FTR+II$;/1-AS3T6F18Q8/G19Y25IDU7;C.BUR*+;W,HIA!@ES'(-=
M_/UW%OOL#S#'6('K.#HOHL?0SNZ&C_XBMX^#13XAT=BF53?99T[8#5EE3@+U
M&"<RALZ1Z#$.?HP32*??_/[M@OUQ_?&"77_YX^KV#N%=;BMQV^>@PD"=)5GS
M]-2PVBVCT5SSSH[.DAR&>.@LR?JT:]::.DNRH2Q)U:QOP[1D\8AEA1Z[36,A
M4H.U=/V('D,[O#NJ'S&KXNCJ,4YD#)T;T6,<_!@GD%+_Z#_X"?=$'"G7;#8P
MRDU5#,A!A((Z4[)NIJ3>:!JMCKYF<]3BH3,E+XBFUX4AT9F2RMMBVV[4V1\^
M8E3[O,B48-9$9TKT&-K]W8+(??9A4(-]^HW9MFG;5?%R]1@G,H9.D^@Q#GZ,
M$\BH7T:/(F2?_)"'U$GE)HZ\C!H\Z2H2G1O9!=U,H]5J&*V.K7,CQRP>.C?R
MDMR(OFMSM%4DG0[[3?R V:91J)!8=4)$CZ$=W>V6CF@@5CV&SHGH,?08>S<5
M5<N=7_9Y',!H'VOLYRCR'OV075]7Q5H<1+"G<R'KYD*:;=. 5QQ<+J1J'1QG
MT_?,7[/_W:D*LL[:K$\[1]_].=ZLC6DVV._! &84A>R;5],I&SV&]L,W[$4&
M@L>/'$RB*F1I->M5L=YZC!,90R=M]!@'/\8)&(O/4=(7[-)/XRB,'GWW[ZI8
MBH.(\W3"9CVZM1H-HU$_/)C8@TG7Z'R-SM?LB'96S=+Y&IVO.7!73X]1S3%.
MP 77^1H]QM['T/D:/<;!CT%,_";EW4# ?SW_X?V_X)\)GG:L6@O8^MTP2OS4
MC\#-% %/_0?Q[M'WTKY2RN4O2@_L;7WT%=Y-HB!+YW]E*MK9M&DQZ\_9%HNN
MD(\L"9&C_&^_D/8AOQ?GW5CP[^>\!Y-]RX-'_I2\>C.VIH$?GD_0<'+Y<I'O
M_]6-X:MC+U[XX=1635MKU$*XKZ,]B3T1(U,$?)B(M_D/[SP_&0;\Z:T?$C7H
M2^\&'"_1GZN-Q)E/&G]\H?Q8+:K3J36:)JY+>1_JQ6K)-5KR1*@C/[.;-:=C
MSOVX7EOWLX;MK/7-19,UK5JCT3S^R2[<L%K+:1P_"?8SV>;\C\O#GH"??Q%Z
M,0STF7^/?4]4ICW%023H=*)]S42[V33L]N'A9QU*HOU!Y]EUGGU7>79]FW53
M>?:JN08ZSZ['J$#JY+C];YUGUV/L?0R=9]=C'/P8)X![<!=Y'OLEBL.D^U05
M(W$0(9[.U*QY[<VRC&:S?0R9FH6R_-PISS[2.*4LCCR/TH*N<SE;O;"N:R9U
M+N?@W4 ]1C7'T+F<ZL3[>HSC'>,9.<LKD<(H%(M?JY_<_I,Z\:;'./@Q3L"R
MW_&8LULQZ%;%G!]$,*ZS;FL655B-8\&-.[RLFZ_3;CKMMDO:U36TW,;2;E4[
ML--I-SV&=LYUVDV/<>QCZ$R.'N/@QS@!8_$;?XQ%Z KV)P\\&*PJAN(@PCR=
MT%DSH6,VC'KS\)HB'D="1V=T=$9'9W1T1D=G=/081S#&"3CI.J.CQ]C[&#JC
MH\<X^#%.P%A\]MT^%P&[JK&?1<SA WTW3B=U=G!=IMG453K[2^KHK([.ZNPX
MJ]/061V=U3EPAU"/4<TQ3L!1UUD=/<;>Q]!9'3W&P8]Q L;BUZ@?,@*GUIC4
M.INS@VR.W38:.INS'\#J'SJ7HW,YN\WE[*?-ZS'F<JKF.>A<CAY#N^<ZEZ/'
M./8Q="Y'CW'P8YR L?CLAZ$OV ?^!*\[_T6$L:[0T3F=[=.MW=8%.GM*Z>B,
MCL[H[#BCLY_KE3JCHS,Z>HQC'^,$G'2=T=%C['T,G='18QS\&*=@+&+NW[/;
M1QYZ6PY6CBW&T[F<-7,Y+9W+V5<N1U^UTLD<G<S1R1R=S-%C',$8I^"?ZV2.
M'F/?8^ADCA[CX,<X 6/QIPB])_:;>(!/JF(D#B+$T[F<]>AF.SJ7L[=<CD[F
MZ&3.CI,YID[FZ&3.@?N!>HQJCG$"_KE.YN@Q]CZ&3N;H,0Y^C!,P%E][$*>(
M.&$\]-A'/Q9N&N%O\#^&:QNR,]-D0Q$- _'Z)*S(4095CM&P.H9I[0?&8A/[
MM$QVY/V_NO&;]]7*5VA>71U:Z:0S &]2W@U$SKXEME>K.\<DXEN[.=.N;'H5
M[>=684E$IM?L T^$QR"JMQVC:=I&PVRQ*$N3% P+S)HE?1[#"Z,>DVEP=IM&
M[G<T-/"G7[-0,*MNP/\MV\"_//9]MP\_E*R35UBGZ#&$=W&61BD/\&G3L)PF
MJ+=._AJ>CH]98W\*UN</@L&^NUD T9''TKX RQ9C^I#?"QHU3OK^D/DA?48;
MP7@W@J]%\D]=GO@T8_PES 9=$>-O8PL5;A;[J0^S& 998K!>%#/!837PK@3&
M@5_)LAJPJJ?RXVD?ICWQ$$PZ8?!$#)/$/_:R-(L%(T:&]3/N_C<#NK!A%B<9
M#^EOT3#UHQ#>_,CC&/X&/[E1"%R?P)_9,/8?_$#<XV; Y&$AL1PNP=7)/<35
MF?;/1';3_LANKRY9SX>-OY\F+3O#I\0/(*2?$,4>_;0/)&S6F<>?<%DB%KP'
M\>CKVKANIG_F*>Y%G+\O-@<^OP[=(/-@3*>.IQ(%PR&EC*9CTA\?1((,IC;B
M911ZC@@'0[LQXC6:1J/NE*EG=3J:=G-H]U B7=-R#+O=*9.N8VG*S:9<F7!C
MLNI8EM%LMC7-9M#,GT<TRVJ\E-'8IJFFYNY8M58#UC>,$A]G]3868.3]!_'N
MT??2OG*WRE^4;M_;^N@KO)M$09;._\K4F>.F=\BL+[5%MCD1XY3^[<<C@MZ+
M\RY0_OLY$?\M#QYA.UZ]&5O3P _/)V@XN?R%^[ @\JHN@Y<YW&X9C:8]9L=;
M+<1V?1&;WX$'-?%]&)_U1>"A>\E9,HRR!+S7P.^)%%8'GIPK$A@E!D]^\V)2
M(=J7B6])2H]17R+K:LT\PP_X,4\S:Z+-)=I<FDFX'TVR&20KBVBS;IBM,?UH
M-8VVU=*$FT6XN;Z3+&*K M&V[;.T)FACV1;0YJ. O_TWPS3&K7!Q]<QLGO'7
M[)L81G&:S+=X*Z5[=UI$MZ2[-KY>E3RZ'>5]KGZX?1[>"W;AII3-ZM@.BP4E
M=A(69?&\/!C^)O-%"?O_VWOWIK:Q;'WXJZCZG#HO5"D>C D)R6^FR@&GPPP!
M!I/NZ;].R=*V44>6W)(%\?GT[[KMBV09#"&Q 5>=.1UL>6M?UE[W]:R;JPP]
M6-XX S5C"N-Y4Y5J]Q:.&L"0HQBH+P?Z"Y.@*-ASE7OXIJGKB?+1BS2,@1QS
M.1Q\TKC'\+4\XP)U&?L%$F]]<?BP62"Z_N("W5 M3T>>_-J"1D#P,$FSAE=Z
M#04Z#*^R),*-V,+7_,]_O=W=W7G/%(2^MW/>#/J\_7Z;5"[9R,@;S,B/!;N
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M@)E/5$B5@ EHJ<Z;P2)J>#?-6-[: #C\C.YU_<ZRHE0XP Q 8K;Y%5SX89G
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M<V"68NY+7NG/:APAWA;,DKO(HCU!%UCS%?X%0\-4'I 8A$D[M^(79U-X(&]
MFZ<H9<Z=: .WLG;QE)ZV"BZ,M%MQ2C&G?ZX:VV6E]>6\'D-2!^:+F4-%42YR
MTH,<18,20[$6T745S-&S;L<M:_9/RAR#G20.FZWB8IO:!N,5D:4[RIN1H RQ
MP7J;^9#AO J#M@4O"Z^"8BT=:*R(X$PKFDD\=-9H@NB:B:C"N-$IZ*\2V#W.
M8,#]8O<NZSV%H\^R+FM*I4A-L$PV;5:<J0X*G1RC )6!6FO6N<>M_[BFW-25
M('9,X +]&OB%7@6A6?"F8!H;'K5EHKXP:YK6+8YK40NKDP'* BX<L2KMNWMF
MT.'*0EN^KNE!:#H(U)23(PFCH+*[<WXD9L%">CK2YNQ3*$[2<I*EUAYE+X[X
MA4R$>N:::(CRA9N)RA[#^-!(?,3.%2.\+\SETW!X[H/;_%['*J -OD:(,O;J
M&/*[SSX_6SOZ6/;JVJ"S-!G)M6;<2 >PRC@2[41T 933\:"D(][2]I*XU3#]
M '?_=IMGWLK9]O%>ZUP>?4.(G19 .5/\FN!-ZA]F^2A(S2_&*A\A.[!0)3P0
M/OVJG."_0#_-AD-\9#PP=S%7AM )'4.P?BRYFPF[BZ@X%_U*_@M04TYMW,T/
M"9=6\E'E54N/[3P2 W$$N=.DGH#P= I(+B<<#(<J%#P9>0MG/(DC-XB03C76
MB3GVR,D,%L*0J)JC3<;X'N)&L)2<WQ?%26EFD,($I;Y=EC%0J1K&O!N3#)DD
MWFSS*9ISNO)QH%AY7L2''59?HUY";Z!5PFU)52XZ,6H2I!$C]R  7U^6[VE_
M.3+$(?E_' E"2B[Y> P1H,OE5B(604Z"B6PD[0^@)7&F,?NSC+_(E\SB[WRQ
MD^6-&<!89>Y(#R=_>#Y[8MZZ%Z^,C03XM5#  D'KJ#>S!OW&2DRCX0AO)D.2
MZ S#)XD>_&GK_@]1\]=,:CPD\:^2FCJ7^%?-S6C*L7O:AUY9WS-4)JCNO>:4
MERP<YA:%=NY6[3GR6Q0.7H#.Z04U- !*FES5W?97\GBN-'A=U3&M5;TBO%)1
MR=4CE=WWK<:#GLV2T:ZJD4MTSW^;@%+IUWA:H86F+9Y!0\[YK2_U_HZC&0<4
M6%K'1QW4?D;@IV0;E#F[FAO<XR3,*'(0HJ: 5B#"YQ&F*@I64W+A9"8%QOWL
M"'1"7^"<M8S_6Q?Q7.G3E%0E[+^H*(RDCT@.536!2@==JW?\MGPI?O6=V7S:
M&3! "(R"II-ZZ$\T#&<N6<^)G,&I\'!;0475<4WXRDYN+YOJQ]/' :FJ!T^K
M$A$?(&3<MP:MRO<&Y=3FH#L!=/9WP.((7*&0XT,;&54O#-A84;I@/K<I]<JD
M#D^)(2!*H_8]R'!-$0P6RAEI^6@W&AR*,2C_&4EY_A?A$-*(%JN"38*<_NL:
M>'Y#ZK-_9[ $OR<BT!-<*GY"-&L5?AUA\#$LR&SA(Y+09R:AWYB$:N8EG8"D
MBV9R^1-UC114I>!MWC(G%*?)\5;-"Z<$ [L:(_E*-60K13 '2J7TW=,6DW6A
M_PPEI5&@['W$HR7'NJ95&Z@T90AH5#FA9U/>*:6DCD"Z2_381A&5)X.B)FAQ
M5EC#6;AY34V7LS @-X0F!%.X!EMN?@GBTS=/B</.N!)0N)&+S+>H.=4A-*!\
M-:CJK-UQJW&$Q+BCJJ6M["7BVV\CS[DICK#1F$8N?6N5AAL10?9O2C7P!?3>
M7+()Q##.U9A2#(.B*2G*BVSAJ^,M<\X.RSOBK*$"Z2G=_*Y-G\23N[2;^)QY
M@$T+DIA?D$S1FI;0GT^:KE3]N(YBY83F%ACCB/<\1?(T1K^-RAF-O)(RHU,$
MJPD7?L4E;_)AY8>5NO:ZXRL5;[A)C97U:>\;+;*@?]MUFFOAWB.C-XG#))@^
M?A'.BXSP[Z]KA/_^V?7XT":[GK9KA[/KQ5M-"KD@',Q9LO"OBC&$5A:K%E4A
M6Z^<PK);9#^/6!ZQ.<#Z 5+@T.;*,8/5.P\\<K/Y/^?VA$G *"",)%)4<N:-
M6LXQD,4)*L^_(&+>K''5&BYXL/J,B<3:K"@GK,[F358F$5HA:(4;XZ&6),KJ
MAU.!ASH'?UCI44 *"+_&_EC,:V![AL<YE0[DX-)JC(QAE1%3$!37D[>-;Z70
M4 H%>DH<OR6U/P"U/==. W;D\+J$]#@E%SL!+(Z":N-I+BJZ1 "4 O$2.*3(
MDALSI*57U3<.BFD%3B=QNI51^$!TC:FXB1,0U-E<+G),@\KIY$:;] #X,@EN
MV$K2V6X2/!HK-14KT4D4D!UT^@X4 JW\5.RC9M_Z:5;;I:;L*$.9^J&%ODQO
MC 0O#E/Q*7)DTJ5%Y] :H7IT430!3#GFQ$,KW];,)CU.PVRL/&RJ][M-3'E/
M'WS(TK)03SF40Z]Z1RPE7(*W.SO0:A+5*Q<^F/MD$A (G&8F/4@PE&P])])G
MT.?:</% PT I15+&G(B$G+&>9T2\6">X %<JJFRI\"L>)I1^E S+/)29*J<>
M<.JKFSM! &((ZBV9&,O.>!+,0#HDOILXY<LZ_-M7X+C$8<'*>!2I. 0M>Q18
M%)X38[;:\D)"6$X2&9==TT140J( 3AX3^76TB3;"^4&K<F+<ZJB6ET9Q!0))
MP2VI[0-U+Y*-H"5(GDCS%&KY:#F['R?D@]]:MDYDVR@MM;"DK^5\3<0[ODFF
M TG.J\",.#Y(FYM"/-6G?TY0EV!9YVZ.(R<Y9(1T.P"NPE(2:X'B;:FEX"H7
M W[D%CXBV2#D&W8ILBQ<YR#9'$VI#J64S,?;3R?Y@R]K0\2E$EP)QBC8R8*5
M17/FBY1BT?1DN>Y*W?6PW)-/*$F!\HG6:$$2 )4R&.L7)XP2$P4B36B@AIE<
MV8@=@QKAW8R+A%&[&I7LKJ><W7A/*>:(;MM);JW$V.4=;,6O YF9:D6_$I^&
M<^=,G(JM5'/?2,T5?J^#VCI#S8$E'?"&<:Z%J0YW*R&%O":(\*D3<./\$6Z3
M.*&JN85DG'E#6 OG32*WY.3E"AN[4UQ$:(0B!A2\OTSL%6R:]MR<N1C'F?AV
M<YC=%IC:LM)Y63&7QF)OK\D9QVM,1_&TM6J\@CW*0\55"W]^PASH5K/MTA%!
MMNN=CMIBPNLT$0Q@.M](82=D2M^8J\=MJJ^LU(9C/A63347 H"X,VF4@PY*.
M"^0,NB+#N^('VQ@K9;3$^>( 5 )KF2_N]]BC9)12_I_T%N57<$/! %$B_5I&
M/JJ.I__NG\&=Z0OJ&M>U41R5A1GOA%4V*\L@3H-ZOL"P'$J2:<^ WM8RI;<<
M\";LPB3[VM[?W1I7L!VDU27C-S>^TY9!%*KAQ?IP]0(P0R9-9DV=4-$6R%3A
M9OC\=QM+BJBLB,MEYD^PX)F@@HY5LZEV=M"V3C6R<I82_R([?Y*K5TY$VP<U
M$;52#+Z[T("C+$B*>MH7YMM1=@FZCJ9YR=%XDS1>X%%;+EU1BHW/P&%TJ,_.
M@S8ZLW@U"#"[R%UR%;MQ\=%):E%9B-^P>@B8\:<W=)I-%YTN#U8]5-QSS+O[
MIM&@[2FUO$\ZZJI+'LPU)4K0BVV<_'UW@$;D'DHZ1X+,"+]B0SB)XO@$3T:*
MZA:LD%%7S6T=29%"+742":J>H@,/85\J3+MD.D=JS"-'!6??D$,.NK[&^2A1
MZ0@X7#5?(@^LMEXCX05TFY,R[,]?&MA[J@TS>7,FNA4I%D/U:^PD%SI$5$LC
MJ=_I^8TU*VP@.;[RA4M-3UJR_X9I/Q?B"WZ&$IT35> >C3DW\*\RR\LQ,610
M!*F^IAG]GR3*$+ON4B8!YT>1$!P'?QK\%_R4L!:FFLR<Q(I*D!83:^F% A3O
MZA$T=N,\*I[Z6M>!9XU55DNW&:@D5M=N^G(]JZ6"BEV%O3?W6:>Q-OG#!PR7
M+Z#WQBZH_'X!J!"9"Z3.55'W)QKC&@\.74-UUS_B'G.N,:.,F1!ES9\V5SAZ
MR]&_Z-28-X_2/N?MIGE.M1#F\NSP7Y_.3HYZ%YYNE]/W/IY=>*>]_UQZW=/3
M+]T3[W.O=WE\^NL/XD4_#:3**6W0]W>NJE$W41%<24HM+<0 E(O_37!L22G"
MAX3["^K&M(D__<]_M?>I+<P>_ZLF"K1FIR6,=BR:(GI,5<^Y-VWS"P3&$&L%
M^ VOV^W7WI=D#!89S.HB"\#..$Q4D-\$E-/X$38]C@*OTWFSO^-[W>DT?0>#
MZGI5T(QS:CA">8-8!BB:GW0;HV9C>W[S)M7G5M\TCK;C9Z$I,Q0-E2M#>5O
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MM.=]^-(_/NW!SXZZ=&2TX'/['GGOPT]U!4>H]T[FSM$V60W.K^_U8<M/8.>
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M5EG,:9:^ZHEU9F:H%X9&D^C?HE93T6 )%F![?_"J\\))=+@^)+K;:KLD^C$
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M\M!);6;(ZFQE=I7YUB)9=_X@J+[ SMF!MEMJ^L(FZOO,.GV!G@1&]B@$MB:
M(QL2>M:4OS&!\&HQ5'U%P1UU@QN>\]3< (Q"=BZ!SB]$@>L@A9?"2Y/R8T<B
MUL"W_'I%M<:0F+M-;OZOKK6EN^!72FZ=B+ I<G1#OG%J@M\:ABIH"EW?&=_R
M#1J%,S3VBTU'L$R9!G',.7<[/F>PJP9!$;-OGA)H0DS\PI'",,LC<F:R=6V
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MQKX*)NSZG07(NI/MO?PGI+/O"*S06WQ"JRU$U+A#Y+J(GLA%SZ_<>9D'KLT
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M:J+GW"!=NVN=\AN.3^0?^B2>OS<;^ZKS#/4U9+,O%'9JAHR<5=\<+PHLKI)
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M@?X,6%I\,SIU^[YK8?OMGN66N0OVKNV5,BXZ4^ 4:ACR13;,R#F Y_>43>>
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MV2 MJ?QS1CD0_<68!0"=8:I0S\.4F&/IARG>6-!OO3YZP(.9D#M/$80%&<8
M#-CV&5QD+R#!,YU+T6)N@*=#MKB<P.;MFLK8.E,6X+9-"!550TEGTT=[S&3S
ME]-1QR(D+NN9".^_*_HM9^ :^"N,F^Z:#L7+)Q4]#LFX1:]+ +<HLE/ Y/D@
MW@<^P4B:%!E'4VNUF!:J";99O?!,[M7RN>L[!YC;[-@3.#8*8AR(PV$J+ETJ
MP-97P OI>Q3DKXE%&",UY@M_PUA1")CBOE^.;!AJ_"^"K 6780&Z;A,\&&\W
M68#=%V-*_TJ-42 FP72$Z;Q+$F1,(\D6\_M2[)"WJS!!8QH(AF'6*I#4\VN;
MJV0]$IP%B&N;15$W9)CA@;1:S,,9[)X($H>(@PKC//:HB!E8ZGY5=)>^^\\[
M>_^C\,_3@=R6)+]C-HU!J><+?;_7![  $M#WB'6Q%RQ 1LKW5L01>,SVU4LL
M0/N[ GK?KY]LV$@Q6OV[ K&\]=]$-;B.QA:O3H,V*+$=RP+<B$-GH/Z0'9@Z
M]S$;6XSS[-5E08]:90%^8ZBW][N61Y%L8@'<%-AR^]1?=ZA5@+"X9!#_N/7$
M'?EK=-\J+&TE*C@&EF4]&N^!<E&K=9_TJ*Q_.Y. F'AXG1Z Z@.>\H<O-://
M#'M'E#)C'35N= @=#VT!/KJD5XKJ9.>^ZZ6\;6TN6G]#&05<]OP9]+=]=FCJ
MJ,@^M^TH[2>_=,9)R!^H(YC=;7OR9,B)@(/L''I6T?_45VF$RK36KTD\M3)[
MU4)$/M<ESQJ:Y.-VH?<45?'C=7I;H#!<WO*TF>9?\&[Z528G\O-#7$SS_1:#
M#86.3%K?H"M$LADN64WP"_.><AICZ*SS7+)E#.KUY/XY';I;',@,?X,SN>#I
M9V1**7B><$7=T*I8B!UI'O\=1U22'<R=SIKIZLL N'T"$!L@'(Q\$RTRG:7X
M%#W<-_ZM:?X(9X]'DZ+2^/<26W,)H=NG4%H9*$;@%_\[RH3/[^U7MLXE$9>#
M4PFP=G<<%NPZ6?-HM$\AX:G66:,$]8V/:F!?E<X!'<05\^*K1&GSH*XJMKLU
MB%QJ&62'I)_GI?>=MU15NJ(RA;HJZN;?4WWJ:L=IMY'/:0#MK+%EV,M@B.#K
M8#&V7#LP^ Y;"2/";W97S[7%X&"R\&XF-SN#3IT36375J^W6-:HXO:N8]KYC
MQ@N+YZ9I8RQGZ$!I89Q496+$@,<>II,>$769.5AQR3A0SV*51$M:9.,(/!S^
MY%]QHMY%?<]3;1<NQEY->.SYL1%_76QM%AN-Y)XG.\_EJ';V9L $$G_=[>KK
MY=4NC(VYI]<0TFO;UVIT<)RN@R^>C@H^2 D-/N5P3EAORI,>DR?EATKK4\Q;
M_/S,DNXY"EW8T4XZV[OP:>Y3-OV*BS25BMJ!:CTI!O/ZPVG-M0N+\?DW'C94
M?NR0\"6=V3OD!7RNXVPQLQWY3488HHRXUFZ<=G_N'SO=_D,+0K1H<G1IFJ8!
M3LL</'V+>Z54?>'^O#(F1H?4M0GI8G(&7XR?<XX0T'ACGS$!2B1=N_5':;L=
M6/B0 9 91"^\YMJPCQ9RL/P6=4/JR:6"KP\!&@#([EW03ZT*)L8JJ)0<C$4D
M&4%O[CR3^Q42"2U?A@;"!.,V=M865@W88+4F,_]__AJP#'-T6ITY2 #%A,EA
M5:E>$1$?KPJG!7]E 6K?L0!@[83=I0_UU]UG8<!5D8;9MLHT.:43;[^K&V_>
M!5#'EJ+KBFS)$=;HX2UPR,A\GV84<^@TTPQ_^D$T2?W)[!EB.C."CIWOZR>K
M*9#&DQW.581%C+ #%WU EQV@.XTF;H1?^)6:^\>5&E4<E>5D4YAO+I0I9C7^
MDG-1YQ_;V@P;8OY^J'.07IL4ONFPQ-0L5M0.TP635T.9>#;< YO@@M5XV%OO
M7H'?1S34S15G'(*(3G3+>/+H N+&@CHH:6;V9L$(E0WZG4S/7Y>W%-N'6[V?
M=0^X,^'?V&-5XM_T]U#8DXW:4]2B+V[)[QJ0MS8V%)R'%OVI4O@?^H)XR=#^
MUUPSHPNJ:0\^QQL^8,_P+7M+N#*^ 1.E"<E?KE;GG;XQ\$Y2 UQ0/=,(;JZ6
MS<OG&@Y],S(TD&*:?\'4[,SZ4"U1;[$]._>/BT@46PJ=((56UFPI-!O^J+=X
MW!SU@E%8S\-XAQ/2O.XA+J?RN#5;C^<J #CDM:$]?QEU#+5DVW+TXHD+_@$A
M261OA"=#)@DG^=G^_)P#*0DW$C++-B,]4'J#Q_('?K/2(7\"W5UX)<[_-R/[
M"KUP5Z-%^TP5P>+=+L.N9W%R&Y2L9_+C=/X>YQD&9"<:G<V(#?8D-2@8XXM;
M%@U,GFUX(1923XKI#;R'XI5@ <V6[,@8[F^E)5.]'T:I8"0A#$:,E&AK"AK>
M8P'8B"+CT4K=+R.-&[4U_Z?]&\ ^V <68-NDWH9]@R ,XS2Q9\R0 &7>MHA
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MF# %BA GSD=Z6KOL[*E\3[DPT7"<_@6STPZ,<DY"SX].GV:D17ZT(ZS4GIR
M<[QC<N+U"/M)QU_.XV/46N9J'2>+,\S_E<T\[0(92/-H51%F-/N6]1@?>^S6
M6WD&YE4XO7(KB?#KT%% AP8/9'QB7\ 1C5V$'</>5,V$'KGA9YNX'VX'N!G=
M01S'#H[0RK7\8?:>P5@V&IL]C6XGCTMU:66]?)'.6$H*J&(*!_R<8Y^H$63C
M[TRYF@329W(]AHNYGQS>'/V]:"E8KF@Q;+#3VB NXM6$ZX^SHJ'. WD;Z\R#
M+L18YG'LVV'$RQ7[L6R?9W)75B[BU\7ONL&\]$IYKZ])_ZK',XMLY/UEH6EM
M804KCFJR5 '$Y <60-CJ&OEMO@^W<96MXY2X2KR]KJ1 4>']YWXU#V:V)<1/
M+V^-8P :DE.1-QJT+O0$:&?==MF655A2K_;E=M#E45Q24#O=QD]#$[!M58@6
M8 B5.URI?%^G6:E!W/V9UN:'TY+]Y@HH3^6%>4'XK;#B86AB6_S 7.#G'3WV
MUH1@1>LY 9*F 'N"*I$%:!HSN'-S9T(7XUC:!E7>=89W)QC"W O=\\[DG>[^
MR3F,P3(>.WRJ'D,(HNO6/CEW,7L)NEA.%MG=-F^T]90XR(_N(C?M\FDZM;>B
MB@70H\+:EC0$/E@:U_]87]?;AL;2L ILW-F8WG8K3,"W18@3@)$O"EQ4^"K>
M^[9CVDX$%&)V.D!1TDGI95GW3)QT\T\G>4/%I$KQEBDY)I![9O (AG1%9=C&
M^$6\NXS"IQ>>,PK1[Q!2\34.)&LBEGY^?!?S>ZHAKDIQOYK&ASNW'0A-<O0]
MD!+(EADWO\@S8<%0%W$6X$C=;:9SVT/)5\U]36"?ZH J4!)'R:^I_E](_1\A
ME?-)9']2& %,/XLYCK81))DO(1:_/G [=&).;I*BNK(??1E= G+BR,Q&0\)V
MF:K8A'^&6J6@R(<[>P()NZR8NZ!"N$GZC5?4*"TGZ;&$FCI_QL_Y+=XCMDQ,
M@G8'K7L'VNE::\Y^#B5CL;%NC)$2X,PQV4U6JG:Q,%(\O.4*6-P$OHI9C^#9
MD7*>DB(!AQ!LN(N@_V%]Q?&*A?,!TB->[<L=H0R/.$YE>!]A7'W)AYP#\H(O
M4U;)*,GF05ZT7:^[S9;F[,8$@<%;LI >QOA%Y[F0GEY9&?9SW&+.G4_^K+?7
MI-2K&(04I#S??P&9C'%>%W8QE&X<V("M;RU_TE0S[V,!IN=%OSO/62[4G?4I
M!HOX])H-S(R>7'KTR&RI"!DG0+@K_1$]7S-QBFW8<JQ=_.5T*BBH[F]:W#1U
MKCN!XS@X&L*$<G9+F^8G= [H,6@O+,&@CVZDX1,S6]?F9([H5#Y3S?MH1(\.
MP'7Y/4-I%7RQ'!Q.BY^;,PT^#VSNNL:UR6:(DRS 82LRJ)%J'^Z"E/JY%^DF
M.#YF49?U%A0)PQUX *N3G7I<^ADCP +L9L\&0>-A%+7N\,-'C"4DP8JQ-O&V
MA'WZ5QRFTOX'P[^/.ZK&UFY2C@?J#%FEY7E2Q+CGXK ' T=1G;'#=;N(*J'H
M&@NTS1(UHLYE=C18[UE3M]XG+@#O->E>T)/U,!3A(SF#)M5H/2P1OQ+ZW2?U
M&5*R$N@)*T:$U;S&\$W='UDF(Q_J,]> X4ML-L4"[&%@@S:0*W25BER,+ZCA
M!32/;;(Y81Y'TN_7M$DFG)AZ2W:?FC'(V=_MN?OKV&N?B/G9!.9N?6R15O^<
M"<1,X(0QMZ7RHOHM.2KMYWVSDZD*;PC;<=/BKLN_&)?,+/@M;K*IE7;[N8\V
MAVB7Z"9L&1W^!_N'E5'"U:B4Q#)OC4[ M&N_*O"VG_!.+C.PWM9Q3M!GZN(*
M"\#=#_QI$;SOL_7;5.'"9:(UL.N_IW?^3T.Z%>$D)\(^%XJ3P)4OYT?\\XL"
M ]O?L)F9")ONUT?Z*P=($S?;@(04NAXF24BC\Q!P2_J^Z,$T]0^(FI8HF/PB
M]&)S)0N0\T!<$.,'7V) QR@H:",%@2O9_YT-9>L@F_!U>N*\$IN,"<,W.$+>
MSW5E<Q)*-M02LU B"O1N36R-1$0=,-ZX2"U77>."C'K.@$KD7B'P)\C^I^G$
M%<S _JJ [6.VQ^1F#!#UR[B\G3NGZAD&NP3$U\'CB'0:YA3J%?'*P^V5QEMR
M8R%5=588#(%C$JBQG #DIR,&4YAF ]XW$X?I-Z88!H>=,X<UV^*M7),E;TYS
M%WE+98P%P?G(R&:!<1GBONR")8^RGUE?1CN\/10]?4^'R],[T!C09 Y0R*L%
MSP($6P;0ZY1A=\^N?A]I=5^?4S->%$)CK])N9_"N+- @-1BQ.8^#H]MJ)SLW
M#S+8S/;U_0![FEDR.D"Q3[(K/G-IV-R6!9 9#$J5WWH4Q4U[Y@^9-_5"[65*
MV 2<)F?A,8(6^[Q[U@;T'QH'*DG.QFNP &6GKM(<E!=M+[, %FE2,#^_%!^_
MNM9<U(T=>%A&^O))^-GN%67KJYY5O>L%TU7EJ:#J\\_2HD.*]@C70E-0CW\'
MV&9 I=A7&+P,V5^6?FR]KKNCZCJWA,PC4ZKM84[?*YLO<V\OG?7)U(E1N9>?
MK[!?XZB.^_3EKZT/YT-2>\S8^F[#X=DA?HTC$H(?7 40FU#E-$JVCB>"KT9
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M1N <05O&N+%^&O<^%J"2;8=/T:/)V%,(3"_;R-$'V>^QDSW_MP;-W(:]TM'
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M_9)LJU4&55?AWBTC[]L<OO3G8DO7D4]-%DVCW@I;IQ11XLU629V?=/7BWX@
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M)5!JD5SJ/\3B'IZ&EF^%;;*G"#/IEQ 4H&PWR0+PFB]0 ^#669F/E+%FF@;
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M@8M >C"$UG+$EA*6+?H,6("6[K\N_C%\RK#L+:45W$X&\U$"W^.-.PIY+UB
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M,;-R0G]L\8;PHF$#%KU^")*E]T:^EWD^ YB,B&& %2J$9@E,$3O)A1@Z="%
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M<\K2I-/HA@J\JE@GSW*%)G#54 ,^OH1.!@OCQE)8("XF+_TA&?9Z(^E4[9:
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M2E+&D-P+(^#>E$N.YE8]<?%<.S<N&Z/NNK[S?W44 5CR&@@+--59P<8"N;!
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M73_E[S/P,5+[O)IH[TX[:94>M@-C^-4#D)"]$]MB/3LL_0JG@AS+A:SKX%8
M5UOBN<,#2\:13-';&; MP&H-WMB\@MOZ#@<Z\'P2-SR]1N_<7H8!7:FY")BO
M"L"F/ZQL9,82H8T\% C]1 M3GZ,.3)$:0LY;901XV3 7C7]M+XF3Q_Y,KFR/
M4_; 7@+@<.JS#QKH.FQ'/GNK';=O5WI-?Y A ,S%;3A!NZ>0/ ;Q"SZ^7WYM
M,X,AL&)<0843> E/FI,, @^$/C^H*%.';L=Q9P,NX0: )1]2/5F@!X!O^)50
M7H@=:R1L7&J!A,BJ#^P6&)R<J_W[TDK<#<A8%IB;V9GE QV?SL&TE*CGP"23
M.4KFQMB&)-Y/,HJQG5(AD\6OM+]$/7PC+[.F6)OU,EI[HQ[!2_>CQLLV<(8+
M2Y+=X]8\!?N<'C]CM_AR@D=U0OZ/@'7K%0,M(I2"LF?:Q7[HG<KX66K'!G-$
MUL@B3K% M>ID70MR<<_99;B* \7_B0T+)&L\[<V9KBL!V?P%K?>D@6F'Z8!Q
M#K*A7:?ZVKVNSUQ,+$[,Q[-=>3F];^CA^3"4):$RH8]RWYNG @"9<LW5QI38
MF+EBU=?82.08!G*$!1J_0)7"4/-&I G)_)4'-1O/$=T*<,Q;Q\&?Y2GR#WS6
M:RC(X\HG\ZB.]"<=IM\2FHW#8X\%>7.Z?D(]EYI\WAL09-^SU)&>:T#L?J^$
M?NFYJ4 _&3_QD<39.'=5]V-%I5P][S*FO* V+&A[S';U72=J9Q$F1PU4KR!5
M56;:$U\C])A)[M(9=<CA: 4)/.E,]U6KAZMX8OV;;$QKWQ9%KM'=Y<JF-E>@
M%&<*B#!GDIFUD6%0KJJ:I*63BK;=.91:YA+$5"JB)I%6\552!<22G<IP*,+\
MT_;39H4&@ZR2:=4%ITQL6\8IWHDM+>*7]+Q7H1*9_/_-W'>9.Z+A=T]OG4:.
M'X]$DV/&T6^5SWY=OE\L]3"J%2IV.+B-.XU!8 \@1VY.CY(,6*#MJRY[@,D.
M6)/X(<*OWFV*F/[US&:E3$CKSL(%G=?&2SB1;1KY8&# N)6_86>QKE=13Q$M
M1/K9 T3!SW"3]XQ#5Y/!!-D*V;QY8L-')?.%&P%UWE[=V/O3FD?"55_O@]DA
M:_2K#LN^@;MGT#6ZG2GWG2:7RB/KMXW6Y 7Y=GRC4.UBXKEP+9AO<*Z0'H^A
M)_/C6FSF#7DA)3",.3A:G(1IE#WHPZ;^*\.D,+I=Q?;^&^4)I2Z!R\_\F:M;
MF%&_Y-ZU SQ.VEUYF\OF+7KY+U=<L.*Z_CXB_( S9\]BRQ3E;,B+X+/)7%-_
MI*<3G:OJ\"P \ C[:Z@2\JM\CJ,GY 6]G%2X!4]?_@#'>IY#;#:6:U8C!Q_X
M0^<]GT/V(GC,X=Q4@_%1-F)L5!$-N?&Q!YGWW<W:3.6Y52+_W"4E: #L0$1=
MP),*3#<F9?.#N6IM-,H:\Z_Q\H 5,/72!BQJ+187(FN**/D]@G\?0$M/D4WY
M &WN-UH%D"#/I@K\V%\9FL+_7(9F'KW$29(=7T7A['ZH6-0ACG1Z5NH5"WYM
M&]Y,T#UK8E/T*/)553@+] 9*!53K%@$/H4JCZ%(MOT<*CH;G&ET/#=%>V4$;
MOL&P:1ZM?^H+HU_!U0"**%;%#^CF4^2XUM\;K#,UW/S]<.U,BH>_)+*Y:K(9
M,&&Q3$X YLN3.I@<@)]AA_R]85-'@K*)3&(LJ<1"IF'/?]KH^AA)](C:IYC<
M>P!BVXO6X'GY]<])]!\0R+\4@ZF>1(XX^A4N7L+5!.^>&%7G$?0<!LY+QH\9
MU/E_J/UXEC22<>[-W.WB=^%,DQ$""D$@-L_!"F7KG.*=4_7$="UGA5IOG4&X
M[;$PM.Q]6-&9I&6OO0T.*3(T1_!TM9<!3%>?76C$6MVE:);-/ZA1:&L9]D7A
ML?L$'#4:)JA14%!:HGGQ74-!MH(1J!$2>S\UE%Y$^XSM@%&E#.A=6%HH"[2<
MA B"_N/J"DLL8P4,:?K$M[KE"\==1?A#=Y</Z<H"%N4XLA_KR@)E>,62ZW>7
MO.S_MKM^C,S&"-T"[T =8%8?D.4]&ZK^A^D^X,S=FA8^ 2^@8_'U4M ":N+$
MH@/[Q[-]LB(/*P^?O'Z=GKU5@F/'V4M?GX<(JYX;>%>M/B&M!O4VPCG$.- U
M.2=ANM$0A%.3L)@#J>;34407LQ[Z9(MB0?47D3 JD15FHYV\_7DW($ MAN4#
M'VB0:^9I,*!50UZ]HFUW?KKHH\@KF8S'X*V67&\[W2TN!#)-\1N!UE>!^[FS
M&R()5WWW]]3O-H&RL4OIV1LI'@3;5X;"F(F]5RT><+:%J*TGGO8)><2_9.9$
M)E8!]O/5)_ANV;?"R6-)8S2STG[J$\)6%N;,L#[/Z/7%MW7J_7$\Y+: $:A6
M_WBW?PML315Z&DHT=7A:I(1]"3LZ1?U!]J]-/J%ARYL!#WG>]"FC?'K&9B/"
MDLE#RW39[Y6O=>1RSMV&E!-7^4SN7@()?\ VH/NW)C%!$#OL6X'X4+AV^L(-
M@#$G*HGFW^]X;]7S<]9?YE@O^^6!A*I:  1G[S+<%*VZT5@<"W0:"[F:\K;.
M1.>31>@-$H]]9Z![;*+J0&J5V&]WIC&%<TDT9A#X),*4!:)[5<"6Z- UN>Z=
M:<Y952>@UY'PR\('&)]G^YQ3UC98H)/$+ZD_$'.?$"N/=Z*S9IGEA!;Y3=QR
M%,V""J9\('F%V&78"_1]S'-0B+AZ2J&%,\[&HRYSK>Q,=($PN@8F"B4^J$Q-
MX>LU=5*?*5!.[M-/++>;Q]!/S$[$4V;Q2?[5\48SLS?+:(\3"MTI#DT7LU1X
M=],B!!N8"V%B=<F,? <NSDBARP4HC^A_S-1FQ,"U:[>-CV<U#CSB*J 8PXI,
MUGQSP8_?NEGHPM95Z%68HM288?O=BIJ-Z? H@"'L0D(7  WF;V*980DXB<5-
M=R8[@!#%1H'.VBS"&*?D$8:$P2D6:&7T&KS*EHZ,6D'GK]*3H/C5G9U$%D@[
M SNP0W_ "$9.+52!D82>T1T]:40'(2H)*:R*SE81*J0:;3*. S-_?3;O/[*;
M['_W0O R.V%KSV$G<4MVO9"-///UA0TP40K VA/>C/ =##.VQ3H ]J63*13
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M0HCZ>(]K!3VC:TQ$Z)^6U2VQME9?O]TOJB6PZ7U]7$OL_<.II;@T9PVK9"[
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MW#_)-BNY6N7""P!5%-_=9U:UN\\,PWSMA.'4,\EE=QLH%.CVF&]V\@AD"AL
M> Q9C*;SEE()/=?BM?V=CM:976X-._?HP5AX*!.>O;/W'Y9,;ZQ?Y+EX+KBP
MJI1Q3(A7S"?R&>)-!+>A-?_"_W8%Y(['B#QDS67DU. *;DG%$^ .X]CF&PS
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MW#^S1K*S]UYKS?GYKC77G-F8U\4V/E9)PK'==P&O'XBLW%*!J&]W.0WFZAF
MJ3(@NON;?KCY'^E\JEC]28ZD:@+%&_ Q;?@>&W*2BW0&EQU: 3E'"&TVZ]_F
M!H\4\.\6%D7KA3N&O[EXGJ>^U?L$0))A;P<>"\L@"/3V)X"V=4S/_>-O-:%.
MMH9N\B2>NQR>#SLE#_SR3?^,)@7U51@UNU;)P5:;%Q2<$=])>;TPJOJXP$(8
M68!\]);Q7\99US\(%".W3IB4:RM3S)5"<N1&:AP4%*"+Q7M6(7FYK>-EJZ*Z
MNN8K8M'[!;*,B8Z\G3RIT.NA+D5?A&\>!UR (+NPXPD'OPC5"U%19K3];GU<
MIG9<FN3C9E>[ YQP](.21E$.OFQ+2)Y>D2B]_)VOUMNN\HJ\#T.JGUQ@Q7N0
M6* +49%^#"> IOH3P"?Q%N:WD G(! BZ\_HS"2N^,2E9KR6Q# (;'57-0C;_
M+$P#YX-B??#,;49!V;,$OAJ?2>'-F^*/V :/5&NUM9ZCS!Z=4U#E+$IZ9&\W
M[%O'55GCUM_V\T&J+*I+E6R9CN:GW(4W*OD)$X@O4^4?>:;1#LA<946EY1W>
MJ0^/+1;R(/K3E*R;:4")8))I69V,!$D#KZ&JY=Z=K\GKUC=E+7IL\/R^W4[$
M$G_BIS(1M8G;98=<H:1>,N($,)N5)C#@!C45G0]H+UHM+0Y??]!_Q\!]NDKV
M)CUOI.0'[MQN'J8_B@EY1M D^Y\9V5.M/A8>U_H<7<\%1[X:.UM4(!MPZ281
MD_BY2:^I:X2][\>TRE7P%>39:1:#WA- 1=5F1)9?[\$]6W>VDO4T*518;U5Q
M=$C0Q'U5YN<J#_FOW[Q9R20Z6IRE[O;SAZ9IF=&IYM-Q5QED,9AO#T?;BX=3
MI&OBH5$WUHS>.&A-^MX(C%%F,G]])E)!36@FAV!Y4$OHG)/KV!)3Y(4F*'$K
MFF6_=]2N#^VM#3UDTS#"7D/W[%#U^Q_LG,UF(>M1]#S5[-*$D"QPX(U122 M
M3*4"_:EB!G&MOF*I",.HJ\IM>7$\[M$^30Z/#Z[JH(?0AX0]QT4F^R[DUX9Q
M3YO]GIEGJZPZL^ 5;:AV=>6+ZGQQI$Z(LTM<7(29A9I4W'0?)NFT7N#0:?J%
MA]@(X([*Z: UYSX!D(6\23S(&>"_MA5V*M(>9ZSL@D.%-AS_34SXOU=CD$?_
M.U(\K>V_QF,]<[.]L&BFUR+1Q^-:^A<#.CHWOPEN[QC"<Y-@291?1]W$M64)
MQA883QEE&FBG/WJQFU[<?/;1^<BX0A&'0M4FN:K7(FHZ8;&K/N(DOAHP^>P&
M59+< #65 ^@ Y\ZB.>#_I%U(V?YX6.-PDPM1.77+U0)_KP42;40=J+I^ ]CR
MJ';01SA7G=Z<'GYSQ]!H.O%.E=%DRJ3JN>;.J!0^ #@OZ7";(!2U*3,/#SN.
M"I.763"UKT@UFA"NH.?,4AVH2SER*;JJ:_&J!3YK79$;/Y*M,CDMC4JSIG*>
MFV]<DLVDE#;5TWUG,5B$MS%-ULY''+8RL:C-@3A-;%%<QD>60X5S5?Y?'P>_
M?F!(VWV!P4N^!%D FDU#*1+B\- G>% HS'G>N-!&(_+]T-ZJ8( PID<;97-T
M5:WA[;!KI%&]W;B]$4M]^435PA&/K_P[D>$#Y^?$LZ'+E%NDI_V*K 3E$T +
M2@"M*:=:JCFHWA#_6HN55>64P&0QRPEM8,)MFRB2A:^S_:SG/,XZE*/ E2/&
M9]Q@9-Q?MR^=(6J;IZ(OJ%&_%4:OM5R!E\*= 'C(42-<HKB9A8,40K6KYUT(
MU;5\^K[RSKMN-=7UD#6 $O<'3K4WLS^ ['47?)D.XDN X5(-*HDV!<I978>3
M]S_,E4R',5F:?2TUZC2[_WP^TD:M5FK@F*CD!=[8)RI[0@["<9]'RCFY,"\J
M)Y*"HIT:^MZN_'0^_#*[Z=S8.'M%U[O"4^=3;F>372]/^9N?7].W D+S<];8
M:A01KKZ^KJQ9<>7V4H?,#W4C6*P2/\\"SO!C5B#M6,+MRGSG7%-;$%VA1>G0
M@L!%=,Z394T)FFTE>E@.*LW\]1-BOBD'3,Q$M]H6N2-1&)+]Q.P=F>=4Y" G
MRA88T9(:;GBAEFC)!_-WD#,#/B< !J7'U_=:P>F4T1, YWO::QJ0D&-20>J%
MS8$:8$B"$RB"ZDO&*NSQ^:0^.:J7I;#Y36E#$K$T\-D<'J&![>]EA(C,2<+'
MY]9TQ_')'%6UX3;Q$A^7.BFKM/N;D P*#\9>7OO[GXG6CZJC,@?XZ<=#?PT\
MBAB^'Q-^[G;C]:MF6D*T!G2;VH[#>\+SM^?9?_6*"*?_^OTE_;_LN!]M(#,4
M 7Z3%%$J3-(+!9:;TB@/%\SL: Q)$Q)ZIM9"5;IF+1=OU&)^N^VQ-R#&$MI!
MY<" -WB58#<(DZ'M'P^!Z"C=ZK1''NGYS)\"VQ2=L0J>R$$)Q>9QJK6"";4.
M'% G6,W4/IC@7=4"/&8YK?@!FX+C)T!S:]@K\-67. QYEPIM[7;!)-GN>329
M@><T$_0DFJ*40;EAA8=0@IA.$T';8ZE8@(E]A^S&*] OU/V.:L+B=+9YUF<$
M!_8ZZT3G.N;KZH*FIR^T+3'.J7'&%EWV^XI9!@6"9K^= %C>B[.\/?YZ?/C)
MC%YNS('_U?;=,%85AL>]Q9P-^\BA4+PD4[X92+\J-0I,L[DI[N"*OHI>3",@
M*(T>D./;^3A9-,R/#]ZI@ >1 [;0>SH&LV[>U<!FG:7CE$?9K4R)>Y@-+R+G
M%&5@QPR:-$(ZEOGX3I!M6[H4.2$NV"!V7<F?CH55H /D"6"2\\,D4&C1."U-
MZ<($]9'7WWYB*^]FBR<Q'1:[)%*A=6&B!CWFH13\C!P/HV%1#<6P#4YW=),T
M^7<4P:A+P"!9@UI,8G@[)LY6N#,SM7Q'SFE,7?VK289[7QM\8O) #TU.)&E;
M%\\HELSYOI!\97?MIB%K O>/KXPR'YYT-)B[ !K/\1T\)B2X47U"(,XO@Z7W
M1NK^HK?ICD-3'7-Q^-8^72MD+0!%HJJ21%LGB%]O^K+N1:B8]>C;Y.L!?X7
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M*&R(3<ZY7T)AO4-2UK*]*]?M/WWDX/ME^UQ=Y8<T452JTY&^F^]\!$N9Y'4
M8!%3F*I?&\%*M6;//M[)LA*)ZB>=ENJ(@+G\(OCCO<$7QDT0!)6Z.[#X".ZE
MI#WDMLGQU[YXR?Y\*G=7BX_M'JA5DS-)3[R\<DTULPARZFX:W?E.\G\6^7@Y
M/I\_%ZEQQ3W@X2/6.451_'G*';QR29'I-0<WT4ZDE5"NU_5:OP+H'O1 @@J-
M3"0^*C2"?D#]Q,L&]Y?CE]<H4Y._>_B]$ [J;4\47X2X*8@.%N69XT)96)<J
M$6$/<UU>.S.ZF2%&HC>-X!NB.-EVM0= 7,#D%)_P9>G6Z>;G,T123R[519Q%
M29/+018^D(_>S 1LP^!4WUS(HBYZR '2$]/N3%<JNO^V^THF,%&-AI^Y:I/I
M7]A9'/_LX!>!=0$11+F-VTN3+?G%]3/1^2W?@ZIS=_"E14P)C9WG>5JLZ^XH
MF+B)A+Y\"2T<4E ?QE7<''0&_VQ?3MA8QR>= &956B/86Q_$@,;YOCS)-<Z=
MGQ_HV'T1N0*XMV>E,X%V%G-(KZ\*FJ=E>ROXA-_E5E=I])<G5(F/$"%7D6-(
M3X0^4TT2.MA@L#KF2:;2NQ[7V,7EZRG[H-KUF=JR/)'^O*JQY6X1N2Y$#SZ*
M<+N]!8JF)3$/R<M92CX1"MEG$IG[.EM1KE$_A$F0L!F[VH]9H6E$!QF@.16%
M/'T::V#=]L[Y)E[*<PE.0=(O=]2J^.2T#4NB4]Q8C_FH_*",4QJMQL&;*;P5
M@3\UF71$70Q -4'O)^N(7I^OD4U\,"N@)F3(1$(3*,2;/6PO,%*#++CP6_7G
M[TZ6@**(2*>NGCIOC)DA99&<T(K$#NT]PF.W%2D3ONWK- $G '/'@)FK0Q95
MR4U8W!?3O,T8HGYUC,&7XZ\,?$ <*ZMQ*Q8'=@Q($RZ+D8,SFGCZ_?D:6#.(
MS-*'^,9(9E/D3 P"X;,Y< 8WXX?PRCU?^)-ZOL.<8A57NA0X?7Z0Q>37&]X&
M7AGPQL>HB^N,T55ABT.+YO>J:NR[&*)CZ"]UA?ND>%O7W5:1^%2-D*;8Y&5]
MC"E=DL^@FFIF\'.<>"M]!+2UIAX=6J?P>OUNG,7B5TFT*4;$Y5XPQPM5U\Z&
M+L2OQZ<[9L7RW/ASS9 K>T/PN52X%F;S3+-&]E1F(U.&O9#MP4/I?@-&WGJ[
MG7J;/-F<P6SU!S_+3\M#W?ZO"2/.4$WBV@J)F9VBB5JG-&,@QW>Y_B-=A: X
M*=D70PXN0N^92!]RMA.K>H$2"7#@HJ\C]2+-"*U3\___8U7>UUH%-WSDE^V?
M!'MQA*!21@F&E,S>C"1>0%(^C6S$+<#_T;#K&;4 'J'8E/V=2J(;B'L)/WK
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MZ<S0/_XECU(2V@)[)(L,QN[ORU!B-?ZNPFL$7XZ#3U$9Z-WZ,O(?A6NR T\
MT39=D-SFD!. [Q&RGXSXCWI+("KZ.&Y3WS</?#*8\L78H!;>* 1?-"=06=6L
M$G1\?60.5'5(2NV+ FTVGP!4Q?*GT;.QZ)U[,)73\XY ,J,=T42%%,9.L#P&
M2JB0CX[1PT2;@\#/*X0+^+L/A^NBYE(U]73?Q-B_ ="1Q)#8$P#+6V="<K,L
M*N+V)-L/6^D,A%(T'7 %XB_[,]DU?<TCR7?1FKM6+8TVPR%OK?45\,?%ZE*U
MNX;M_5@ILSU#H@U1N"<!6.;8;!WQ,:=_\VOTVI6SH+.7O>MAU"<]/TG^+N7K
M.E<'NNPFM_J.]"Q#XW9QD V=HUBFJU '>.:]M9.N:Y4MYPH06G;^9<_C%_?5
M5D57\.^7U.L6!(8/[NWJW58J:F^#X/3H.Q8(K'/Y+^&^0I]YXU2(HE 7)DI0
MQ1$&!Z%HL/N#-A2HTRR+%J)&??$J*- ?$ O,.<-3ISEAP$Y6)5A?Y5==I1->
MTTVP_VGQ7("(?_3TE#LR69&>VL^O<4+DX +XW@_1]6*I)8T+M@Y;?:FMO;HM
M,XHJVS=8M"%TOB].U5,;Z>T)($9N 4T$4%_:'SG,[+X?[E_;?!W4<. 1("@)
MI@VRA,\BJ(+E[<RY$T 5E93%JY$_\E<0_W95K ="; 7C03T']_XC16O ::VK
M[Z++"()P BD)266'-2H[J%LBL_+_I:VH!TCL!>D=I8PA9OL&$%_TR+28W7%(
M?ZI/]0JI]H@2G!!'1B>LL1(&B"XP4:I],2 J>49RW-HI[[4-*K/Q]Z]\_3Q4
M04+XZYG5"W[=F%8XC@J3@0A<#$QT4-X>RDA$,TY[R=S)0)3^UG/QBPG!4X@&
MJ7&C!Z\"V<NI$,]7!M28T+9WJ'BX31!P;&6ZCVE%,SE8'658C1;$1?KI5-YN
MV ,<"0$WI6'^1"W8Z8I7-7ZRC4<@$B+;!1T-Z"QK'T\_*QRRU_7=,9]K69&;
MI#+JQ^89:@I]EMQ1%].VUI*28I_&'I(FEVN^0,XT:L-M??291UZQ3;J;?!7Q
M8MC!LKPJ!,X2<T\)^)D7E9?&)E7"W.*A06%:];Q6M*8=P8,=!&F<EI.DDB]3
M$(5MW>Q!;; 5)J2H+NRT7,?=XFO5P&WU-S24ZD+?J$+C^M&(G&?7MN,UO*ZR
M> BHGBU%72<(=L^A/^PQT?^9I=<4[!+]ZYVE7RN@^M R7G$1HP)A^ERP/AIG
MMG&<)$6.$SB-Z?,C0(F,)#"A9#9"O#6-IVHP>V"?U=U_":T+CU&.\#=Q>L;'
MU%2WOE#EGT6 XJ/:%+GCQ07>D[7>!/I:6(O3^TF4 MO0CT&SW["<=]RP08<(
MQJ(B?06;9VG&M0\Y=L4R"ZM#(XE6UGWD]T9$$P?>K#NRA2JFJ&78;ZYP$?T#
M-_A/&.8$P#A^FB9/45:&PI!PNM$5_(Y$M5F(&U03<U&#PGH\K:KZ0NWAN7K8
MRD&;4/<6U>GZ@,;+87V=X@3WOC;$$7X C7N#GH-DH,N$FLF0.4@#DI9@8*9J
M.5(^QA\Y9Q[;\]C(]KI%L!F'@<8L(C3M*B'6.;]Q+NJ*(53'5D;,UCN^U$%"
M%91T_+ KY3KS1U,KU]<E%?BKNFOYQJ81Q00C78B"C$_BS$T<)76^D)&H/+(Q
M/RQ5NVHTLSQJ\37F <?-$T":Z.[D A/I&E8WZF4-BF"/-.K+KF77Y#.RCGSE
M#W(6?/',?])))S(S#;SJ7DAE-EG3T:Q<TV;+[(F_AL"N3G-49K-*_(8#L";,
M0H">\'F;H,T*ZBA8JSS^'>T<?:.W^F''6L&E"Z\\] &1\R7-\] YI*R/W\6*
MG$'D5A^\A10^@C9'1"9I/(!=.72.C#&R8RN]N"!_YNYVCP&"T'S@0TB8I:<5
M)SV9]75]7ASN$+.C(?26CZ>0-R"?D$0>^MG)U14>^6,@B*ZX@V^P7G5%+Z&5
MA7("( @A[I0BQF-!Y^IH\.=:0 PP3=MY)@:[*B[E_'?C:M_?.7 NW?"635MK
M^/@'4@XILVG[IJA(NC50]ZI$Q1XNN&[_=)17O=DEF/$B_!-N]IH6QB0%LY#=
M+FIZK6]!)F(6AXV1XMA/+B]E:Y>X]*F 18C(5_7N-?HI?#8.Y4&Z#6+9FCZ
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M#]L>_8&D&X%(UZ*:BJ=NC\ \"LR::P7N;/)6O5:0D8A%P P&@1=/ %;(H!/
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M87&\$!W<=?;AR$696_*!-]8#J&"F2SHM[5+;@DU%GP"XD,4_$BTLGTJM*<2
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MJ8=*6^*:V3-WJ*3B! E&H7I)<.$H5<S16>$^;H)=KO6,KT^:^7K1R%F3L-*
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M>F%LAJFK$]"X10I53M+<&CY01&*BV/T5!(OIR!_#LUCG'S=;#JDW]%CZI\
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MR[F<R[F<RW]O^6>V(2$A)R[S;\_AA82 \*^<@@3_Q (0_Y$':)X3L/X]_YJ
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MPV;_%.Z]3Q& 32G=PG@%#K#5Q0$JK=K[<3@@.H_PE!MV0KD!?0W%J(&GZ'#
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M8+^\Q31E%@@%J4>4W VB2_<0&F<^SILE0+D'/0[H8X!MHD9PP&V>/) C--
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M!<B"#C/H)S26V\(EI3B<@\F=T>#2[2_OM2Y+7KFP"PHLX:PT2$L6=?G2 D&
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MS56P0$"[P* 0X@=H[4]QT@VE4YO2 5'A58*21ZD_?"];39!LJ8'3*7A?XH"
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M\=PM5E&>"*L,)D^2J/"/3%]%-7C3C5:!H'LXX+(JMA2$U1RNPEQCPP&#RO@
MB.7DI^ZTQF)A#O,I\\22:67+U6G77Y+F>OJKG :LD0FOL7NZ+\W]/D.>#-?[
MZD['+89LVVN[V<]E!9Y2FC%@/]51F$&NV(<ZJ $RF2 B-]WY/=:U68+]AJVC
M99&IM4\0%@5PA<N'$+FFFIK1BC6P8Z#8A=N5%(]N,U)\+[-^J4(4&G V<D9\
M[;AIY61B47?; <FZY-&52^RTOJ3HY"[5RFC2[,C#$F N-)C]Y4FY1GKQC#?K
M<V5>[]#$>P:B#*?DI[08?+05<8@GYN!NB7[>II):EI"W(TIK+LVPV2]</-@
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MD=LCPH#VZ(1Q8/Q6]!M.(,\.6?L.MEGO-B8,"P3*!V^5AGRA*]-JU)9\?YM
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M0P3\W2$D_E7&<88MR"O/&E#&"+2[!>_"E8_U=;6UZ4JS'%//NVT'.KEZIV=
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M9M+^1F>J?JHQF]=0;+A=AK/MM1%V4LC"H8K/FSIL/Z/@I)]R-=\Z[&ZJ.H1
M5W#WM\BXEH#"?)!R[V5;8\I A8POE;Z2.B.; Z.%=4W#Q$_Q5X?41#E5@7/+
M[$A(>IY3)[',$9U</G:<CY3+S6:>TR!G<-L)DZ:9G%%/N+YNM/.JT*^;H";
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M'-J=-#!!'6]MB?]="'!*N7AOFQC#CK</D2NA;D?U"S[-DQCDIF9MF5_[Y_T
M;37/)_Q,?C0[XA_*)&MS-<?&"\+-6U&T IWU=66)U&)+[2MS\%D33]/>8&M/
MIYJ#ISR6KG.O)'?TY1V&_2H#"=%Q:O3#='P4IAS 9)<)A,07Z\DA(Y&#3+B
M# G"Q1"=KQK9<P+%J5A[+'8E3\X_7=T8LD0W'Q=3)I&U2889]("D<[!+E/"
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M,RYH=&U02P$"% ,4    " #H2==6:3^AEIT#  "J$   $0
M@ 'S) $ 87!Y>"TR,#(S,#8R,RYX<V102P$"% ,4    " #H2==6Y.BI.SP#
M   %#P  %0              @ &_* $ 87!Y>"TR,#(S,#8R,U]D968N>&UL
M4$L! A0#%     @ Z$G75FRV2"!F$0$ 3#P! !0              ( !+BP!
M &%P>7@M,C R,S V,C-?9S$N:G!G4$L! A0#%     @ Z$G75F9TIO<JA
M2N   !0              ( !QCT" &%P>7@M,C R,S V,C-?9S(N:G!G4$L!
M A0#%     @ Z$G75H'T-5DZ!   "B(  !4              ( !(L(" &%P
M>7@M,C R,S V,C-?;&%B+GAM;%!+ 0(4 Q0    ( .A)UU:A8E&V-P,  +$4
M   5              "  8_& @!A<'EX+3(P,C,P-C(S7W!R92YX;6Q02P4&
2      < !P#+ 0  ^<D"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
